Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl) cyclopropanamine, its crystalline form and its salts .

Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl) cyclopropanamine, its crystalline form and its salts

Номер патента: WO2016179123A1
Опубликовано: 10-11-2016
Автор(ы): Changren YAN, Guoqing Paul Chen
Принадлежит: Advenchen Pharmaceuticals, LLC
Получить PDF файл: Открыть в новом окне

Рисунок 1. Взаимосвязь патентов (ближайшие 20).

An anti-cancer agent 1-((4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl) cyclopropanamine, its crystalline form and its salts

Номер патента: EP3291814B1. Автор: Guoqing Paul Chen,Changren YAN. Владелец: Advenchen Pharmaceuticals LLC. Дата публикации: 2024-07-10.

Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts

Номер патента: TW201639830A. Автор: 國慶保羅陳,昌仁顏. Владелец: 愛德程醫藥有限公司. Дата публикации: 2016-11-16.

Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl) cyclopropanamine, its crystalline form and its salts

Номер патента: CA2984444A1. Автор: Guoqing Paul Chen,Changren YAN. Владелец: Advenchen Pharmaceuticals LLC. Дата публикации: 2016-11-10.

Process for preparing an anti-cancer agent, 1-((4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl) cyclopropanamine, its crystalline form and its salts

Номер патента: AU2016257816A1. Автор: Guoqing Paul Chen,Changren YAN. Владелец: Advenchen Pharmaceuticals LLC. Дата публикации: 2017-12-14.

PROCESS FOR PREPARING AN ANTI-CANCER AGENT, 1-((4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-6-METHOXYQUINOLIN-7-YLOXY)METHYL)CYCLOPROPANAMINE, ITS CRYSTALLINE FORM AND ITS SALTS

Номер патента: US20180002311A1. Автор: Chen Guoqing Paul,Yan Changren. Владелец: . Дата публикации: 2018-01-04.

Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts

Номер патента: US9751859B2. Автор: Guoqing Paul Chen,Changren YAN. Владелец: Advenchen Pharmaceuticals LLC. Дата публикации: 2017-09-05.

Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts

Номер патента: US10544125B2. Автор: Guoqing Paul Chen,Changren YAN. Владелец: Advenchen Pharmaceuticals LLC. Дата публикации: 2020-01-28.

Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts

Номер патента: US10100034B2. Автор: Guoqing Paul Chen,Changren YAN. Владелец: Advenchen Pharmaceuticals LLC. Дата публикации: 2018-10-16.

PROCESS FOR PREPARING AN ANTI-CANCER AGENT, 1-((4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-6-METHOXYQUINOLIN-7-YLOXY)METHYL)CYCLOPROPANAMINE, ITS CRYSTALLINE FORM AND ITS SALTS

Номер патента: US20190002435A1. Автор: Chen Guoqing Paul,Yan Changren. Владелец: . Дата публикации: 2019-01-03.

Process for preparing an anti-cancer agent, 1-((4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts

Номер патента: US20160326138A1. Автор: Chen Guoqing Paul,Yan Changren. Владелец: . Дата публикации: 2016-11-10.

Treatment of lung cancer using a combination of an anti-pd-1 antibody and another anti-cancer agent

Номер патента: CA2949121A1. Автор: David FELTQUATE,Allen C. CHEN. Владелец: Bristol Myers Squibb Co. Дата публикации: 2015-11-19.

Methods of treating cancer using tigit inhibitors and anti-cancer agents

Номер патента: US20230226180A1. Автор: Jane L. Grogan. Владелец: Genentech Inc. Дата публикации: 2023-07-20.

Methods of treating cancer using tigit inhibitors and anti-cancer agents

Номер патента: US20240082396A1. Автор: Jane L. Grogan. Владелец: Genentech Inc. Дата публикации: 2024-03-14.

Methods of reversing cachexia and prolonging survival comprising administering a gdf15 modulator and an anti-cancer agent

Номер патента: US20230295285A1. Автор: Jie Lin,Jeno Gyuris,Lorena Lerner. Владелец: Aveo Pharmaceuticals Inc. Дата публикации: 2023-09-21.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: WO2012010551A1. Автор: Herbert Andres,Johann Karl,Gregory D. Plowman,Sanne Lysbet De Haas,Stefan Scherer,Rebecca Elliott,Norbert Wild,Gloria Meng. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2012-01-26.

METHODS OF REVERSING CACHEXIA AND PROLONGING SURVIVAL COMPRISING ADMINISTERING A GDF15 MODULATOR AND AN ANTI-CANCER AGENT

Номер патента: US20190292253A1. Автор: Lin Jie,Lerner Lorena,Gyuris Jeno. Владелец: . Дата публикации: 2019-09-26.

METHODS OF REVERSING CACHEXIA AND PROLONGING SURVIVAL COMPRISING ADMINISTERING A GDF15 MODULATOR AND AN ANTI-CANCER AGENT

Номер патента: US20170306008A1. Автор: Lin Jie,Lerner Lorena,Gyuris Jeno. Владелец: . Дата публикации: 2017-10-26.

Methods of reversing cachexia and prolonging survival comprising administering a gdf15 modulator and an anti-cancer agent

Номер патента: PT3197493T. Автор: . Владелец: Aveo Pharmaceuticals Inc. Дата публикации: 2021-06-04.

Methods of reversing cachexia and prolonging survival comprising administering a gdf15 modulator and an anti-cancer agent

Номер патента: HUE054670T2. Автор: Jie Lin,Jeno Gyuris,Lorena Lerner. Владелец: Aveo Pharmaceuticals Inc. Дата публикации: 2021-09-28.

Antibody-Linker-Drug Conjugates, Process for Preparing the Same and Anti-cancer Agents Comprising the Same

Номер патента: KR101597110B1. Автор: 김준우,이진서,이상엽,이종협,박성준,김경석,박영준,정진교,최영미,이민섭,최준헌,조은주,송현남,이인숙,홍승서,김연정. Владелец: (주)셀트리온. Дата публикации: 2016-02-25.

Antibody-Linker-Drug Conjugates, Process for Preparing the Same and Anti-cancer Agents Comprising the Same

Номер патента: KR101597105B1. Автор: 김준우,이진서,이상엽,이종협,박성준,김경석,박영준,정진교,최영미,이민섭,최준헌,조은주,송현남,이인숙,홍승서,김연정. Владелец: (주)셀트리온. Дата публикации: 2016-02-25.

Antibody-Linker-Drug Conjugates, Process for Preparing the Same and Anti-cancer Agents Comprising the Same

Номер патента: KR101597101B1. Автор: 김준우,이진서,이상엽,이종협,박성준,김경석,박영준,정진교,최영미,이민섭,최준헌,조은주,송현남,이인숙,홍승서,김연정. Владелец: (주)셀트리온. Дата публикации: 2016-02-25.

Antibody-Linker-Drug Conjugates, Process for Preparing the Same and Anti-cancer Agents Comprising the Same

Номер патента: KR20140088841A. Автор: 김준우,이진서,이상엽,이종협,박성준,김경석,박영준,정진교,최영미,이민섭,최준헌,조은주,송현남,이인숙,홍승서,김연정. Владелец: (주)셀트리온. Дата публикации: 2014-07-11.

USE OF ANTIBODIES AGAINST ICAM-1 IN COMBINATION WITH AN ANTI CANCER DRUG IN THE TREATMENT OF PATIENTS

Номер патента: US20180221482A1. Автор: Frendeus Bjorn,Hansson Markus. Владелец: BIOINVENT INTERNATIONAL AB. Дата публикации: 2018-08-09.

Treatment of lung cancer using a combination of an anti-pd-1 antibody and another anti-cancer agent.

Номер патента: MX2016014753A. Автор: FELTQUATE David,C Chen Allen. Владелец: Bristol Myers Squibb Co. Дата публикации: 2017-03-06.

Anti-fugetactic agent and anti-cancer agent combination therapy and compositions for the treatment of cancer.

Номер патента: MX2017013668A. Автор: Reeves Patrick,C Poznansky Mark. Владелец: Massachusetts Gen Hospital. Дата публикации: 2018-07-06.

ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND COMPOSITIONS FOR THE TREATMENT OF CANCER

Номер патента: US20200093928A1. Автор: Poznansky Mark C.,Reeves Patrick. Владелец: . Дата публикации: 2020-03-26.

ANTI-FUGETACTIC AGENT AND ANTI-CANCER AGENT COMBINATION THERAPY AND COMPOSITIONS FOR THE TREATMENT OF CANCER

Номер патента: US20180117155A1. Автор: Poznansky Mark C.,Reeves Patrick. Владелец: . Дата публикации: 2018-05-03.

PHARMACEUTICAL COMPOSITION COMPRISING TGFbetaRII AND ANOTHER ANTI-CANCER AGENT

Номер патента: IL264730B2. Автор: Kin-Ming Lo,Yan Lan. Владелец: Lo Kin Ming. Дата публикации: 2024-09-01.

METHODS OF INCREASING DELIVERY OF ANTI-CANCER AGENTS TO TARGETS

Номер патента: US20180002441A1. Автор: Nicodemus Christopher F.,Madiyalakan Ragupathy,Hollingsworth Michael A. Владелец: . Дата публикации: 2018-01-04.

COMBINATIONS OF IRS/STAT3 DUAL MODULATORS AND ANTI-CANCER AGENTS FOR TREATING CANCER

Номер патента: US20180028475A1. Автор: Haviv Izhak,REUVENI Hadas,KUPERSHMIDT Lana. Владелец: TYRNOVO LTD.. Дата публикации: 2018-02-01.

BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICROENVIRONMENT

Номер патента: US20220047620A1. Автор: Bose Nandita,Qiu Xiaohong,GORDEN Keith,FULTON Ross,GRAFF Jeremy,CHAN Anissa SH.,LEONARDO Steven,KANGAS Takashi,FRASER Kathryn A.,BYKOWSKI JONAS Adria,OTTOSON Nadine. Владелец: . Дата публикации: 2022-02-17.

BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICROENVIRONMENT

Номер патента: US20190060351A1. Автор: Bose Nandita,Qiu Xiaohong,GORDEN Keith,FULTON Ross,GRAFF Jeremy,CHAN Anissa SH.,LEONARDO Steven,KANGAS Takashi,FRASER Kathryn A.,BYKOWSKI JONAS Adria,OTTOSON Nadine. Владелец: . Дата публикации: 2019-02-28.

TREATMENT OF RENAL CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT

Номер патента: US20170088626A1. Автор: Jure-Kunkel Maria,GAGNIER Paul,FELTQUATE David. Владелец: BRISTOL-MYERS SQUIBB COMPANY. Дата публикации: 2017-03-30.

Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironment

Номер патента: US20170100425A1. Автор: Xiaohong Qiu,Nandita BOSE,Keith GORDEN,Anissa SH. CHAN,Steven LEONARDO,Jeremy Graff,Takashi KANGAS,Kathryn A. FRASER,Adria BYKOWSKI JONAS,Nadine OTTOSON. Владелец: Biothera Inc. Дата публикации: 2017-04-13.

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

Номер патента: US20170143825A1. Автор: GROGAN Jane L.. Владелец: . Дата публикации: 2017-05-25.

TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT

Номер патента: US20170158776A1. Автор: FELTQUATE David,CHEN Allen C.. Владелец: BRISTOL-MYERS SQUIBB COMPANY. Дата публикации: 2017-06-08.

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

Номер патента: US20180169239A1. Автор: GROGAN Jane L.. Владелец: . Дата публикации: 2018-06-21.

Combinations of irs/stat3 dual modulators and anti-cancer agents for treating cancer

Номер патента: US20210220297A1. Автор: Hadas Reuveni,Lana Kupershmidt,Izhak Haviv. Владелец: TyrNovo Ltd. Дата публикации: 2021-07-22.

TREATMENT OF RENAL CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT

Номер патента: US20190263923A1. Автор: Jure-Kunkel Maria,GAGNIER Paul,FELTQUATE David. Владелец: BRISTOL-MYERS SQUIBB COMPANY. Дата публикации: 2019-08-29.

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

Номер патента: US20200289647A1. Автор: GROGAN Jane L.. Владелец: . Дата публикации: 2020-09-17.

TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT

Номер патента: US20180319892A1. Автор: FELTQUATE David,CHEN Allen C.. Владелец: BRISTOL-MYERS SQUIBB COMPANY. Дата публикации: 2018-11-08.

Methods of increasing delivery of anti-cancer agents to targets

Номер патента: WO2016112466A1. Автор: Ragupathy Madiyalakan,Christopher F. Nicodemus,Michael A. Hollingsworth. Владелец: Oncoquest Inc.. Дата публикации: 2016-07-21.

Anti-cancer Agent Comprising Anti-Glypican 3 Antibody

Номер патента: KR100953520B1. Автор: 히로유키 아브라타니,테츠오 나카무라,마사유키 츠치야. Владелец: 츄가이 세이야꾸 가부시키가이샤. Дата публикации: 2010-04-21.

Treatment of lung cancer using a combination of an anti-pd-1 antibody and another anti-cancer agent

Номер патента: WO2015176033A1. Автор: David FELTQUATE,Allen C. CHEN. Владелец: BRISTOL-MYERS SQUIBB COMPANY. Дата публикации: 2015-11-19.

Treatment of lung cancer using a combination of an anti-pd-1 antibody and another anti-cancer agent

Номер патента: KR20170003692A. Автор: 데이빗 펠트퀘이트,앨런 씨. 첸. Владелец: 브리스톨-마이어스 스큅 컴퍼니. Дата публикации: 2017-01-09.

anti-lipid antibody-3, anti-cancer agent comprising the same, as well as its use and production process.

Номер патента: BRPI0617412A2. Автор: Gregory Alan Lazar,Masamichi Sugimoto,Izumi Sugo,Shigeyuki Iijima,Hisafumi Okabe,Bassil I Dahiyat. Владелец: Xencor Inc. Дата публикации: 2011-07-26.

Methods of treating cancer using tigit inhibitors and anti-cancer agents

Номер патента: CA2953245A1. Автор: Jane L. Grogan. Владелец: Genentech Inc. Дата публикации: 2016-01-21.

Anti-cancer agents and preparation thereof

Номер патента: CA2931111A1. Автор: Arun K. Ghosh. Владелец: PURDUE RESEARCH FOUNDATION. Дата публикации: 2015-05-28.

Pharmaceutical composition comprising the anti-4-1bb monoclonal antibody and chemotherapeutic anti-cancer agent for preventing and treating cancer disease

Номер патента: KR100745488B1. Автор: 권병세. Владелец: 학교법인 울산공업학원. Дата публикации: 2007-08-02.

Antagonists of Sema3E/PlexinD1 interaction as anti-cancer agents

Номер патента: AU2011249750A1. Автор: Sophie Chauvet,Jonathan Luchino,Fanny Mann,Amelie Royet. Владелец: Universite de la Mediterranee Aix Marseille II. Дата публикации: 2012-12-13.

Anti-cancer agents and preparation thereof

Номер патента: FI3071563T3. Автор: Arun K Ghosh. Владелец: PURDUE RESEARCH FOUNDATION. Дата публикации: 2023-05-29.

Anti-cancer agent comprising an iNKT ligand and anti-PD-1 antibody or anti-PD-L1 antibody

Номер патента: EP2172219B1. Автор: Ji Yeon Kim,Chang Yuil Kang,Woo Sung Chang. Владелец: SNU R&DB FOUNDATION. Дата публикации: 2013-09-11.

Combinations of IRS/Stat3 dual modulators and anti-cancer agents for treating cancer

Номер патента: US10912745B2. Автор: Hadas Reuveni,Lana Kupershmidt,Izhak Haviv. Владелец: TyrNovo Ltd. Дата публикации: 2021-02-09.

Antagonists of sema3e/plexind1 interaction as anti-cancer agents

Номер патента: WO2011138449A3. Автор: Sophie Chauvet,Jonathan Luchino,Fanny Mann,Amelie Royet. Владелец: NETRIS PHARMA. Дата публикации: 2015-07-30.

Combinations of irs/stat3 dual modulators and anti-cancer agents for treating cancer

Номер патента: AU2020250235A1. Автор: Hadas Reuveni,Lana Kupershmidt,Izhak Haviv. Владелец: TyrNovo Ltd. Дата публикации: 2020-11-05.

Pharmaceutical composition comprising tgfbetarii and another anti-cancer agent

Номер патента: IL264730A. Автор: Kin-Ming Lo,Yan Lan. Владелец: Lo Kin Ming. Дата публикации: 2019-03-31.

PHARMACEUTICAL COMPOSITION COMPRISING TGFbetaRII AND ANOTHER ANTI-CANCER AGENT

Номер патента: IL264730B1. Автор: Kin-Ming Lo,Yan Lan. Владелец: Lo Kin Ming. Дата публикации: 2024-05-01.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: US20130336960A1. Автор: Herbert Andres,Johann Karl,Gregory D. Plowman,Sanne Lysbet De Haas,Stefan Scherer,Rebecca Elliott,Yu-Ju Gloria Meng,Norbert Wild. Владелец: Genentech Inc. Дата публикации: 2013-12-19.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: US20140017231A1. Автор: Herbert Andres,Johann Karl,Gregory D. Plowman,Sanne Lysbet De Haas,Stefan Scherer,Rebecca Elliott,Yu-Ju Gloria Meng,Norbert Wild. Владелец: Genentech Inc. Дата публикации: 2014-01-16.

METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY

Номер патента: US20140193397A1. Автор: Scherer Stefan,ANDRES Herbert,De Haas Sanne Lysbet,Karl Johann,Wild Norbert,Elliott Rebecca,Meng Yu-Ju Gloria,Plowman Gregory D.. Владелец: . Дата публикации: 2014-07-10.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: EP2596358A1. Автор: Herbert Andres,Johann Karl,Gregory D. Plowman,Sanne Lysbet De Haas,Stefan Scherer,Rebecca Elliott,Yu-Ju Gloria Meng,Norbert Wild. Владелец: F Hoffmann La Roche AG. Дата публикации: 2013-05-29.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: EP2801826A1. Автор: Herbert Andres,Johann Karl,Sanne Lysbet De Haas,Stefan Scherer,Rebecca Elliott,Yu-Ju Gloria Meng,Norbert Wild,Gregory D. Plowmann. Владелец: F Hoffmann La Roche AG. Дата публикации: 2014-11-12.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: EP2824457A1. Автор: Herbert Andres,Johann Karl,Sanne Lysbet De Haas,Stefan Scherer,Norbert Wild. Владелец: F Hoffmann La Roche AG. Дата публикации: 2015-01-14.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: WO2012010548A1. Автор: Herbert Andres,Johann Karl,Gregory D. Plowman,Sanne Lysbet De Haas,Stefan Scherer,Rebecca Elliott,Norbert Wild,Gloria Meng. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2012-01-26.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: EP2848939A1. Автор: Herbert Andres,Johann Karl,Gregory Plowman,Sanne Lysbet De Haas,Stefan Scherer,Rebecca Elliott,Norbert Wild,Yu-Ju Meng. Владелец: F Hoffmann La Roche AG. Дата публикации: 2015-03-18.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: WO2012010547A1. Автор: Herbert Andres,Johann Karl,Gregory D. Plowman,Sanne Lysbet De Haas,Stefan Scherer,Rebecca Elliott,Norbert Wild,Gloria Meng. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2012-01-26.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: WO2012010550A1. Автор: Herbert Andres,Johann Karl,Gregory D. Plowman,Sanne Lysbet De Haas,Stefan Scherer,Rebecca Elliott,Norbert Wild,Gloria Meng. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2012-01-26.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: EP2866032A1. Автор: Herbert Andres,Johann Karl,Gregory Plowman,Sanne Lysbet De Haas,Stefan Scherer,Rebecca Elliott,Norbert Wild,Yu-Ju Meng. Владелец: F Hoffmann La Roche AG. Дата публикации: 2015-04-29.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: HK1216039A1. Автор: ．卡爾,．安德烈斯,．德哈斯,．謝勒,．懷爾德. Владелец: Hoffmann La Roche. Дата публикации: 2016-10-07.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: CN104634971A. Автор: J·卡尔,H·安德烈斯,S·谢勒,R·埃利奥特,S·L·德哈斯,N·怀尔德,G·D·普洛曼,Y－J·G·孟. Владелец: F Hoffmann La Roche AG. Дата публикации: 2015-05-20.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: CA2805708A1. Автор: Herbert Andres,Johann Karl,Gregory D. Plowman,Sanne Lysbet De Haas,Stefan Scherer,Rebecca Elliott,Yu-Ju Gloria Meng,Norbert Wild. Владелец: F Hoffmann La Roche AG. Дата публикации: 2012-01-26.

Methods of inducing an anti-cancer immune response

Номер патента: WO2020150434A1. Автор: Charles D. Smith,Lynn W. Maines. Владелец: APOGEE BIOTECHNOLOGY CORPORATION. Дата публикации: 2020-07-23.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: AU2011281702A1. Автор: Herbert Andres,Johann Karl,Gregory D. Plowman,Sanne Lysbet De Haas,Stefan Scherer,Rebecca Elliott,Yu-Ju Gloria Meng,Norbert Wild. Владелец: F Hoffmann La Roche AG. Дата публикации: 2013-01-31.

Method for Overcoming Tolerance to Targeted Anti-Cancer Agent

Номер патента: US20140341922A1. Автор: LEE Ho Young. Владелец: . Дата публикации: 2014-11-20.

Method for overcoming resistance to anti-cancer agents

Номер патента: KR101470700B1. Автор: 이호영. Владелец: 서울대학교산학협력단. Дата публикации: 2014-12-12.

Method of delivering an anti-cancer agent to a cell

Номер патента: EP2214715A1. Автор: Jackie Y. Ying,Motoichi Kurisawa,Joo Eun Chung. Владелец: Agency for Science Technology and Research Singapore. Дата публикации: 2010-08-11.

Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof

Номер патента: EP3823674A1. Автор: Stephen B. Kahl,Constance McKee. Владелец: Manzanita Pharmaceuticals Inc. Дата публикации: 2021-05-26.

Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof

Номер патента: CA3105879A1. Автор: Stephen B. Kahl,Constance McKee. Владелец: Manzanita Pharmaceuticals Inc. Дата публикации: 2020-01-23.

Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof

Номер патента: US11897928B2. Автор: Constance A. McKee,Stephen B. Kahl. Владелец: Manzanita Pharmaceuticals Inc. Дата публикации: 2024-02-13.

Anti-cancer agents

Номер патента: US20140200250A1. Автор: Yibin Wang,Wenbing Chen,Sheng CAO,Xiaohua Peng,Yunyan Kuang. Владелец: UWM Research Foundation Inc. Дата публикации: 2014-07-17.

Methods of preventing and/or treating side effects associated with anti-cancer agents using non-naturally occurring melanocortin analogs with anti-gdf-15 antibodies

Номер патента: WO2024173905A1. Автор: Russell Potterfield. Владелец: Endevica Bio, Inc.. Дата публикации: 2024-08-22.

Anti-cancer agent comprising anti-HB-EGF antibody as active ingredient

Номер патента: US9023993B2. Автор: Naoki Kimura. Владелец: Chugai Pharmaceutical Co Ltd. Дата публикации: 2015-05-05.

Compositions and methods for treating cancer resistant to an anti-cancer agent

Номер патента: WO2019220441A8. Автор: Simon Benita,Taher Nassar,Riki Perlman,Ihab Abd-Elrahman,Dina Ben Yehuda,Boaz Nachmias. Владелец: HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD.. Дата публикации: 2020-01-23.

Anti-cancer agent comprising a tumour homing peptide having arsenic bonded to cysteine residues

Номер патента: US11819489B2. Автор: Carolyn Therese DILLON,Judith Anne CARRALL. Владелец: University of Wollongong. Дата публикации: 2023-11-21.

Anti-cancer agent

Номер патента: NZ761556A. Автор: Carolyn Therese DILLON,Judith Anne CARRALL. Владелец: Univ Wollongong. Дата публикации: 2024-02-23.

Imatinib dichloroacetate and anti-cancer agent comprising the same

Номер патента: EP2519518A2. Автор: Young Jun Park,Joon Woo Kim,Kyoung Soo Kim,Hyun-Nam Song. Владелец: Celltrion Chemical Research Institute. Дата публикации: 2012-11-07.

An anti-cancer cytotoxic monoclonal antibody

Номер патента: WO2009094751A8. Автор: David S. F. Young,Helen P. Findlay,Susan E. Hahn,Lisa A. Popp. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2010-04-01.

Compositions for treating a hyperproliferative disorder with a gsh synthesis inhibitor and an anti-cancer composition

Номер патента: EP4188357A1. Автор: Somya KAPOOR,Michael K. Schultz,Douglas R. Spitz. Владелец: University of Iowa Research Foundation UIRF. Дата публикации: 2023-06-07.

A recombinant protein having an anti-cancer effect, its encoding gene and uses thereof

Номер патента: CA2544473C. Автор: Bing Zhu. Владелец: Beijing Sunbio Biotech Co Ltd. Дата публикации: 2013-08-13.

Agent intensifying action of anti-cancer agents

Номер патента: RU2589713C2. Автор: Хиденори ФУДЗИТА,Масанори КАТО. Владелец: Тайхо Фармасьютикал Ко., Лтд.. Дата публикации: 2016-07-10.

Anti-cancer agent

Номер патента: EP2080512A4. Автор: Nobufumi Ono. Владелец: Wan Station Co Ltd. Дата публикации: 2011-02-16.

Anti-cancer agent

Номер патента: US20100137419A1. Автор: Nobufumi Ono. Владелец: Wan Station Co Ltd. Дата публикации: 2010-06-03.

Aryl imidazoles and their use as anti-cancer agents

Номер патента: US10080739B2. Автор: Aiping H. Young,Mario Huesca,Raed Al-Qawasmeh,Yoon Lee,Lisa Lock. Владелец: Aptose Bioscience Inc. Дата публикации: 2018-09-25.

Anti-cancer agents and preparation thereof

Номер патента: US11851441B2. Автор: Arun K. Ghosh. Владелец: PURDUE RESEARCH FOUNDATION. Дата публикации: 2023-12-26.

Anti-cancer agents and methods of use

Номер патента: US20150225426A1. Автор: Anthony J. Berdis. Владелец: CASE WESTERN RESERVE UNIVERSITY. Дата публикации: 2015-08-13.

Anti-cancer agents and methods of use

Номер патента: US09821173B2. Автор: Anthony J. Berdis. Владелец: CASE WESTERN RESERVE UNIVERSITY. Дата публикации: 2017-11-21.

Podocalyxin and tra-related antibody, methods of preparation and uses as an anti-cancer therapeutic agent

Номер патента: US20170328907A1. Автор: Edwin Saavedra Tan,An Mary HOLMQVIST,Mats Harald HOLMQVIST,Yawen JU,William Michael Schopperle,Youngbin TAK. Владелец: Curemeta Therapeutics LLC. Дата публикации: 2017-11-16.

Synthetic rigidin analogues as anti-cancer agents, salts, solvates and prodrugs thereof, and method of producing same

Номер патента: EP3240541A1. Автор: Snezna Rogelj,Igor MAGEDOV,Liliya V. FROLOVA,Alexander V. KORNIENKO. Владелец: New Mexico Tech Research Foundation. Дата публикации: 2017-11-08.

Synthetic rigidin analogues as anti-cancer agents, salts, solvates and prodrugs thereof, and method of producing same

Номер патента: WO2016109292A1. Автор: Snezna Rogelj,Igor MAGEDOV,Liliya V. FROLOVA,Alexander V. KORNIENKO. Владелец: New Mexico Tech Research Foundation. Дата публикации: 2016-07-07.

Azine-carboxamides as anti-cancer agent

Номер патента: CA2570169A1. Автор: Brian Aquila,Paul Lyne,Timothy Pontz,Stephanos Ioannidis. Владелец: Stephanos Ioannidis. Дата публикации: 2006-01-12.

EPIPODOPHYLLOTOXIN AMINOALKYLAMINOACETAMIDE (POLY) DERIVATIVES AND PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS AS ANTI-CANCER AGENT

Номер патента: FR2869035B1. Автор: Yves Guminski,Thierry Imbert,Jean Marc Barret,Anna Kruczynski. Владелец: Pierre Fabre Medicament SA. Дата публикации: 2006-07-14.

Nimbolide analogs as anti-cancer agents and preparation thereof

Номер патента: US10947249B2. Автор: KATRAGADDA Suresh Babu,SRIVARI Chandrasekhar,TOGAPUR Pavan Kumar,PRATHAMA Satyendra Mainkar,Debabrata Mukhopadhyay,Ummanni RAMESH,Boggavarapu Subrahmanya Sastry,Karre Nagaraju,Kanchanapally Tejaswini,Jerald Mahesh Kumar. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2021-03-16.

Nimbolide analogs as anti-cancer agents and preparation thereof

Номер патента: US11932654B2. Автор: KATRAGADDA Suresh Babu,SRIVARI Chandrasekhar,TOGAPUR Pavan Kumar,PRATHAMA Satyendra Mainkar,Debabrata Mukhopadhyay,Ummanni RAMESH,Boggavarapu Subrahmanya Sastry,Karre Nagaraju,Kanchanapally Tejaswini,Jerald Mahesh Kumar. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2024-03-19.

Benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent comprising the same

Номер патента: US11667661B2. Автор: Junghun KIM,Keumsoo SONG,Taisun Kim. Владелец: Biometrix Technology Inc. Дата публикации: 2023-06-06.

Method of delivering an anti-cancer agent to a cell

Номер патента: EP2214715A4. Автор: Jackie Y Ying,Motoichi Kurisawa,Joo Eun Chung. Владелец: Agency for Science Technology and Research Singapore. Дата публикации: 2014-09-10.

Use of il-13 receptor subunit alpha 2 as an anti-cancer vaccine

Номер патента: CA2480008C. Автор: Waldemar Debinski,Neil Christensen,Akiva Mintz. Владелец: PENN STATE RESEARCH FOUNDATION. Дата публикации: 2015-10-06.

Use of il-13 receptor subunit alpha 2 as an anti-cancer vaccine

Номер патента: CA2480008A1. Автор: Waldemar Debinski,Neil Christensen,Akiva Mintz. Владелец: Akiva Mintz. Дата публикации: 2003-11-13.

Nitrobenzyl derivatives of anti-cancer agents

Номер патента: CA2981494C. Автор: Mark Matteucci,Jian-Xin Duan,Hailong Jiao,Xiaohong Cai,Yeyu Cao,Jing Yuan MA. Владелец: OBI Pharma Inc. Дата публикации: 2023-09-05.

Nitrobenzyl derivatives of anti-cancer agents

Номер патента: MY198613A. Автор: Mark Matteucci,Jian-Xin Duan,Hailong Jiao,Xiaohong Cai,Yeyu Cao,Jing Yuan MA. Владелец: Ascenta Pharmaceuticals Ltd. Дата публикации: 2023-09-11.

Antagonists of Sema3E/PlexinD1 interaction as anti-cancer agents

Номер патента: US20130149306A1. Автор: Royet Amélie,Mann Fanny,Chauvet Sophie,Luchino Jonathan. Владелец: . Дата публикации: 2013-06-13.

COMBINATION CANCER THERAPY WITH ANTI-CANCER AGENTS AND ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN

Номер патента: US20200399377A1. Автор: Weidanz Jon. Владелец: . Дата публикации: 2020-12-24.

COMPOSITIONS AND METHODS FOR REGULATING EGFR AMPLIFICATION IN CANCER CELLS FOR IMPROVING EFFICACY OF EGFR-TARGETED ANTI-CANCER AGENTS

Номер патента: US20220411879A1. Автор: WHETSTINE Johnathan R.,Clarke Thomas L.. Владелец: . Дата публикации: 2022-12-29.

Nitrobenzyl derivatives of anti-cancer agents

Номер патента: AU2016244000A1. Автор: Mark Matteucci,Jian-Xin Duan,Hailong Jiao,Xiaohong Cai,Yeyu Cao,Jing Yuan MA. Владелец: OBI Pharma Inc. Дата публикации: 2017-10-12.

Nitrobenzyl Derivatives of Anti-Cancer Agents

Номер патента: KR102276681B1. Автор: 지엔신 두안,예위 차오,시아오홍 차이,하이롱 쟈오,장위엔 마,마크 마투치. Владелец: 아센타위츠 파마슈티컬즈 리미티드. Дата публикации: 2021-07-13.

Nitrobenzyl derivatives of anti-cancer agents

Номер патента: TWI730957B. Автор: 段建新,曹冶宇,蔡曉宏,海龍矯,靖原馬,馬克馬特西. Владелец: 大陸商深圳艾欣達偉醫藥科技有限公司. Дата публикации: 2021-06-21.

Compositions and methods for regulating egfr amplification in cancer cells for improving efficacy of egfr-targeted anti-cancer agents

Номер патента: US20220411879A1. Автор: Johnathan R. WHETSTINE,Thomas L. Clarke. Владелец: Institute for Cancer Research. Дата публикации: 2022-12-29.

Compositions and methods for regulating egfr amplification in cancer cells for improving egfr-targeted anti-cancer agent

Номер патента: EP4058604A4. Автор: Johnathan R. WHETSTINE,Thomas L. Clarke. Владелец: Institute for Cancer Research. Дата публикации: 2023-12-13.

Compositions and methods for regulating egfr amplification in cancer cells for improving egfr-targeted anti-cancer agent

Номер патента: EP4058604A1. Автор: Johnathan R. WHETSTINE,Thomas L. Clarke. Владелец: Institute for Cancer Research. Дата публикации: 2022-09-21.

Compositions and methods for regulating egfr amplification in cancer cells for improving egfr-targeted anti-cancer agent

Номер патента: CA3158438A1. Автор: Johnathan R. WHETSTINE,Thomas L. Clarke. Владелец: Institute for Cancer Research. Дата публикации: 2021-05-20.

Anthracene derivatives as anti-cancer agents

Номер патента: EP1087935A1. Автор: David John Mincher,Agnes Turnbull. Владелец: BTG International Ltd. Дата публикации: 2001-04-04.

Anthracene derivatives as anti-cancer agents

Номер патента: WO1999065866A1. Автор: David John Mincher,Agnes Turnbull. Владелец: BTG International Limited. Дата публикации: 1999-12-23.

4-((2-(2-(2-(4-methoxyphenyl)-4,5-diphenyl-1H-imidazol-1-yl)acetyl)hydrazono)methyl)benzoic acid as an anti-cancer compound

Номер патента: US11939299B1. Автор: Mai Mostafa Khalaf Ali,Hany Mohamed Abd El-Lateef Ahmed,Antar Ahmed Abdelhamid Ahmed,Adel A. Marzouk,Ehab S. Taher,Amira S. Wanas. Владелец: King Faisal University SA. Дата публикации: 2024-03-26.

5-((2-isopropyl-5-methylphenoxy)methyl)-3-(naphthalen-1-yl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound

Номер патента: US12049454B1. Автор: Amer A. Amer,Mai Mostafa Khalaf Ali,Hany Mohamed Abd El-Lateef Ahmed,Antar Ahmed Abdelhamid Ahmed. Владелец: King Faisal University SA. Дата публикации: 2024-07-30.

3-(2-(4-methoxypyridin-3-yl)-4,5-diphenyl-1H-imidazol-1-yl)-N,N-dimethylpropan-1-amine as an anti-cancer compound

Номер патента: US11905272B1. Автор: Mai Mostafa Khalaf Ali,Hany Mohamed Abd El-Lateef Ahmed,Antar Ahmed Abdelhamid Ahmed,Adel A. Marzouk. Владелец: King Faisal University SA. Дата публикации: 2024-02-20.

3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound

Номер патента: US11958814B1. Автор: Amer A. Amer,Mai Mostafa Khalaf Ali,Hany Mohamed Abd El-Lateef Ahmed,Antar Ahmed Abdelhamid Ahmed. Владелец: King Faisal University SA. Дата публикации: 2024-04-16.

5-((2-isopropyl-5-methylphenoxy)methyl)-3-(naphthalen-1-yl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound

Номер патента: US11970472B1. Автор: Amer A. Amer,Mai Mostafa Khalaf Ali,Hany Mohamed Abd El-Lateef Ahmed,Antar Ahmed Abdelhamid Ahmed. Владелец: King Faisal University SA. Дата публикации: 2024-04-30.

3-(3-chlorophenyl)-5-((2-isopropyl-5- methylphenoxy)methyl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound

Номер патента: US11919871B1. Автор: Amer A. Amer,Mai Mostafa Khalaf Ali,Hany Mohamed Abd El-Lateef Ahmed,Antar Ahmed Abdelhamid Ahmed. Владелец: King Faisal University SA. Дата публикации: 2024-03-05.

5-((2-isopropyl-5-methylphenoxy)methyl)-3-(naphthalen-2-yl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound

Номер патента: US11952354B1. Автор: Amer A. Amer,Mai Mostafa Khalaf Ali,Hany Mohamed Abd El-Lateef Ahmed,Antar Ahmed Abdelhamid Ahmed. Владелец: King Faisal University SA. Дата публикации: 2024-04-09.

Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent

Номер патента: CA2788150A1. Автор: Naomi Kitamoto. Владелец: Takeda Pharmaceutical Co Ltd. Дата публикации: 2011-08-04.

Compounds for suppressing a peripheral nerve disorder induced by an anti - cancer agent

Номер патента: HUE027310T2. Автор: Naomi Kitamoto. Владелец: Takeda Pharmaceuticals Co. Дата публикации: 2016-10-28.

Compounds for suppressing a peripheral nerve disorder induced by an anti - cancer agent

Номер патента: TN2012000364A1. Автор: Naomi Kitamoto. Владелец: Takeda Pharmaceuticals Co. Дата публикации: 2014-01-30.

Compounds for suppressing a peripheral nerve disorder induced by an anti - cancer agent

Номер патента: PL2528598T3. Автор: Naomi Kitamoto. Владелец: Takeda Pharmaceuticals Co. Дата публикации: 2016-06-30.

Novel sphingosine kinase type 1 inhibitors, compositions and processes for using same

Номер патента: EP2424554A1. Автор: Sarah Spiegel,Robert Elliot Zipkin,Jeffrey Kroll Adams. Владелец: Enzo Therapeutics Inc. Дата публикации: 2012-03-07.

Dolastatin 10 derivatives, process for preparing the same and anti-cancer agents comprising the same

Номер патента: KR20140038324A. Автор: 이종협,박성준,박영준,정진교,최영미,이민섭,최준헌,조은주,송현남,홍승서. Владелец: (주)셀트리온. Дата публикации: 2014-03-28.

Anti-viral and anti-cancer agents

Номер патента: OA10311A. Автор: Washington Odur Ayuko. Владелец: Radopath Ltd. Дата публикации: 1997-10-07.

NITROBENZYL DERIVATIVES OF ANTI-CANCER AGENTS

Номер патента: US20210017120A1. Автор: Matteucci Mark,Duan Jian-Xin,Jiao Hailong,Cao Yeyu,Cai Xiaohong,Ma Jing Yuan. Владелец: OBI Pharma, Inc.. Дата публикации: 2021-01-21.

Smac mimetic dimers and trimers useful as anti-cancer agents

Номер патента: US20140127155A1. Автор: Gunnar Hanson,Haizho Sun. Владелец: Joyant Pharmaceuticals Inc. Дата публикации: 2014-05-08.

Anti-cancer agents

COMBINATION INCLUDING COMBRETASTATIN AND ANTI-CANCER AGENTS

Номер патента: RU2008130043A. Автор: Мари-Кристин БИССЕРИ,Патрисья ВРИНЬО,Брижитт ДЕМЕР,Мариелль ШИРОН-БЛОНДЕЛЬ,Мари-Кристин БИССЕРИ (FR),Патрисья ВРИНЬО (FR),Брижитт ДЕМЕР (FR),Мариелль ШИРОН-БЛОНДЕЛЬ (FR). Владелец: Авентис Фарма С.А. (Fr). Дата публикации: 2010-01-27.

Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents

Номер патента: WO2003002595A3. Автор: Torsten Hoffmann,Hans-Ulrich Demuth,Hoersten Stephan Von. Владелец: Hoersten Stephan Von. Дата публикации: 2003-05-08.

Smac mimetic dimers and trimers useful as anti-cancer agents

Номер патента: US20090104151A1. Автор: Gunnar Hanson,Haizhou Sun. Владелец: Joyant Pharmaceuticals Inc. Дата публикации: 2009-04-23.

New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents

Номер патента: CA2418543A1. Автор: Torsten Hoffmann,Hans-Ulrich Demuth,Stephan Von Horsten. Владелец: Individual. Дата публикации: 2003-01-09.

Anthracene derivatives as anti-cancer agents

Номер патента: EP1244624A1. Автор: David John Napier University MINCHER,Agnes Napier University TURNBULL,Graeme Gillies Kay. Владелец: BTG International Ltd. Дата публикации: 2002-10-02.

Dipepitdyl peptidase IV inhibitors and their uses as anti-cancer agents

Номер патента: AU2002321135B2. Автор: Torsten Hoffmann,Hans-Ulrich Demuth,Stephan Von Horsten. Владелец: PROBIODRUG AG. Дата публикации: 2007-11-08.

SMAC mimetic dimers and trimers useful as anti-cancer agents

Номер патента: AU2008240153B2. Автор: Gunnar Hanson,Haizhou Sun. Владелец: Joyant Pharmaceuticals Inc. Дата публикации: 2013-01-31.

Anthracene derivatives as anti-cancer agents

Номер патента: AU2199201A. Автор: Graeme Gillies Kay,David John Mincher,Agnes Turnbull. Владелец: BTG International Ltd. Дата публикации: 2001-06-25.

Novel dipeptidyl peptidase IV inhibitors and their use as anti-cancer agents

Номер патента: NO20030896D0. Автор: Torsten Hoffmann,Hans-Ulrich Demuth,Stephan von Hoersten. Владелец: PROBIODRUG AG. Дата публикации: 2003-02-26.

Smac mimetic dimers and trimers useful as anti-cancer agents

Номер патента: CA2684169A1. Автор: Gunnar Hanson,Haizhou Sun. Владелец: Haizhou Sun. Дата публикации: 2008-10-23.

NOVEL CATIONIC 17 α- SUBSTITUTED-ESTRADIOL DERIVATIVES USEFUL AS ANTI-CANCER AGENT

Номер патента: WO2008099414A1. Автор: Rajkumar Banerjee,Surendar Reddy Bathula. Владелец: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH. Дата публикации: 2008-08-21.

Novel cationic 17 alpha- substituted-estradiol derivatives useful as anti-cancer agent

Номер патента: EP2111409A1. Автор: Rajkumar Banerjee,Surendar Reddy Bathula. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2009-10-28.

Novel cationic 17 alpha- substituted-estradiol derivatives useful as anti-cancer agent

Номер патента: EP2111409B1. Автор: Rajkumar Banerjee,Surendar Reddy Bathula. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2012-06-27.

Lectin protein prepared from korean marine crab philyra pisum, process for preparing the same and the use thereof

Номер патента: WO2002090376A1. Автор: Bum-soo Kim,Tae-Hong Min,Yun-Jung Kim,Ha-Hyung Kim,Chang-Soo Ryu,Jai-Il Jun,Due-Hyeon Cho. Владелец: Pike Corporation. Дата публикации: 2002-11-14.

Lectin protein prepared from korean marine crab philyra pisum, process for preparing the same and the use thereof

Номер патента: US20040185428A1. Автор: Bum-soo Kim,Tae-Hong Min,Yun-Jung Kim,Ha-Hyung Kim,Chang-Soo Ryu,Jai-Il Jun,Due-Hyeon Cho. Владелец: Individual. Дата публикации: 2004-09-23.

Cancer treatment and metastasis inhibition using an anti-cancer stem cell agent in combination with a neul sialidase inhibitor or a cytokine inhibitor after primary cancer treatment

Номер патента: EP3474859A1. Автор: William Warren HARLESS,Myron SZEWCZUK. Владелец: Individual. Дата публикации: 2019-05-01.

Cancer treatment and metastasis inhibition using an anti-cancer stem cell agent in combination with a neu1 sialidase inhibitor or a cytokine inhibitor after primary cancer treatment

Номер патента: US20200306283A1. Автор: William Warren HARLESS,Myron SZEWCZUK. Владелец: Individual. Дата публикации: 2020-10-01.

(20S)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses

Номер патента: US20050096300A1. Автор: Margaret Clagett-Dame,Hector DeLuca,Lori Plum. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION. Дата публикации: 2005-05-05.

Anti-cancer vaccine composition comprising an anti-CD223 antibody and kit comprising an anti-cancer vaccine and an anti-CD223 antibody

Номер патента: US8551481B2. Автор: Charles Drake,Jonathan Powell,Ching-Tai Huang,Dario A Vignali,Drew M Pardoll,Creg J Workman. Владелец: St Jude Childrens Research Hospital. Дата публикации: 2013-10-08.

Use of an anti-cancer compound

Номер патента: WO2008063045A1. Автор: Ahmad Bustamam Abdul,Munammad Nazrul Hakim Abdullah,Mohd Nordin Lajis,Nirmala Devi Tailan,Zetty Nadia Mohd Zain,Siddig Ibrahim Abdel Wahab,Adel Sharaf Al-Zubairi. Владелец: UNIVERSITI PUTRA MALAYSIA. Дата публикации: 2008-05-29.

PFKFB3 inhibitor and methods of use as an anti-cancer therapeutic

Номер патента: US09649305B2. Автор: Pooran Chand,Gilles H. Tapolsky. Владелец: Advanced Cancer Therapeutics LLC. Дата публикации: 2017-05-16.

1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications

Номер патента: CA2420026C. Автор: Hector F. DeLuca,Rafal R. Sicinski,Lori A. Plum,Margaret Clagett-Dame,Sumithra Gowlugari. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION. Дата публикации: 2010-01-19.

Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses

Номер патента: EP1482951B1. Автор: Hector F. DeLuca,Lori A. Plum,Margaret Clagett-Dame. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION. Дата публикации: 2006-10-04.

1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses

Номер патента: CA2474771A1. Автор: Hector F. DeLuca,Lori A. Plum,Margaret Clagett-Dame. Владелец: Individual. Дата публикации: 2003-09-18.

Cancer treatment and metastasis inhibition using an anti-cancer stem cell agent in combination with a neu1 sialidase inhibitor or a cytokine inhibitor after primary cancer treatment

Номер патента: CA3029074A1. Автор: William Warren HARLESS,Myron SZEWCZUK. Владелец: Individual. Дата публикации: 2018-01-25.

Process for preparing certain pyrrolotriazine compounds

Номер патента: US6933386B2. Автор: Zhen-wei Cai,Rajeev S. Bhide,Junying Fan,Francis S. Gibson,Ligang Qian,Luca Parlanti,Stephanie Barbosa. Владелец: Bristol Myers Squibb Co. Дата публикации: 2005-08-23.

Paraspeckle component 1 (pspc1) promoting epithelial-mesenchymal transition, stemness and metastasis as an anti-cancer target

Номер патента: WO2019160840A1. Автор: Yuh-Shan Jou,Yaw-Dong LANG,Hsi-Wen YEH. Владелец: Shih, Ming-Che. Дата публикации: 2019-08-22.

PDLIM2 AS A BIOMARKER FOR CANCER AND AS AN ANTI-CANCER TREATMENT TARGET

Номер патента: US20220135634A1. Автор: Qu Zhaoxia,XIAO Gutian. Владелец: University of Pittsburgh - of the Commonwealth System of Higher Education. Дата публикации: 2022-05-05.

NEUROMODULATING COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF CANCER BY MODULATING AN ANTI-CANCER IMMUNE RESPONSE

Номер патента: US20210154272A1. Автор: AFEYAN Noubar B.,KAHVEJIAN Avak,MATA-FINK Jordi,HUROV Jonathan Barry,FANKHAUSER Manuel Andreas,WEINSTEIN Erica,JEANBART Laura Kristina,LANTERMANN Alexandra,SHU Chengyi J.,ZHU Eric Franklin. Владелец: . Дата публикации: 2021-05-27.

NEUROMODULATING COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF CANCER BY MODULATING AN ANTI-CANCER IMMUNE RESPONSE

Номер патента: US20190240293A1. Автор: AFEYAN Noubar B.,KAHVEJIAN Avak,MATA-FINK Jordi,HUROV Jonathan Barry,FANKHAUSER Manuel Andreas,WEINSTEIN Erica,JEANBART Laura Kristina,LANTERMANN Alexandra,SHU Chengyi J.,ZHU Eric Franklin. Владелец: . Дата публикации: 2019-08-08.

Use of an anti-cancer compound

Номер патента: EP2083806A1. Автор: Ahmad Bustamam Abdul,Munammad Nazrul Hakim Abdullah,Mohd Nordin Lajis,Nirmala Devi Tailan,Zetty Nadia Mohd Zain,Siddig Ibrahim Abdel Wahab,Adel Sharaf Al-Zubairi. Владелец: UNIVERSITI PUTRA MALAYSIA (UPM). Дата публикации: 2009-08-05.

Phage-peptide constructs for stimulation of an anti-cancer immune response against cd47

Номер патента: US20230338462A1. Автор: Tatiana I. Samoylova,Alexandre M. Samoylov,Anna M. Cochran,Kenny V. Brock,James W. Gillespie. Владелец: Edward Via College Of Osteopathic Medicine Auburn. Дата публикации: 2023-10-26.

Phage-peptide constructs for stimulation of an anti-cancer immune response against cd47

Номер патента: US20210085750A1. Автор: Tatiana I. Samoylova,Alexandre M. Samoylov,Anna M. Cochran,Kenny V. Brock,James W. Gillespie. Владелец: Edward Via College Of Osteopathic Medicine Auburn. Дата публикации: 2021-03-25.

PHAGE-PEPTIDE CONSTRUCTS FOR STIMULATION OF AN ANTI-CANCER IMMUNE RESPONSE AGAINST CD47

Номер патента: US20210085750A1. Автор: Samoylova Tatiana I.,Gillespie James W.,SAMOYLOV Alexandre M.,Brock Kenny V.,Cochran Anna M.. Владелец: . Дата публикации: 2021-03-25.

Paraspeckle component 1 (pspc1) promoting epithelial-mesenchymal transition, stemness and metastasis as an anti-cancer target

Номер патента: US20210087239A1. Автор: Yuh-Shan Jou,Yaw-Dong LANG,Hsi-Wen YEH. Владелец: Academia Sinica. Дата публикации: 2021-03-25.

Synthetic enhancement of the t-cell armamentarium as an anti-cancer therapy

Номер патента: US20180148480A1. Автор: Samuel R. Denmeade,John T. Isaacs,Nathaniel E. Brennen. Владелец: JOHNS HOPKINS UNIVERSITY. Дата публикации: 2018-05-31.

Cell-permeable endostatin recombinant protein, a polynucleotide coated with the same, and an anti-cancer preparation containing the same as an active component

Номер патента: KR101263424B1. Автор: 이종민,박경호,조대웅,민탐 동. Владелец: 주식회사 프로셀제약. Дата публикации: 2013-05-14.

An anti-cancer cytotoxic monoclonal antibody

Номер патента: KR20100028642A. Автор: 데이비드 에스 에프 영,헬렌 피 핀들레이,수잔 이 한. Владелец: 에프. 호프만-라 로슈 아게. Дата публикации: 2010-03-12.

An anti-cancer cytotoxic monoclonal antibody

Номер патента: CA2724782A1. Автор: David S. F. Young,Helen P. Findlay,Susan E. Hahn,Lisa A. Popp. Владелец: Takeda Pharmaceutical Co Ltd. Дата публикации: 2009-11-26.

Novel Retinoid Derivatives And Methods For Producing Said Compounds And An Anti-cancer Pharmaceutical Composition Comprising Said Compounds

Номер патента: KR100508627B1. Автор: 김동명,박종섭,박시호,배태성,권윤자,오덕근,신홍식,김소미,박명순,노영쇠,한혜숙,엄수종. Владелец: (주)케비젠. Дата публикации: 2005-08-17.

Novel Retinoid Derivatives And Methods For Producing Said Compounds And An Anti-cancer Pharmaceutical Composition Comprising Said Compounds

Номер патента: KR20020090850A. Автор: 김동명,박종섭,박시호,배태성,권윤자,오덕근,신홍식,김소미,박명순,노영쇠,한혜숙,엄수종. Владелец: (주)케비젠. Дата публикации: 2002-12-05.

Recombinant protein having an anti-cancer effect, its encoding gene and uses thereof

Номер патента: US7666989B2. Автор: Bing Zhu. Владелец: Beijing Sunbio Biotech Co Ltd. Дата публикации: 2010-02-23.

PFKFB3 inhibitor and methods of use as an anti-cancer therapeutic

Номер патента: AU2013240340A1. Автор: Pooran Chand,Gilles H. Tapolsky. Владелец: Advanced Cancer Therapeutics LLC. Дата публикации: 2014-10-23.

An anti-cancer cytotoxic monoclonal antibody

Номер патента: WO2009026692A1. Автор: Helen P. Findlay,Susan E. Hahn,Lisa M. Cechetto,David S.F. Young. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2009-03-05.

4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents.

Номер патента: MX9603593A. Автор: Lee D Arnold. Владелец: Pfizer. Дата публикации: 1997-03-29.

Cell-permeable endostatin recombinant protein, a polynucleotide coated with the same, and an anti-cancer preparation containing the same as an active component

Номер патента: WO2009145489A3. Автор: 이종민,박경호,조대웅,동민탐. Владелец: 주식회사 프로셀제약. Дата публикации: 2010-01-21.

An anti-cancer cytotoxic monoclonal antibody

Номер патента: WO2009009882A1. Автор: David S. F. Young,Helen P. Findlay,Susan E. Hahn. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2009-01-22.

An anti-cancer cytotoxic monoclonal antibody

Номер патента: WO2009124381A1. Автор: Helen P. Findlay,Susan E Hahn,Lisa A Popp,David S F. Young. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2009-10-15.

An anti-cancer cytotoxic monoclonal antibody

Номер патента: CA2692826A1. Автор: David S. F. Young,Helen P. Findlay,Susan E. Hahn. Владелец: Susan E. Hahn. Дата публикации: 2009-01-22.

Amidobenzothiazoles and process for the preparation thereof

Номер патента: EP2670740A1. Автор: Kamal Ahmed,Suresh Paidakula,Adla Malla Reddy,Neigapula Sankara Rao,Rajesh V. C. R. N. C. Shetti. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2013-12-11.

Amidobenzothiazoles And Process For The Preparation Thereof

Номер патента: US20130317231A1. Автор: Kamal Ahmed,Suresh Paidakula,Adla Malla Reddy,Neigapula Sankara Rao,Rajesh V. C. R. N. C. Shetti. Владелец: Individual. Дата публикации: 2013-11-28.

Amidobenzothiazoles and process for the preparation thereof

Номер патента: US9102638B2. Автор: Kamal Ahmed,Suresh Paidakula,Adla Malla Reddy,Neigapula Sankara Rao,Rajesh V. C. R. N. C. Shetti. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2015-08-11.

Quinazoline derivatives, process for their preparation and their use as anti-cancer agents

Номер патента: ZA200805247B. Автор: Brian Aquila,Jayachandran Ezhuthachan,Paul Lyne,Timothy Pontz,Xiaolan Zheng. Владелец: AstraZeneca AB. Дата публикации: 2010-02-24.

Quinazoline derivatives, process for their preparation and their use as anti-cancer agents

Номер патента: KR20080079673A. Автор: 브라이언 아퀼라,자야칸드란 에추타칸,폴 린,티모시 폰츠,지아올란 젱. Владелец: 아스트라제네카 아베. Дата публикации: 2008-09-01.

3-(1h-indol-3-yl)-alkyl-benzene-1,4-diamine derivatives, process for their preparation, combinations thereof with anti-cancer agents, pharmaceutical compositions comprising them and their use in the manufacture of medicaments for treatment of disorders mediated by mdm2 and p53 interaction

Номер патента: IL182009A. Автор: . Владелец: Janssen Pharmaceutica NV. Дата публикации: 2012-06-28.

Composition for treating cancer, combining anti-cd26 antibody and other anti-cancer agent

Номер патента: RU2742953C2. Автор: Тикао МОРИМОТО,Такэто ЯМАДА,Муцуми ХАЯСИ,Кохдзи ЯМАДА,Тосихиро ОКАМОТО,Ютаро КАНЭКО. Владелец: И'с АК Ко., Лтд.. Дата публикации: 2021-02-12.

4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as anti-cancer agents

Номер патента: WO1995023141A1. Автор: Lee D. Arnold. Владелец: PFIZER INC.. Дата публикации: 1995-08-31.

Quinazoline derivatives, process for their preparation and their use as anti-cancer agents

Номер патента: WO2007071963A3. Автор: Brian Aquila,Jayachandran Ezhuthachan,Paul Lyne,Timothy Pontz,Xiaolan Zheng. Владелец: Xiaolan Zheng. Дата публикации: 2007-08-09.

Quinazoline derivatives replaced with 4-heterocyclyl processes for their preparation and use as anti-cancer agents

Номер патента: BR9506936A. Автор: Lee D Arnold. Владелец: Pfizer. Дата публикации: 1997-09-09.

Quinazoline derivatives, process for their preparation and their use as anti-cancer agents

Номер патента: WO2007071963A2. Автор: Brian Aquila,Jayachandran Ezhuthachan,Paul Lyne,Timothy Pontz,Xiaolan Zheng. Владелец: AstraZeneca UK Limited. Дата публикации: 2007-06-28.

Flavin n-oxides: new anti-cancer agents and pathogen eradication agents

Номер патента: AU2003299486A1. Автор: Matthew S. Platz. Владелец: Ohio State University. Дата публикации: 2004-06-03.

Flavin n-oxides: new anti-cancer agents and pathogen eradication agents

Номер патента: AU2003299486A8. Автор: Matthew S Platz. Владелец: Ohio State University. Дата публикации: 2004-06-03.

Design, Synthesis, and Structure-Activity Relationships of Substituted Pyrido[3,2-d]Pyrimidines as Microtubule Targeting Agents and Anti-Cancer Agents

Номер патента: US20240350496A1. Автор: Aleem Gangjee. Владелец: Duquesne Univ of Holy Spirit. Дата публикации: 2024-10-24.

FUNCTIONALIZED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS

Номер патента: RU2016122731A. Автор: Питер ГАННИНГ,Айан ДЖЕЙМС,Айан ДИКСОН,Джон Фьютрилл,Энтони КАЗЗАП,Херберт ТРОЙТЛАЙН,Цзюнь ЦЗЭН,Трейси НЕРО. Владелец: Новоген Лтд. Дата публикации: 2018-01-09.

Anti-cancer agent resistance to overcome the agent

Номер патента: TWI415613B. Автор: Tomio Yamakawa,Hikaru Saito,Masuharu Hirano,Toshihisa Ishikawa. Владелец: Nippon Chemiphar Co. Дата публикации: 2013-11-21.

Pyrazolyl derivatives useful as anti-cancer agents

Номер патента: CR20220281A. Автор: BO LIU,Stefan Stutz,Pascal Rigollier,Andrea Vaupel,Nadine Schneider,Marc Gerspacher,Robert Mah,Rainer Wilcken,Catherine Leblanc,Rainer Machauer,Simona Cotesta,Edwige Liliane Jeanne Lorthiois,Christophe MURA,Nicolas WARIN. Владелец: NOVARTIS AG. Дата публикации: 2022-07-01.

Cancer diagnosis and assays for screening anti-cancer agents

Номер патента: EP1287020A2. Автор: Wilhelm Krek,Matthias Georg Christian Gstaiger. Владелец: Novartis Forschungsstiftung Zweigniederlassung Friedrich Miescher Institute for Biomedical Research. Дата публикации: 2003-03-05.

Prophylactic or therapeutic agent for a peripheral nerve disorder induced by anti-cancer agents

Номер патента: CA2824735A1. Автор: Tomoyuki Okada,Munekazu Iinuma,Kazuyoshi Sawada,Mitsuru Naiki,Shoei Furukawa,Tomonori Matsumoto. Владелец: Nagoya Industrial Science Research Institute. Дата публикации: 2012-08-09.

Agent for overcoming resistance to anti-cancer agent

Номер патента: US20110257201A1. Автор: Tomio Yamakawa,Hikaru Saito,Masuharu Hirano,Toshihisa Ishikawa. Владелец: Nippon Chemiphar Co Ltd. Дата публикации: 2011-10-20.

Agent for overcoming resistance to anti-cancer agent

Номер патента: EP2036561A1. Автор: Tomio Yamakawa,Hikaru Saito,Masuharu Hirano,Toshihisa Ishikawa. Владелец: Nippon Chemiphar Co Ltd. Дата публикации: 2009-03-18.

Platelets loaded with anti-cancer agents

Номер патента: US11965178B2. Автор: Rafael Jorda,Keith Andrew Moskowitz,Ying Yi ZHENG,Daniel Allen Sheik. Владелец: Cellphire Inc. Дата публикации: 2024-04-23.

Anti-Cancer Agents Synthesized Based On Miliusane Compounds

Номер патента: US20130324580A1. Автор: Hongjie ZHANG. Владелец: Hong Kong Baptist University HKBU. Дата публикации: 2013-12-05.

Method of making and administering quinoline derivatives as anti-cancer agents

Номер патента: EP2188259A4. Автор: Albert Sun-Chi Chan,Johnny Cheuk-on Tang,Sau Hing Chan,Kim-Hung Lam,Chung-Hin Chui,Stanton Hon-Lung Kok,Filly Cheung,Roberto Gambari Ferrara,Chor Hing Cheng. Владелец: Hong Kong Polytechnic University HKPU. Дата публикации: 2011-08-17.

Method of making and administering quinoline derivatives as anti-cancer agents

Номер патента: EP2188259A1. Автор: Albert Sun-Chi Chan,Johnny Cheuk-on Tang,Sau Hing Chan,Kim-Hung Lam,Chung-Hin Chui,Stanton Hon-Lung Kok,Filly Cheung,Roberto Gambari Ferrara,Chor Hing Cheng. Владелец: Hong Kong Polytechnic University HKPU. Дата публикации: 2010-05-26.

Quinoline derivatives as anti-cancer agents

Номер патента: EP2188259B1. Автор: Albert Sun-Chi Chan,Johnny Cheuk-on Tang,Sau Hing Chan,Kim-Hung Lam,Chung-Hin Chui,Stanton Hon-Lung Kok,Filly Cheung,Roberto Gambari Ferrara,Chor Hing Cheng. Владелец: Hong Kong Polytechnic University HKPU. Дата публикации: 2013-11-06.

Synthetic rigidin analogues as anti-cancer agents, salts, solvates and prodrugs thereof, and method of producing same

Номер патента: EP3240541A4. Автор: Snezna Rogelj,Igor MAGEDOV,Liliya V. FROLOVA,Alexander V. KORNIENKO. Владелец: New Mexico Tech Research Foundation. Дата публикации: 2018-07-25.

Mll1 inhibitors and anti-cancer agents

Номер патента: EP4013754B1. Автор: Ming Li,Chunliang Lu,Yihui Zhu,Haibing GUO,Kevin Kun Chin LIU,Zhenting GAO,Zhuming SUN. Владелец: NOVARTIS AG. Дата публикации: 2024-07-24.

Anti-cancer agent

Номер патента: US20130023023A1. Автор: Nobufumi Ono. Владелец: Individual. Дата публикации: 2013-01-24.

Anti-cancer agents and preparation thereof

Номер патента: IL265521B2. Автор: . Владелец: Ghosh Arun K. Дата публикации: 2024-09-01.

Piperidinyl-methyl-purineamines as nsd2 inhibitors and anti-cancer agents

Номер патента: ZA202200519B. Автор: Ce Wang,Jinbiao Liu,Guoliang Xun,Qitao XIAO,Haibing DENG,Counde Oyang,Haiqiang ZENG. Владелец: NOVARTIS AG. Дата публикации: 2024-08-28.

Demethylpenclomedine analogs and their use as anti-cancer agents

Номер патента: US09884051B2. Автор: Lee Roy Morgan. Владелец: Dekk Tek Inc. Дата публикации: 2018-02-06.

Demethylpenclomedine analogs and their use as anti-cancer agents

Номер патента: US09422241B2. Автор: Lee Roy Morgan. Владелец: Dekk Tek Inc. Дата публикации: 2016-08-23.

Anti-Cancer Agents Synthesized Based On Miliusane Compounds

Номер патента: US20130324580A1. Автор: Zhang Hongjie. Владелец: HONG KONG BAPTIST UNIVERSITY. Дата публикации: 2013-12-05.

NO-RELEASING GUANIDINE-COXIB ANTI-CANCER AGENTS

Номер патента: US20140018403A1. Автор: MARTINEZ Eduardo J.,Boehm Terri L.,Talley John J.. Владелец: . Дата публикации: 2014-01-16.

COMPOSITION FOR AUTOPHAGY INHIBITING IN CELL, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING TUMOR DISEASE, OR INHIBITING ANTI-CANCER AGENTS RESISTANCE CONTAINING THE SAME

Номер патента: US20200087344A1. Автор: JUNG Ji Eun,JEON Do Yong,MOON Chang Hoon. Владелец: L-BASE CO., LTD. Дата публикации: 2020-03-19.

Cabozantinib Salts And Their Use As Anti-Cancer Agents

Номер патента: US20180110769A1. Автор: Stefinovic Marijan,Schreiner Erwin Paul. Владелец: SANDOZ AG. Дата публикации: 2018-04-26.

Demethylpenclomedine analogs and their use as anti-cancer agents

Номер патента: US20180117022A1. Автор: Lee Roy Morgan. Владелец: Dekk Tek Inc. Дата публикации: 2018-05-03.

FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS

Номер патента: US20170157135A1. Автор: James Ian,Dixon Ian,Bu Xian. Владелец: . Дата публикации: 2017-06-08.

TREATMENT OF LUNG CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT

Номер патента: US20210206854A1. Автор: Nathan Faith. Владелец: BRISTOL-MYERS SQUIBB COMPANY. Дата публикации: 2021-07-08.

ANTI-CANCER AGENTS AND PREPARATION THEREOF

Номер патента: US20190218228A1. Автор: Ghosh Arun K.. Владелец: . Дата публикации: 2019-07-18.

ANTI-CANCER AGENTS AND PREPARATION THEREOF

Номер патента: US20160297831A1. Автор: Ghosh Arun K.. Владелец: . Дата публикации: 2016-10-13.

COMPOSITION FOR AUTOPHAGY INHIBITING IN CELL, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEOPLASTIC DISEASE OR INHIBITING ANTI-CANCER AGENTS RESISTANCE CONTAINING THE SAME

Номер патента: US20200361989A1. Автор: JUNG Ji Eun,JEON Do Yong,MOON Chang Hoon. Владелец: L-BASE CO., LTD. Дата публикации: 2020-11-19.

DEMETHYLPENCLOMEDINE ANALOGS AND THEIR USE AS ANTI-CANCER AGENTS

Номер патента: US20200375964A1. Автор: Morgan Lee Roy. Владелец: Dekk-Tec, Inc.. Дата публикации: 2020-12-03.

Composition for autophagy inhibiting in cell, And pharmaceutical composition for preventing or treating tumor disease, or inhibiting anti-cancer agents resistance containing the same

Номер патента: KR102119197B1. Автор: 정지은,전도용,문창훈. Владелец: 주식회사 엘베이스. Дата публикации: 2020-06-05.

Anti-cancer agent containing interleukin-2 and monoacethyldiglyceride-3 as an effective ingredient

Номер патента: KR20050103259A. Автор: 김상희. Владелец: 김상희. Дата публикации: 2005-10-27.

Derivatives of tiacumicin b as anti-cancer agents

Номер патента: TWI326284B. Автор: Mei Chiao Wu,Chang Cheng Huang,Yi Chen Lu,Wei Jen Fan. Владелец: Echem Hightech Co Ltd. Дата публикации: 2010-06-21.

Low molecular weight compounds administered together with anti-cancer agents to prevent or treat cancer and pharmaceutical compositions thereof

Номер патента: US6762174B1. Автор: Floyd E. Taub. Владелец: Dovetail Technologies Inc. Дата публикации: 2004-07-13.

Skp2 inhibitor as a novel anti-cancer agent

Номер патента: KR101769911B1. Автор: 임현석,오미숙. Владелец: 포항공과대학교 산학협력단. Дата публикации: 2017-08-21.

NEW AZAINDOLTIZAZOLINES AS ANTI-CANCER AGENTS

Номер патента: RU2007117764A. Автор: Шаоцзин ЧЭНЬ,Ахютарао СИДДУРИ,Шаоцзин ЧЭНЬ (US),Ахютарао СИДДУРИ (US). Владелец: Ф.Хоффманн-Ля Рош Аг (Ch). Дата публикации: 2008-11-20.

5-substituted quinazolinone derivatives as anti-cancer agents

Номер патента: HUE035389T2. Автор: George W Muller,Hon-Wah Man. Владелец: Celgene Corp. Дата публикации: 2018-05-02.

Imatinib dichloroacetate and anti-cancer agent including the same

Номер патента: KR101138840B1. Автор: 김준우,김경수,박영준,송현남. Владелец: 주식회사 셀트리온제약. Дата публикации: 2012-05-10.

Fluoro substituted omega-carboxyaryl diphenyl urea, combination with anti-cancer agents, pharmaceutical compositions containing them and their use in the manufacture of medicaments for the treatment and prevention of diseases and conditions

Номер патента: IL173256A. Автор: . Владелец: Bayer Pharmaceuticals Corp. Дата публикации: 2011-03-31.

Novel isoindolo[2,1-b]isoquinolinone derivatives and anti-cancer agents including them

Номер патента: KR101034051B1. Автор: 조원제. Владелец: (재)광주테크노파크. Дата публикации: 2011-05-11.

Anti-cancer agent

Номер патента: JP5798199B2. Автор: 宇田　泰三,泰三宇田,一二三　恵美,恵美一二三. Владелец: JAPAN SCIENCE AND TECHNOLOGY AGENCY. Дата публикации: 2015-10-21.

Functionalised and substituted indoles as anti-cancer agents

Номер патента: CA2952557A1. Автор: Andrew Heaton,Eleanor Eiffe,Narender POTTABATHINI,Peter Gunning. Владелец: Novogen Ltd. Дата публикации: 2016-01-21.

TRI- AND TETRACYCLIC PYRAZOLO [3,4-B] PYRIDINE COMPOUNDS AS ANTI-CANCER AGENTS

Номер патента: FR2974088A1. Автор: Philippe Schmitt,El Bachir Kaloun,Remi Rabot,Karim Bedjeguelal,Patrice Mayer,Nicolas Rahier,Emmanuel Fournier. Владелец: Pierre Fabre Medicament SA. Дата публикации: 2012-10-19.

Triazolopyrazine derivatives useful as anti-cancer agents

Номер патента: CA2651363A1. Автор: HONG Shen,LEI Jia,Robert Steven Kania,Jingrong Jean Cui,Mary Catherine Johnson,Mason Alan Pairish,Hengmiao Cheng,Mitchell David Nambu,Phuong Thi Quy Le,Jacqui Elizabeth Hoffman,Michelle Bich Tran-Dube. Владелец: Michelle Bich Tran-Dube. Дата публикации: 2007-11-22.

Hydrazinomethyl, HYDR zonomethyl and 5-membered heterocylic compounds which act as MTOR inhibitors and their use as anti cancer agents

Номер патента: AU2006217742A1. Автор: Sylvie Gomez,Keith Allan Menear,Marc Geoffrey Hummersone,Graeme Cameron Murray Smith,Xiao-Ling Fan Cockcroft. Владелец: Kudos Pharmaceuticals Ltd. Дата публикации: 2006-08-31.

Functionalised and substituted indoles as anti-cancer agents

Номер патента: CA2931279A1. Автор: Jun Zeng,John Feutrill,Peter Gunning,Ian James,Ian Dixon,Anthony CUZZUPE,Herbert Treutlein,Tracy Nero. Владелец: Novogen Ltd. Дата публикации: 2015-05-28.

Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same

Номер патента: EP2597086A1. Автор: Oleg Dmitrievich Mitkin. Владелец: Savchuk, Nikolay Filippovich. Дата публикации: 2013-05-29.

Protein complexes and assays for screening anti-cancer agents

Номер патента: US20030092054A1. Автор: Matthias Georg Gstaiger,Wilhelm Krek. Владелец: Gstaiger Matthias Georg Christian. Дата публикации: 2003-05-15.

Triazolopyrazine derivatives useful as anti-cancer agents.

Номер патента: MX2008014399A. Автор: HONG Shen,LEI Jia,Robert Steven Kania,Jingrong Jean Cui,Mary Catherine Johnson,Mason Alan Pairish,Hengmiao Cheng,Mitchell David Nambu,Phuong Thi Quy Le,Jacqui Elizabeth Hoffman,Michelle Bich Tran-Dube. Владелец: Pfizer Prod Inc. Дата публикации: 2008-11-27.

Pyrazolyl derivatives useful as anti-cancer agents

Номер патента: CA3165148A1. Автор: BO LIU,Stefan Stutz,Pascal Rigollier,Andrea Vaupel,Nadine Schneider,Marc Gerspacher,Robert Mah,Rainer Wilcken,Catherine Leblanc,Rainer Machauer,Simona Cotesta,Edwige Liliane Jeanne Lorthiois,Christophe MURA,Nicolas WARIN. Владелец: NOVARTIS AG. Дата публикации: 2021-06-24.

Novel inhibitor hy53 against cell cycle regulating factor, preparation thereof and use thereof in anti-cancer agent

Номер патента: KR100418392B1. Автор: 김민경,김지홍,이창호,이민아,백두진,서수민,임융호,조율희,임혜영,서한규. Владелец: (주)디스진. Дата публикации: 2004-02-11.

Triazolopyrazine derivatives useful as anti-cancer agents

Номер патента: NZ572361A. Автор: HONG Shen,LEI Jia,Robert Steven Kania,Jingrong Jean Cui,Mary Catherine Johnson,Mason Alan Pairish,Hengmiao Cheng,Mitchell David Nambu,Phuong Thi Quy Le,Jacqui Elizabeth Hoffman,Michelle Bich Tran-Dube. Владелец: Pfizer Prod Inc. Дата публикации: 2012-02-24.

5-substituted quinazolinone derivatives as anti-cancer agents

Номер патента: LT2420498T. Автор: Hon-Wah Man,George W. Muller. Владелец: Celgene Corporation. Дата публикации: 2017-10-25.

Novel azaindole thiazolinones as anti-cancer agents

Номер патента: CA2582986A1. Автор: Achyutharao Sidduri,Shaoqing Chen. Владелец: Shaoqing Chen. Дата публикации: 2006-04-20.

Covalent irreversible inhibitors of usp7 as anti-cancer agents

Номер патента: WO2017023684A2. Автор: Feng Wang,Jian Wu,Joseph Weinstock,Suresh Kumar Kizhakkethil-George,Matthew P. KODRASOV,Saket Agarwal. Владелец: Progenra, Inc.. Дата публикации: 2017-02-09.

Imatinib dichloroacetate and anti-cancer agent comprising the same

Номер патента: WO2011081408A2. Автор: Young Jun Park,Joon Woo Kim,Kyoung Soo Kim,Hyun-Nam Song. Владелец: Celltrion Pharm, Inc.. Дата публикации: 2011-07-07.

Aryl imidazoles and their use as anti-cancer agents

Номер патента: US20080262015A9. Автор: Mario Huesca,Raed Al-Qawasmeh,Yoon Lee,Aiping Young. Владелец: Lorus Therapeutics Inc. Дата публикации: 2008-10-23.

5-substituted quinazolinone derivatives as anti-cancer agents

Номер патента: EP2420497B1. Автор: Hon-Wah Man,George W. Muller. Владелец: Celgene Corp. Дата публикации: 2015-12-16.

Cancer diagnosis and assays for screening anti-cancer agents

Номер патента: CA2408297A1. Автор: Wilhelm Krek,Matthias Georg Christian Gstaiger. Владелец: Individual. Дата публикации: 2001-11-15.

Imatinib dichloroacetate and anti-cancer agent comprising the same

Номер патента: CN102666530B. Автор: 金炅秀,朴永濬,宋贤南,金俊雨. Владелец: Celltrion Chemical Research Institute. Дата публикации: 2014-02-26.

Novel anti-cancer agents

Номер патента: CA2814120C. Автор: Antony Wilks Burgess,Keith Geoffrey Watson,Guillaume Lessene,Francesca Walker,Helen Witchard. Владелец: Walter And Eliza Hall Institute Of Medical Research. Дата публикации: 2018-08-07.

Use in anti-cancer agent of 5,4‘-dimethoxyflavone showing regulatory effect on p21

Номер патента: KR101456212B1. Автор: 이은정,이선희,이영한,임융호,신순영. Владелец: 건국대학교 산학협력단. Дата публикации: 2014-11-03.

Piperidinyl-methyl-purineamines as nsd2 inhibitors and anti-cancer agents

Номер патента: WO2021028854A1. Автор: Ce Wang,Jinbiao Liu,Guoliang Xun,Qitao XIAO,Haibing DENG,Counde Oyang,Haiqiang ZENG. Владелец: NOVARTIS AG. Дата публикации: 2021-02-18.

DERIVATIVES OF TRIAZOLPYRAZINES APPLICABLE AS ANTI-CANCER AGENTS

Номер патента: EA200870423A1. Автор: Цзинжун Джин Цуй,Хун Шэнь,Роберт Стивен Кания,Хэнмяо Чэнь,Джэки Элизабет Хоффман,Лэй Цзя,Мари Кэтрин Джонсон,Фыонг Тхи Куи Ле,Митчелл Дэвид Намбу,Мейсон Алан Пэйриш,Мишель Бить Чан-Дьюб. Владелец: Пфайзер Продактс Инк.. Дата публикации: 2009-04-28.

Method for overcoming tolerance to targeted anti-cancer agent

Номер патента: WO2013077675A1. Автор: 이호영. Владелец: 서울대학교 산학협력단. Дата публикации: 2013-05-30.

Pyrazolyl derivatives useful as anti-cancer agents

Номер патента: WO2021120890A1. Автор: BO LIU,Stefan Stutz,Pascal Rigollier,Andrea Vaupel,Nadine Schneider,Marc Gerspacher,Robert Mah,Rainer Wilcken,Catherine Leblanc,Rainer Machauer,Simona Cotesta,Edwige Liliane Jeanne Lorthiois,Christophe MURA,Nicolas WARIN. Владелец: NOVARTIS AG. Дата публикации: 2021-06-24.

INDOLES SUBSTITUTED AND FUNCTIONALIZED AS ANTI-CANCER AGENTS

Номер патента: BR112016011734A2. Автор: Zeng Jun,James Ian,Feutrill John,Cuzzupe Anthony,Dixon Ian,Gunning Peter,Treutlein Herbert,Nero Tracy. Владелец: Novogen Ltd. Дата публикации: 2017-08-08.

Imidazolidin-4-one derivatives can be used as anti-cancer agents

Номер патента: DE69811329T2. Автор: Joseph Peter Lyssikatos,Bingwei Vera Yang. Владелец: Pfizer Products Inc. Дата публикации: 2003-08-14.

Indoline anti-cancer agents

Номер патента: CA2720516C. Автор: Qi Wei,Ming Zhou,Lai Wang,Gunnar James Hanson,Susan Harran,Charles Caldwell. Владелец: Joyant Pharmaceuticals Inc. Дата публикации: 2013-10-01.

Piperidinyl-methyl-purineamines as nsd2 inhibitors and anti-cancer agents

Номер патента: IL289754A. Автор: . Владелец: NOVARTIS AG. Дата публикации: 2022-03-01.

Cancer diagnosis and assays for screening anti-cancer agents

Номер патента: AU2001256353A1. Автор: Wilhelm Krek,Matthias Georg Christian Gstaiger. Владелец: NOVARTIS FORSCHUNGSSTIFTUNG. Дата публикации: 2001-11-20.

2,4-diaminopyrimidine compounds as anti-cancer agents

Номер патента: AU5569098A. Автор: Roger John Griffin,Malcolm Francis Graham Stevens. Владелец: British Technology Group Ltd. Дата публикации: 1998-08-03.

Indoline anti-cancer agents

Номер патента: CA2720516A1. Автор: Qi Wei,Ming Zhou,Lai Wang,Gunnar James Hanson,Susan Harran,Charles Caldwell. Владелец: Joyant Pharmaceuticals Inc. Дата публикации: 2009-11-05.

Anti-cancer agent comprising protein c inhibitor

Номер патента: EP1894574A1. Автор: Koji Suzuki. Владелец: Mie University NUC. Дата публикации: 2008-03-05.

5-substituted quinazolinone derivatives as anti-cancer agents

Номер патента: RS56279B1. Автор: George W Muller,Hon Wah Man. Владелец: Celgene Corp. Дата публикации: 2017-12-29.

Imidazolidin-4-one derivatives can be used as anti-cancer agents

Номер патента: DE69811329D1. Автор: Joseph Peter Lyssikatos,Bingwei Vera Yang. Владелец: Pfizer Products Inc. Дата публикации: 2003-03-20.

Tubulin binding anti cancer agents and prodrugs thereof

Номер патента: WO2006057946A2. Автор: Mark Matteucci,Jian-Xin Duan,Xiaohong Cai. Владелец: Threshold Pharmaceuticals, Inc.. Дата публикации: 2006-06-01.

Mll1 inhibitors and anti-cancer agents

Номер патента: TW202200589A. Автор: 郭海兵,厲銘,高振霆,劉康志,盧春亮,孫祝明,朱怡暉. Владелец: 瑞士商諾華公司. Дата публикации: 2022-01-01.

Novel anti-cancer agents comprising peptides with cancer-specific toxicity

Номер патента: KR101171381B1. Автор: 김다정,임기정,김선창,성봉현,이영웅,장수아,신주리. Владелец: 한국과학기술원. Дата публикации: 2012-08-13.

6-ARILPYRIMIDINE USED AS ANTI-CANCER AGENT

Номер патента: RU2006107578A. Автор: Нан ЖАНГ,Семирамис АЙРАЛ-КАЛУСТЯН,Тай Хайп НГУЙЕН,Нан ЖАНГ (US),Семирамис АЙРАЛ-КАЛУСТЯН (US),Тай Хайп НГУЙЕН (US). Владелец: Вайет Холдингз Корпорейшн (Us). Дата публикации: 2007-10-27.

Anti-cancer agent

Номер патента: CA3075650A1. Автор: Carolyn Therese DILLON,Judith Anne CARRALL. Владелец: University of Wollongong. Дата публикации: 2019-04-25.

Enzymatic assays for screening anti-cancer agents

Номер патента: CA2408002A1. Автор: Wilhelm Krek,Matthias Georg Christian Gstaiger. Владелец: Individual. Дата публикации: 2001-11-15.

ANTI-CANCER AGENTS AND THEIR PREPARATION

Номер патента: RU2019111768A. Автор: Арун К. ГХОШ. Владелец: Пердью Ресерч Фаундейшн. Дата публикации: 2020-10-23.

5-substituted quinazolinone derivatives as anti-cancer agents

Номер патента: HRP20160266T1. Автор: Hon-Wah Man,George W. Muller. Владелец: Celgene Corporation. Дата публикации: 2016-04-08.

Demethylpenclomedine Analogs and Their Use as Anti-Cancer Agents

Номер патента: US20090197844A1. Автор: Lee Roy Morgan. Владелец: Dekk Tek Inc. Дата публикации: 2009-08-06.

Anti-cancer agents and preparation thereof

Номер патента: CA3037883A1. Автор: Arun K. Ghosh. Владелец: PURDUE RESEARCH FOUNDATION. Дата публикации: 2018-03-29.

Imatinib dichloroacetate and anti-cancer agent comprising the same

Номер патента: EP2519518B1. Автор: Young Jun Park,Joon Woo Kim,Kyoung Soo Kim,Hyun-Nam Song. Владелец: Celltrion Chemical Research Institute. Дата публикации: 2014-04-23.

2,4-diaminopyrimidine compounds as anti-cancer agents

Номер патента: CA2275566A1. Автор: Roger John Griffin,Malcolm Francis Graham Stevens. Владелец: Malcolm Francis Graham Stevens. Дата публикации: 1998-07-16.

Combination of small molecule cd-47 inhibitors with other anti-cancer agents

Номер патента: IL282972A. Автор: . Владелец: Aurigene Discovery Tech Ltd. Дата публикации: 2021-06-30.

Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents

Номер патента: WO2008036067A2. Автор: James T. Dalton,Duane D. Miller,Veeresa Gududuru,Eunju Hurh. Владелец: Ohio State University Research Foundation. Дата публикации: 2008-03-27.

A dihydropyrazolecarbothioamide derivative, Method of preparing the same, and anti-cancer agent comprising the same

Номер патента: KR101457637B1. Автор: 이영한,고동수,임융호,신순영. Владелец: 건국대학교 산학협력단. Дата публикации: 2014-11-20.

DIAMINO-QUINOLEINE 2.4 SUBSTITUTE AS NEW ANTI-CANCER AGENTS

Номер патента: ECSP17026748A. Автор: ABRAMS Tinya,Cohen Steven,Del Continente Americano S A Avianca Aerovias,Light Industrial Products Import Export Corporation Zhejiang,Development Industries Co Ltd Italpharma,Suntory Spain S L Beam,Licensing B V Damiano. Владелец: GENOSCIENCE PHARMA. Дата публикации: 2018-03-31.

Piperidinyl-methyl-purineamines as nsd2 inhibitors and anti-cancer agents

Номер патента: US20230002388A1. Автор: Ce Wang,Jinbiao Liu,Guoliang Xun,Qitao XIAO,Haibing DENG,Counde Oyang,Haiqiang ZENG. Владелец: NOVARTIS AG. Дата публикации: 2023-01-05.

Triazolopyrazine derivatives useful as anti-cancer agents

Номер патента: CA2651363C. Автор: HONG Shen,LEI Jia,Robert Steven Kania,Jingrong Jean Cui,Mary Catherine Johnson,Mason Alan Pairish,Hengmiao Cheng,Mitchell David Nambu,Phuong Thi Quy Le,Jacqui Elizabeth Hoffman,Michelle Bich Tran-Dube. Владелец: Pfizer Products Inc. Дата публикации: 2011-07-12.

Benzothiazole AS ANTI-CANCER AGENTS

Номер патента: DK2358689T3. Автор: Masaaki Hirose,Terufumi Takagi,Masanori Okaniwa. Владелец: Takeda Pharmaceutical. Дата публикации: 2015-12-14.

Protein anti-cancer agent

Номер патента: CA2010256C. Автор: Allen I. Oliff,Gwynneth M. Edwards,Deborah D. Jones. Владелец: Merck and Co Inc. Дата публикации: 2000-07-25.

Heterocyclic and carbonate derivatives of NDGA and their use as new anti-HIV and anti-cancer agents

Номер патента: US8420692B1. Автор: Jih Ru Hwu,Ru Chih C. Huang,Ming-Hua Hsu,Apostolos Gittis,Evangelos Moudrianakis,Julie A. Dohm. Владелец: JOHNS HOPKINS UNIVERSITY. Дата публикации: 2013-04-16.

Protein anti-cancer agent

Номер патента: HK15597A. Автор: Allen Oliff,Deborah D Jones,Gwynneth M Edwards. Владелец: Merck & Co Inc. Дата публикации: 1997-02-14.

Aryl imidazoles and their use as anti-cancer agents

Номер патента: US8969372B2. Автор: Aiping H. Young,Mario Huesca,Raed Al-Qawasmeh,Yoon Lee. Владелец: Aptose Bioscience Inc. Дата публикации: 2015-03-03.

5-substituted quinazolinone derivatives as anti-cancer agents

Номер патента: PT2428513T. Автор: Man Hon-Wah,W Muller George. Владелец: Celgene Corp. Дата публикации: 2017-08-28.

Indoline anti-cancer agents

Номер патента: AU2009243056B2. Автор: Qi Wei,Ming Zhou,Lai Wang,Gunnar James Hanson,Susan Harran,Charles Caldwell. Владелец: Joyant Pharmaceuticals Inc. Дата публикации: 2015-05-14.

HDAC inhibitors as anti-cancer agents

Номер патента: US9469656B2. Автор: Pravin Bhansali,L. M. Viranga Tillekeratne,Jehad Almaliti,Ayad Al-Hamashi. Владелец: UNIVERSITY OF TOLEDO. Дата публикации: 2016-10-18.

Derivatives of tiacumicin B as anti-cancer agents

Номер патента: TW200918537A. Автор: Mei-Chiao Wu,Yi-Chen Lu,Chang-Cheng Huang,Wei-Jen Fan. Владелец: Echem Hightech Co Ltd. Дата публикации: 2009-05-01.

Combination of small molecule cd-47 inhibitors with other anti-cancer agents

Номер патента: WO2020095256A1. Автор: Muralidhara Ramachandra,Pottayil Govindan Nair Sasikumar,Girish Chandrappa DAGINAKATTE,Kiran Aithal BALKUDRU. Владелец: AURIGENE DISCOVERY TECHNOLOGIES LIMITED. Дата публикации: 2020-05-14.

2,4-diaminopyrimidine compounds as anti-cancer agents

Номер патента: WO1998030550A1. Автор: Roger John Griffin,Malcolm Francis Graham Stevens. Владелец: BTG International Limited. Дата публикации: 1998-07-16.

NICOTINAMIDE DERIVATIVES, METHOD FOR PRODUCING THEREOF AND USE IN THERAPY AS ANTI-CANCER AGENTS

Номер патента: RU2011142753A. Автор: Самир ЖЕГАМ,Монсиф Буабуля,Клод Бернар,Жером АРИГОН,Ромэн КОМБЕ,Сандрин ИЛЭРЕ. Владелец: Санофи. Дата публикации: 2013-04-27.

Novel azaindole thiazolinones as anti-cancer agents

Номер патента: RU2391342C2. Автор: Шаоцзин ЧЭНЬ,Ахютарао СИДДУРИ. Владелец: Ф.Хоффманн-Ля Рош Аг. Дата публикации: 2010-06-10.

Pyrazolyl derivatives useful as anti-cancer agents

Номер патента: EP4076662B1. Автор: BO LIU,Stefan Stutz,Pascal Rigollier,Andrea Vaupel,Nadine Schneider,Marc Gerspacher,Robert Mah,Rainer Wilcken,Catherine Leblanc,Rainer Machauer,Simona Cotesta,Edwige Liliane Jeanne Lorthiois,Christophe MURA,Nicolas WARIN. Владелец: NOVARTIS AG. Дата публикации: 2024-01-31.

Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents

Номер патента: US10947198B2. Автор: Krishna Kumar Gnanasekaran,Kenneth Darrell Berlin,Richard A. Bunce,Field M. Watts, Jr.,Donghua Howard Zhou. Владелец: Oklahoma State University. Дата публикации: 2021-03-16.

New carbazole derivatives sensitizing cells to anti-cancer agents

Номер патента: US20230404973A1. Автор: Jean-Charles Lancelot,Sylvain Rault,Patrick Dallemagne,Peggy Suzanne,Eric Denarier,Laurence Lafanechere,Renaud Prudent,Serge Perato,Lauralie PERONNE,Marc BILLAUD,Audrey VERNET,Aurélien Lesnard. Владелец: Université de Caen Normandie. Дата публикации: 2023-12-21.

Discovery of yeats2 yeats domain inhibitors as novel anti-cancer agents

Номер патента: US20230355705A1. Автор: Xin Li,Sha Liu,Xiang David Li. Владелец: University of Hong Kong HKU. Дата публикации: 2023-11-09.

Mll1 inhibitors and anti-cancer agents

Номер патента: EP4013756B1. Автор: Ming Li,Chunliang Lu,Yihui Zhu,Jichen Zhao,Kevin Kun Chin LIU,Zhuming SUN. Владелец: NOVARTIS AG. Дата публикации: 2024-05-08.

Hdac inhibitors as anti-cancer agents

Номер патента: WO2015175770A1. Автор: Pravin Bhansali,Jehad Almaliti,Ayad Al-Hamashi,Viranga L.M. TILLEKERATNE. Владелец: The University of Toledo. Дата публикации: 2015-11-19.

New carbazole derivatives sensitizing cells to anti-cancer agents

Номер патента: CA3153269A1. Автор: Jean-Charles Lancelot,Sylvain Rault,Patrick Dallemagne,Peggy Suzanne,Eric Denarier,Renaud Prudent,Serge Perato,Lauralie PERONNE,Marc BILLAUD,Audrey VERNET,Aurélien Lesnard. Владелец: Individual. Дата публикации: 2021-04-15.

Discovery of yeats2 yeats domain inhibitors as novel anti-cancer agents

Номер патента: EP4257196A1. Автор: Sha Liu,Xiang David Li,Xin Ll. Владелец: University of Hong Kong HKU. Дата публикации: 2023-10-11.

Sulfonyl bearing thienopyrimidine compound, preparation method therefor, pharmaceutical composition, and application as anti-cancer agent

Номер патента: EP3498716B1. Автор: Li Li,Yue Lu,Zhiyu Hu,Shuang Liu,Xianming Deng,Xihuan SUN,Zhou Deng,Chao Dong,Baoding ZHANG,Xiaoxing HUANG,Yunzhan LI. Владелец: XIAMEN UNIVERSITY. Дата публикации: 2024-04-17.

Inhibitors of the bromodomain phd finger transcription factor (bptf) as anti-cancer agents

Номер патента: US20230391730A1. Автор: Huda Zahid,William Pomerantz,Caroline Buchholz. Владелец: University of Minnesota. Дата публикации: 2023-12-07.

Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents

Номер патента: US20210163415A1. Автор: Krishna Kumar Gnanasekaran,Kenneth Darrell Berlin,Richard A. Bunce,Field M. Watts, Jr.,Donghua Howard Zhou. Владелец: Oklahoma State University. Дата публикации: 2021-06-03.

Chromane-substituted, tetrahydroquinoline-substituted and thiochromane-substituted heteroarotinoids as anti-cancer agents

Номер патента: US11993573B2. Автор: Krishna Kumar Gnanasekaran,Kenneth Darrell Berlin,Richard A. Bunce,Field M. Watts, Jr.,Donghua Howard Zhou. Владелец: Oklahoma State University. Дата публикации: 2024-05-28.

Chroman-substituted, tetrahydroquinoline-substituted and thiochroman-substituted heteroarotinoids as anti-cancer agents

Номер патента: US20200062711A1. Автор: Krishna Kumar Gnanasekaran,Kenneth Darrell Berlin,Richard A. Bunce,Field M. Watts, Jr.,Donghua Howard Zhou. Владелец: Oklahoma State University. Дата публикации: 2020-02-27.

Anti-cancer agents and preparation thereof

Номер патента: IL265521B1. Автор: . Владелец: Ghosh Arun K. Дата публикации: 2024-05-01.

Anti-cancer agent

Номер патента: IL272705B1. Автор: Therese DILLON Carolyn,Anne Carrall Judith. Владелец: Anne Carrall Judith. Дата публикации: 2024-03-01.

New carbazole derivatives sensitizing cells to anti-cancer agents

Номер патента: EP4041395A1. Автор: Jean-Charles Lancelot,Sylvain Rault,Patrick Dallemagne,Peggy Suzanne,Eric Denarier,Laurence Lafanechere,Renaud Prudent,Serge Perato,Lauralie PERONNE,Marc BILLAUD,Audrey VERNET,Aurélien Lesnard. Владелец: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS. Дата публикации: 2022-08-17.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: EP2848940A1. Автор: Herbert Andres,Johann Karl,Sanne Lysbet De Haas,Stefan Scherer,Norbert Wild. Владелец: F Hoffmann La Roche AG. Дата публикации: 2015-03-18.

8-(1-{4-{(5-chloro-4-{(2-(dimethylphosphoryl)phenyl)amino}pyrimidin-2-yl)amino)-3-methoxyphenyl}piperidin-4-yl)-1-methyl-1,8-diazaspiro(4.5)decan-2-one and its pharmaceutically acceptable salts as an alk and eger modulator for treatment of cancer

Номер патента: RU2654695C1. Автор: Александр Васильевич Иващенко,Василий Геннадьевич Игнатьев,Алексей Евгеньевич Репик,Михаил Айратович Шафеев. Владелец: Акционерное Общество "Р-Фарм" (Ао "Р-Фарм"). Дата публикации: 2018-05-22.

Multi-functional nucleic acid-based anti-cancer drug capable of targeting and therapy, method for preparing same and anti-cancer composition comprising same

Номер патента: US9163048B2. Автор: Soong Ho Um,A Ra Kim. Владелец: Sungkyunkwan University Research and Business Foundation. Дата публикации: 2015-10-20.

Combinations of an anti-cancer agent and a cholestanol derivative

Номер патента: HK1145455A1. Автор: Shin Yazawa,Toyo Nishimura,Takayuki Asao. Владелец: Univ Gunma Nat Univ Corp. Дата публикации: 2011-04-21.

Combinations of an anti-cancer agent and a cholestanol derivative

Номер патента: EP2251014B8. Автор: Shin Yazawa,Toyo Nishimura,Takayuki Asao. Владелец: Gunma University NUC. Дата публикации: 2014-01-08.

Method of using a porphyrin-like molecule conjugated with an anti-cancer drug for the treatment of cancer

Номер патента: US20020155999A1. Автор: In Han. Владелец: Han In Suk. Дата публикации: 2002-10-24.

PODOCALYXIN AND TRA-RELATED ANTIBODY, METHODS OF PREPARATION AND USES AS AN ANTI-CANCER THERAPEUTIC AGENT

Номер патента: US20170328907A1. Автор: SCHOPPERLE WILLIAM MICHAEL,TAN EDWIN SAAVEDRA,JU YAWEN,HOLMQVIST MATS HARALD,TAK YOUNGBIN,HOLMQVIST AN MARY. Владелец: CUREMETA THERAPEUTICS, LLC. Дата публикации: 2017-11-16.

READY INJECTABLE SOLUTIONS CONTAINING AN ANTI-CANCER ANTHRACYCLINIC GLYCOSIDE.

Номер патента: IT8620917D0. Автор: Giuseppe Bottoni,Gaetano Gatti,Diego Oldani,Carlo Confalonieri,Luciano Gambini,Ponti Roberto De. Владелец: Erba Farmitalia. Дата публикации: 1986-06-26.

Podocalyxin and TRA-related antibody, methods of preparation and uses as an anti-cancer therapeutic agent

Номер патента: AU2017234134B2. Автор: Edwin Saavedra Tan,An Mary HOLMQVIST,Mats Harald HOLMQVIST,Yawen JU,William Michael Schopperle,Youngbin TAK. Владелец: Curemeta Therapeutics LLC. Дата публикации: 2023-08-17.

Podocalyxin and tra-related antibody, methods of preparation and uses as an anti-cancer therapeutic agent

Номер патента: EP3430166A4. Автор: Edwin Saavedra Tan,An Mary HOLMQVIST,Mats Harald HOLMQVIST,Yawen JU,William Michael Schopperle,Youngbin TAK. Владелец: Curemeta Therapeutics LLC. Дата публикации: 2019-11-13.

Benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent or anti-virus agent comprising the same

Номер патента: US12043644B2. Автор: Junghun KIM,Keumsoo SONG,Taisun Kim. Владелец: Biometrix Technology Inc. Дата публикации: 2024-07-23.

Novel benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent or anti-virus agent comprising the same

Номер патента: US20240018178A1. Автор: Junghun KIM,Keumsoo SONG,Taisun Kim. Владелец: Biometrix Technology Inc. Дата публикации: 2024-01-18.

Mixed ligand gold(III) complexes as anti-cancer agents

Номер патента: US9481693B1. Автор: Abdulaziz Al-Saadi,Muhammad Altaf,Anvarhusein Abdulkadir Isab,Said Al-Jaroudi. Владелец: KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS. Дата публикации: 2016-11-01.

Gold(III) anti-cancer agents

Номер патента: US09796734B2. Автор: Anvarhusein A. Isab,Muhammad Altaf. Владелец: KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS. Дата публикации: 2017-10-24.

Bis-(triethylphosphine)platinum(II) complexes with thiones as anti cancer agents

Номер патента: US09561237B1. Автор: Muhammad Altaf,Anvar Husain Abdul Kadir Isab. Владелец: KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS. Дата публикации: 2017-02-07.

Gold(iii) anti-cancer agents

Номер патента: US20170217994A1. Автор: Anvarhusein A. Isab,Muhammad Altaf. Владелец: KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS. Дата публикации: 2017-08-03.

Method of treating cancer and gold(iii) complexes as anti-cancer agents

Номер патента: US20170158713A1. Автор: Anvarhusein A. Isab,Muhammad Altaf. Владелец: KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS. Дата публикации: 2017-06-08.

Method of treating cancer and gold(III) complexes as anti-cancer agents

Номер патента: US9657035B1. Автор: Anvarhusein A. Isab,Muhammad Altaf. Владелец: KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS. Дата публикации: 2017-05-23.

Rna methyltransferase inhibitor, screening method therefor, anti-cancer agent efficacy assessment marker, and kit for effectively predicting ftsj1 inhibitor

Номер патента: US20230210834A1. Автор: Yoshinobu Ishikawa,Takayuki Ando,Atsushi Fujimura,Kengo Inoue,Kazuhito Tomizawa. Владелец: Pharma Valley Project Supporting Organization ISH. Дата публикации: 2023-07-06.

Arsenoplatin anti-cancer agents

Номер патента: US09725475B2. Автор: Thomas V. O'halloran,Denana U. Miodragovic. Владелец: Northwestern University. Дата публикации: 2017-08-08.

POTENTIATOR OF ACTIVITY OF ANTI-CANCER AGENT AND USE THEREOF, AND BIOMARKER FOR PREDICTION OF PROGNOSIS IN CANCER PATIENT AND USE THEREOF

Номер патента: US20130177660A1. Автор: Kikkawa Fumitaka,Takahashi Masahide,Kato Takuya. Владелец: National University Corporation Nagoya University. Дата публикации: 2013-07-11.

Method for treating a cancer with a mixed ligand gold(iii) complexes as anti-cancer agents

Номер патента: US20170071893A1. Автор: Abdulaziz Al-Saadi,Muhammad Altaf,Anvarhusein Abdulkadir Isab,Said Al-Jaroudi. Владелец: KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS. Дата публикации: 2017-03-16.

Method of treating cancer and gold(iii) complexes as anti-cancer agents

ANTI-CANCER AGENTS AND METHODS OF USE

Номер патента: US20150225426A1. Автор: Berdis Anthony J.. Владелец: CASE WESTERN RESERVE UNIVERSITY. Дата публикации: 2015-08-13.

Mixed ligand gold(i) complexes as anti-cancer agents

Номер патента: US20170305942A1. Автор: Muhammad Altaf,Said S. Al-Jaroudi,Ali ALHOSHANI,Anvarhusein Abdulkadir Isab. Владелец: KING SAUD UNIVERSITY. Дата публикации: 2017-10-26.

ARSENOPLATIN ANTI-CANCER AGENTS

Номер патента: US20170355722A1. Автор: "OHalloran Thomas V.",Miodragovic Denana U.. Владелец: . Дата публикации: 2017-12-14.

Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof

Номер патента: CN102131525A. Автор: 高桥雅英,加藤琢哉,吉川史隆. Владелец: Nagoya University NUC. Дата публикации: 2011-07-20.

Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents

Номер патента: US9428540B2. Автор: Finn Myhren,Marit Liland Sandvold,Ole Henrik Eriksen,Steinar Hagen. Владелец: CLAVIS PHARMA ASA. Дата публикации: 2016-08-30.

Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof

Номер патента: EP2322224A4. Автор: Takuya Kato,Masahide Takahashi,Fumitaka Kikkawa. Владелец: Nagoya University NUC. Дата публикации: 2012-02-29.

Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents

Номер патента: AU2008227246B2. Автор: Finn Myhren,Marit Liland Sandvold,Ole Henrik Eriksen,Steinar Hagen. Владелец: CLAVIS PHARMA ASA. Дата публикации: 2012-06-14.

Anti-cancer agent and method for killing cancer cells

Номер патента: EP3199152A4. Автор: Yoshihiro Ishikawa,Haruki Eguchi. Владелец: IHI Corp. Дата публикации: 2018-04-11.

Method for treating a cancer with a mixed ligand gold(III) complexes as anti-cancer agents

Номер патента: US9585861B1. Автор: Abdulaziz Al-Saadi,Muhammad Altaf,Anvarhusein Abdulkadir Isab,Said Al-Jaroudi. Владелец: KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS. Дата публикации: 2017-03-07.

Rna methyltransferase inhibitor, screening method therefor, anti-cancer agent efficacy assessment marker, and kit for effectively predicting ftsj1 inhibitor

Номер патента: WO2021039824A1. Автор: 隆幸安藤,一仁富澤,篤史藤村,吉伸石川,Kengo INOUE (井上謙吾). Владелец: 一般社団法人ファルマバレープロジェクト支援機構. Дата публикации: 2021-03-04.

Glcnac-cholestanol, cyclodextrin inclusion complexation thereof and liposomal formulations thereof as anti-cancer agents

Номер патента: IL189752A. Автор: . Владелец: Otsuka Pharma Co Ltd. Дата публикации: 2013-07-31.

Photoactivated anti-viral and anti-cancer agent

Номер патента: WO2004012667A2. Автор: Mark A. Billadeau,Harry Morrison,Elton Menon,Devanesan Loganathan,Taj Mohammad,Maribel Coromoto Navarro Acosta. Владелец: PURDUE RESEARCH FOUNDATION. Дата публикации: 2004-02-12.

Photoactivated anti-viral and anti-cancer agent

Номер патента: AU2003257992A1. Автор: Mark A. Billadeau,Harry Morrison,Elton Menon,Devanesan Loganathan,Taj Mohammad,Maribel Coromoto Navarro Acosta. Владелец: PURDUE RESEARCH FOUNDATION. Дата публикации: 2004-02-23.

Photoactivated anti-viral and anti-cancer agent

Номер патента: EP1546168A2. Автор: Harry Morrison,Elton Menon,Devanesan Loganathan,Taj Mohammad. Владелец: Loganathan Devaneson. Дата публикации: 2005-06-29.

Photoactivated anti-viral and anti-cancer agent

Номер патента: WO2004012667A3. Автор: Mark A Billadeau,Harry Morrison,Elton Menon,Devanesan Loganathan,Taj Mohammad,Acosta Maribel Coromot Navarro. Владелец: Acosta Maribel Coromot Navarro. Дата публикации: 2004-09-30.

Photoactivated anti-viral and anti-cancer agent

Номер патента: WO2004012667A8. Автор: Mark A Billadeau,Harry Morrison,Elton Menon,Devanesan Loganathan,Taj Mohammad,Acosta Maribel Coromot Navarro. Владелец: Acosta Maribel Coromot Navarro. Дата публикации: 2005-05-19.

Marker for determination of sensitivity to triplet combination anti-cancer agent

Номер патента: CA2819399A1. Автор: Masahiko Nishiyama,Satoru Wada,Hidetaka Eguchi. Владелец: Yakult Honsha Co Ltd. Дата публикации: 2012-06-07.

Anti-cancer agent comprising hvj-e and cxcl2

Номер патента: US20180243355A1. Автор: Toshihiro NAKAJIMA,Yasufumi Kaneda. Владелец: GENOMLDEA Inc. Дата публикации: 2018-08-30.

Anti-cancer agent comprising HVJ-E and CXCL2

Номер патента: US10441613B2. Автор: Toshihiro NAKAJIMA,Yasufumi Kaneda. Владелец: GenomIdea Inc. Дата публикации: 2019-10-15.

Antisense oligonucleotides for their use in an anti-cancer treatment

Номер патента: US20240158797A1. Автор: Sandrine Humbert,Frèdèric Saudou,Fabienne Agasse,Kassem Rayane. Владелец: Centre Hospitalier Universitaire de Grenoble. Дата публикации: 2024-05-16.

Spalax fibroblast-derived anti-cancer agents

Номер патента: US20180200304A1. Автор: Aaron Avivi,Imad Shams,Irena Manov. Владелец: CARMEL-HAIFA UNIVERSITY ECONOMIC DEVELOPMENT CORP Ltd. Дата публикации: 2018-07-19.

Stereocomplexes for the delivery of anti-cancer agents

Номер патента: US12029792B2. Автор: Der-Yang Tien. Владелец: Individual. Дата публикации: 2024-07-09.

Stereocomplexes for the delivery of anti-cancer agents

Номер патента: US20240350644A1. Автор: Der-Yang Tien. Владелец: Individual. Дата публикации: 2024-10-24.

Spalax fibroblast-derived anti-cancer agents

Номер патента: US20220079992A1. Автор: Aaron Avivi,Imad Shams,Irena Manov. Владелец: CARMEL-HAIFA UNIVERSITY ECONOMIC DEVELOPMENT CORP Ltd. Дата публикации: 2022-03-17.

Stereocomplexes for the delivery of anti-cancer agents

Номер патента: EP3891207A1. Автор: Der-Yang Tien. Владелец: Individual. Дата публикации: 2021-10-13.

Stereocomplexes for the delivery of anti-cancer agents

Номер патента: CA3121902A1. Автор: Der-Yang Tien. Владелец: Individual. Дата публикации: 2020-06-11.

Stereocomplexes for the delivery of anti-cancer agents

Номер патента: AU2019394855A1. Автор: Der-Yang Tien. Владелец: Individual. Дата публикации: 2021-06-24.

ANTHRACEN DERIVATIVES FOR USE AS AN ANTI-CANCER OR DYE

Номер патента: DE69408683T2. Автор: David Mincher. Владелец: Napier University Ventures Ltd. Дата публикации: 1998-10-01.

Isothiazole derivatives useful as anti-cancer agents, uses and methods for their preparation, as well as pharmaceutical composition

Номер патента: NO318798B1. Автор: Mark Carl Noe,Thomas George Gant,Eric Robert Larson. Владелец: Pfizer Prod Inc. Дата публикации: 2005-05-09.

Type 1, 4-naphtoquinone compounds, compositions comprising them and use of these compounds as anti-cancer agents

Номер патента: CA2650480A1. Автор: Michel Laguerre,Jean Dessolin,Gaeelle Depierre,Claude Commandeur. Владелец: Individual. Дата публикации: 2007-11-08.

Synthetic spiroketal pyranes as potent anti-cancer agents

Номер патента: CA2336294A1. Автор: Chen Mao,Fatih M. Uckun,Shyi-Tai Jan. Владелец: Individual. Дата публикации: 2000-01-06.

Substituted alkine derivatives as anti-cancer agents

Номер патента: WO2008098077A2. Автор: Bo Xu,Paula J. Bates,Gerald B. Hammond. Владелец: UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION. Дата публикации: 2008-08-14.

Rooperol and its derivatives

Номер патента: CA1293735C. Автор: Roelof Wilke Liebenberg,Siegfried Drewes. Владелец: Rooperol NA NV. Дата публикации: 1991-12-31.

Process for preparing (5s)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4- yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound

Номер патента: AU2022429647A1. Автор: Peter Fey,Britta Olenik,Heiko Schirmer,Guido Becker,Birgit Keil,Bernd Rösler,Julian Egger,Clemens Bothe,Helene Faber. Владелец: Bayer AG. Дата публикации: 2024-07-04.

2alpha-methyl-19-nor-1alpha-hydroxy-homopregnacalciferol and its uses

Номер патента: CA2588412A1. Автор: Hector F. DeLuca,Rafal R. Sicinski,Lori A. Plum,Margaret Clagett-Dame,Sumithra Gowlugari. Владелец: Individual. Дата публикации: 2006-06-01.

Imidazolone-chalcone derivatives as potential anticancer agent and process for the preparation thereof

Номер патента: EP2523941A2. Автор: Kamal Ahmed,Viswanath Arutla,Ramakrishna Gadupudi,Raju Paidakula,Balakishan Gorre,Balakrishna Moku. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2012-11-21.

Imidazolone-chalcone derivatives as potential anticancer agent and process for the preparation thereof

Номер патента: US20130066081A1. Автор: Kamal Ahmed,Viswanath Arutla,Ramakrishna Gadupudi,Raju Paidakula,Balakishan Gorre,Balakrishna Moku. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2013-03-14.

Indazoles substituted with an anti-cancerous activity

Номер патента: AU2003242808B2. Автор: Dominique Damour,Bruno Filoche,Corinne Terrier,Jean-Christophe Carry,Frederico Nardi,Patrick Nemecek,Daniel Bezard,Marie-Pierre Cherrier. Владелец: AVENTIS PHARMA SA. Дата публикации: 2008-09-18.

UNSATURATED AMINO COMPOUNDS FOR USE AS AN ANTI-CANCER AND ANTIPROTOZOIC AGENT.

Номер патента: ES2119371T3. Автор: Jörg Frei,Jaroslav Stanek. Владелец: NOVARTIS AG. Дата публикации: 1998-10-01.

(Poly)aminoalkylaminoacetamide compounds of epipodophyllotoxin, a process for their preparation, and their applications in therapeutics as anti-cancer agents

Номер патента: TW200604191A. Автор: Yves Guminski,Thierry Imbert,Anna Kruczynski,Jean-Marc Barret. Владелец: Pf Medicament. Дата публикации: 2006-02-01.

BIS(ARYLMETHYLIDENE)ACETONE COMPOUND, ANTI-CANCER AGENT, CARCINOGENESIS-PREVENTIVE AGENT, INHIBITOR OF EXPRESSION OF Ki-Ras, ErbB2, c-Myc AND CYCLINE D1, BETA-CATENIN-DEGRADING AGENT, AND p53 EXPRESSION ENHANCER

Номер патента: US20100152493A1. Автор: Hiroyuki Shibata,Hiroyuki Yamakoshi,Yoshiharu Iwabuchi,Hisatsugu Ohori,Yuichi Kakudo. Владелец: Individual. Дата публикации: 2010-06-17.

Melamine derivatives as potent anti-cancer agents

Номер патента: EP1189892A1. Автор: Fatih M. Uckun,Xing-Ping Liu,Rama K. Narla. Владелец: Parker Hughes Institute. Дата публикации: 2002-03-27.

Biaryl-pyridoquinazolinone derivatives as anti-cancer agents

Номер патента: WO1998023616A1. Автор: Nan Zhang,Douglas Bruce Kitchen,Michael Peter Trova. Владелец: American Cyanamid Company. Дата публикации: 1998-06-04.

Aza-podophyllotoxin analogues as potential anti-cancer agents

Номер патента: US11952383B1. Автор: Christophe Tratrat,Michelyne Haroun. Владелец: King Faisal University SA. Дата публикации: 2024-04-09.

PYRAZOLOPYRIDINE DERIVATIVES AS ANTI-CANCER AGENT

Номер патента: FR2951172A1. Автор: Arnaud Marchand,Hugues Bienayme,El Bachir Kaloun,Remi Rabot,Karim Bedjeguelal,Patrice Mayer,Nicolas Rahier,Philippe Schambel. Владелец: Pierre Fabre Medicament SA. Дата публикации: 2011-04-15.

Heterocyclic hydrazones as novel anti-cancer agents

Номер патента: CA2413971C. Автор: Gerhard PÜRSTINGER,Heinz-Herbert Fiebig,Johann Hofmann,Gottfried Heinisch,Johnny Easmon. Владелец: Innovationsagentur GmbH. Дата публикации: 2010-11-02.

Heterocyclic hydrazones as novel anti-cancer agents

Номер патента: CA2413971A1. Автор: Gerhard PÜRSTINGER,Heinz-Herbert Fiebig,Johann Hofmann,Gottfried Heinisch,Johnny Easmon. Владелец: Individual. Дата публикации: 2002-12-02.

Aza-podophyllotoxin analogues as potential anti-cancer agents

Номер патента: US11820779B1. Автор: Christophe Tratrat,Michelyne Haroun. Владелец: King Faisal University SA. Дата публикации: 2023-11-21.

Aza-Podophyllotoxin analogues as potential anti-cancer agents

Номер патента: US11858893B1. Автор: Christophe Tratrat,Michelyne Haroun. Владелец: King Faisal University SA. Дата публикации: 2024-01-02.

Melamine derivatives as potent anti-cancer agents

Номер патента: AU3714500A. Автор: Fatih M. Uckun,Xing-Ping Liu,Rama K. Narla. Владелец: Parker Hughes Institute. Дата публикации: 2001-01-09.

SHP2-Targeting Small Molecules For Use As Anti-Cancer Agents

Номер патента: US20240199525A1. Автор: Yehenew Agazie. Владелец: WEST VIRGINIA UNIVERSITY. Дата публикации: 2024-06-20.

A new class of highly apoptotic anti-cancer agents

Номер патента: WO2011099947A1. Автор: Ali Cagir,Pinar Kasaplar,Ozgur Yilmazer Cakmak. Владелец: Ali Cagir. Дата публикации: 2011-08-18.

Substituted tetrahydroisoquinoline ethylbenzamide anti-cancer agents

Номер патента: US20190100495A1. Автор: Kinfe Ken Redda,Suresh Kumar V. K. Eyunni. Владелец: Florida Agricultural and Mechanical University FAMU. Дата публикации: 2019-04-04.

Quinoline derivatives as anti-cancer agents

Номер патента: US09493419B2. Автор: Johnny Cheuk-on Tang,Albert Sun Chi CHAN,Kim Hung LAM,Sau Hing Chan. Владелец: Hong Kong Polytechnic University HKPU. Дата публикации: 2016-11-15.

Quinoline derivatives as anti-cancer agents

Номер патента: US20120165370A1. Автор: Johnny Cheuk-on Tang,Albert Sun Chi CHAN,Kim Hung LAM,Sau Hing Chan. Владелец: Hong Kong Polytechnic University HKPU. Дата публикации: 2012-06-28.

N-aminotetrahydroisoquinolines as anti-cancer agents

Номер патента: US20130109716A1. Автор: Kinfe Ken Redda,Madhavi Gangapuram. Владелец: Florida Agricultural and Mechanical University FAMU. Дата публикации: 2013-05-02.

CHROMAN-SUBSTITUTED, TETRAHYDROQUINOLINE-SUBSTITUTED AND THIOCHROMAN-SUBSTITUTED HETEROAROTINOIDS AS ANTI-CANCER AGENTS

Номер патента: US20200062711A1. Автор: Watts,BUNCE Richard A.,GNANASEKARAN Krishna Kumar,BERLIN KENNETH DARRELL,JR. FIELD M.,ZHOU DONGHUA HOWARD. Владелец: . Дата публикации: 2020-02-27.

SUBSTITUTED TETRAHYDROISOQUINOLINE ETHYLBENZAMIDE ANTI-CANCER AGENTS

Номер патента: US20190100495A1. Автор: Redda Kinfe Ken,Eyunni Suresh Kumar V. K.. Владелец: . Дата публикации: 2019-04-04.

Bis-diazeniumdiolate compounds as anti-cancer agents

Номер патента: US20190106396A1. Автор: Shengxi Chen. Владелец: Arizona Board of Regents of ASU. Дата публикации: 2019-04-11.

CHROMAN-SUBSTITUTED, TETRAHYDROQUINOLINE-SUBSTITUTED AND THIOCHROMAN-SUBSTITUTED HETEROAROTINOIDS AS ANTI-CANCER AGENTS

Номер патента: US20210163415A1. Автор: Watts,BUNCE Richard A.,GNANASEKARAN Krishna Kumar,BERLIN KENNETH DARRELL,JR. FIELD M.,ZHOU DONGHUA HOWARD. Владелец: THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY. Дата публикации: 2021-06-03.

Nimbolide Analogs As Anti-Cancer Agents And Preparation Thereof

Номер патента: US20210171538A1. Автор: Mukhopadhyay Debabrata,Mainkar Prathama Satyendra,Kumar Togapur Pavan,Chandrasekhar Srivari,Nagaraju Karre,Ramesh Ummanni,Tejaswini Kanchanapally,Kumar Jerald Mahesh,Babu Katragadda Suresh,Sastry Boggavarapu Subrahmanya. Владелец: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH. Дата публикации: 2021-06-10.

4-ANILINO-QUINOLINE COMPOUNDS AS ANTI-CANCER AGENTS

Номер патента: US20200181089A1. Автор: Martin Anthony,PASSERON Thierry,BENHIDA Rachid,DAO Pascal,DE DONATIS Gian Marco. Владелец: . Дата публикации: 2020-06-11.

Nimbolide analogs as anti-cancer agents and preparation thereof

Номер патента: US20190211027A1. Автор: KATRAGADDA Suresh Babu,SRIVARI Chandrasekhar,TOGAPUR Pavan Kumar,PRATHAMA Satyendra Mainkar,Debabrata Mukhopadhyay,Ummanni RAMESH,Boggavarapu Subrahmanya Sastry,Karre Nagaraju,Kanchanapally Tejaswini,Jerald Mahesh Kumar. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2019-07-11.

HETEROCYCLIC CONSTRAINED TRICYCLIC SULFONAMIDES AS ANTI-CANCER AGENTS

Номер патента: US20180251444A1. Автор: OHLMEYER Michael,ZAWARE Nilesh. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2018-09-06.

HETEROCYCLES USEFUL AS ANTI-CANCER AGENTS

Номер патента: US20180370991A1. Автор: Liu Shifeng,ZHANG Hancheng. Владелец: . Дата публикации: 2018-12-27.

Tricyclic derivatives and their use as anti-cancer agents

Номер патента: EP0635507A1. Автор: Andrew John Barker. Владелец: Zeneca Ltd. Дата публикации: 1995-01-25.

Quinazoline derivatives and their use as anti-cancer agents

Номер патента: EP0635498A1. Автор: Andrew John Barker. Владелец: Zeneca Ltd. Дата публикации: 1995-01-25.

Heterocyclic limited tricyclic sulfonamides as anti-cancer agents

Номер патента: JP6966425B2. Автор: オールメイヤー，マイケル,ザワレ，ニーレシュ. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2021-11-17.

HETEROCYCLIC COMPOUNDS AND THEIR APPLICATION AS ANTI-CANCER AGENTS

Номер патента: RU2012140020A. Автор: Лун МАО,Сяобо ВАН,Сяо СЮЙ,Ли ЧЖАО,Цзя ЛЮ. Владелец: Ацея Байосайенсиз Инк.. Дата публикации: 2014-03-27.

Dipeptidylquinazolones as anti-cancer agents

Номер патента: CA2117543C. Автор: Vassilios Bavetsias,Graham M. F. Bisset. Владелец: British Technology Group Ltd. Дата публикации: 2002-12-03.

N-monoacylated o-phenylenediamines as anti -cancer agents

Номер патента: WO2004069133A2. Автор: Manfred Kubbies,Michael Weidner,Anja Limberg,Ulrike Reiff,Frank Herting,Georg Fertig. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2004-08-19.

N-monoacylated o-phenylenediamines as anti -cancer agents

Номер патента: WO2004069133A3. Автор: Manfred Kubbies,Michael Weidner,Anja Limberg,Ulrike Reiff,Frank Herting,Georg Fertig. Владелец: Hoffmann La Roche. Дата публикации: 2004-11-25.

Variolin derivatives as anti-cancer agents

Номер патента: AU2001270783B2. Автор: Ignacio Manzanares,Regan James Anderson,Jonathan Charles Morris,Modesto Remuinan. Владелец: Pharmamar SA. Дата публикации: 2006-06-15.

4-anilino-quinoline compounds as anti-cancer agents

Номер патента: CA3029889A1. Автор: Thierry Passeron,Rachid BENHIDA,Pascal DAO,Gian Marco DE DONATIS,Anthony Martin. Владелец: Universite de Nice Sophia Antipolis UNSA. Дата публикации: 2018-01-11.

Cis-dihalo-bis(ethyleneimine) platinum (ii) derivs - anti-cancer agents

Номер патента: FR2182943A1. Автор: . Владелец: Rustenburg Platinum Mines Ltd. Дата публикации: 1973-12-14.

Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agent

Номер патента: US20100261740A1. Автор: Nannapaneni Venkaiah Chowdary,Bhujanga Rao Adibhatla Kali Satya,MUDDASANI Pulla Reddy,Durga Prasad Konkanchi,Subba Rao Pula,Lakshmi Anathaneni. Владелец: Natco Pharma Ltd. Дата публикации: 2010-10-14.

PLATINUM BODY COMPLEX PARTS COLARLY USEFUL AS ANTI-CANCER AGENT

Номер патента: IT8167551D0. Автор: Kenji Yamaguchi,Tetsushi Totani. Владелец: Shionogi & Co. Дата публикации: 1981-04-23.

Substituted lactams and their use as anti-cancer agents

Номер патента: CA2533335A1. Автор: Frederick Ray Kinder, Jr.,Kenneth Walter Bair,Richard William Versace. Владелец: Individual. Дата публикации: 2005-02-17.

Hypoxia-Activated Anti-Cancer Agents

Номер патента: US20080132458A1. Автор: Mark Matteucci,Jian-Xin Duan. Владелец: Threshold Pharmaceuticals Inc. Дата публикации: 2008-06-05.

Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment

Номер патента: CA2458009A1. Автор: Andrew D. Hamilton,Hairuo Peng,Said Sebti. Владелец: Individual. Дата публикации: 2003-03-06.

Substituted thiophene derivatives as anti-cancer agents

Номер патента: AU2005228899A1. Автор: Annette Walter,Yasheen Zhou,Xiaodong Lin,Alice Rico,Ann B. Jefferson,Xiaojing Michael Wang. Владелец: Chiron Corp. Дата публикации: 2005-10-13.

Inhibitors of cyclin dependent kinases as anti-cancer agent

Номер патента: AU2002249389B2. Автор: Peter Martin Fischer,Shudong Wang,Gavin Wood. Владелец: Cyclacel Ltd. Дата публикации: 2008-03-13.

Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents

Номер патента: US20070155807A1. Автор: James Dalton,Duane Miller,Veeresa Gududuru,Eunju Hurh. Владелец: Ohio State University Research Foundation. Дата публикации: 2007-07-05.

N-monoacylated o-phenylenediamines as anti -cancer agents

Номер патента: CA2513401A1. Автор: Manfred Kubbies,Michael Weidner,Anja Limberg,Ulrike Reiff,Frank Herting,Georg Fertig. Владелец: Georg Fertig. Дата публикации: 2004-08-19.

Inhibitors of cyclin dependent kinases as anti-cancer agent

Номер патента: US20040132746A1. Автор: Peter Fischer,Shudong Wang,Gavin Wood. Владелец: Cyclacel Ltd. Дата публикации: 2004-07-08.

NOVEL DIHYDROPYRIMIDINE DERIVATIVES AND THEIR USE AS ANTI-CANCER AGENTS

Номер патента: FR2883284A1. Автор: Roman Lopez,Bernard Rousseau,Frank Kozielski,Dimitrios Skoufias,Bonis Salvatore De. Владелец: Commissariat a lEnergie Atomique CEA. Дата публикации: 2006-09-22.

Novel dihydroxypyrrolidine derivatives as anti-cancer agents

Номер патента: WO2009118712A3. Автор: Pierre Vogel,Claudia Bello. Владелец: ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL). Дата публикации: 2010-01-07.

SUBSTITUTE QUINAZOLINE AND PYRIDOPYRIMIDINE DERIVATIVES USEFUL AS ANTI-CANCER AGENTS

Номер патента: UY38070A. Автор: Ping Chen,Michael Raymond Collins,Andreas Maderna,Maria Angelica Linton,Hengmiao Cheng,Asako Nagata,Simon Planken,Alexei Brooun,Cynthia Palmer,Jillian Elyse Spangler. Владелец: Pfizer. Дата публикации: 2019-08-30.

Quercetin derivatives as anti-cancer agents

Номер патента: WO2009019721A2. Автор: Manu Jaggi,Anu T. Singh,Anshumali Awasthi,Pawan Aggarwal,Ritu Verma,Narendra Shriram Joshi,Vitthalbhai Ketan Hirpara. Владелец: Dabur Pharma Limited. Дата публикации: 2009-02-12.

Substituted 2,3-dihydro-1H-benzo[a]pyrano[2,3-c]phenazines as anti-angiogenic and anti-cancer agents

Номер патента: US9181265B2. Автор: Olivier Feron,Robert Kiss,Olivier Riant,Joelle Leclercq,Gabrielle Chataigne,Nicolas Vandelaer,Carole Lamy. Владелец: Universite Catholique de Louvain (UCL). Дата публикации: 2015-11-10.

Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment

Номер патента: EP2014291A3. Автор: Andrew D. Hamilton,Hairuo Peng,Said Sebti. Владелец: UNIVERSITY OF SOUTH FLORIDA. Дата публикации: 2009-06-17.

Substituted quinazolones as anti-cancer agents

Номер патента: CA2568756A1. Автор: John Lee,Brian Aquila,Jayachandran Ezhuthachan,Paul Lyne,Timothy Pontz,Les Dakin. Владелец: Les Dakin. Дата публикации: 2005-12-29.

Hypoxia-activated anti-cancer agents

Номер патента: WO2005086951A2. Автор: Mark Matteucci,Jian-Xin Duan. Владелец: Threshold Pharmaceuticals, Inc.. Дата публикации: 2005-09-22.

Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents

Номер патента: CA2997769A1. Автор: Michael Ohlmeyer,Nilesh ZAWARE. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2017-03-16.

Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents

Номер патента: EP3347350A1. Автор: Michael Ohlmeyer,Nilesh ZAWARE. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2018-07-18.

CAMPTOTECIN DERIVATIVES AND THEIR USE AS ANTI-CANCER AGENTS

Номер патента: IT1282673B1. Автор: Sergio Penco,Lucio Merlini,Franco Zunino. Владелец: Ist Naz Stud Cura Dei Tumori. Дата публикации: 1998-03-31.

SUBSTITUTES OF SUBSTITUTED THIOPHENE AS ANTI-CANCER AGENTS

Номер патента: RU2006138036A. Автор: Яшин Чжоу,Сяодун ЛИН,Элис Рико,Энн Б. ДЖЕФФЕРСОН,Аннетт УОЛТЕР,Сяоцзин Майкл ВАН,Яшин ЧЖОУ (US),С одун ЛИН (US),Элис РИКО (US),Энн Б. ДЖЕФФЕРСОН (US),Аннетт УОЛТЕР (US),С оцзин Майкл ВАН (US). Владелец: Чирон Корпорейшн (Us). Дата публикации: 2008-05-10.

Bisanthrapyrazoles as anti-cancer agents

Номер патента: WO2009004496A2. Автор: Hong Liang,Brian B. Hasinoff,Lynn J. Guziec,Frank Guziec. Владелец: UNIVERSITY OF MANITOBA. Дата публикации: 2009-01-08.

Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents

Номер патента: CA2703767A1. Автор: Nannapaneni Venkaiah Chowdary,Bhujanga Rao Adibhatla Kali Satya,MUDDASANI Pulla Reddy,DURGA PRASAD Konakanchi,Subba Rao Pula,Lakshmi Ananthaneni. Владелец: Lakshmi Ananthaneni. Дата публикации: 2009-05-07.

Inhibitors of cyclin dependent kinases as anti-cancer agent

Номер патента: WO2002079193A1. Автор: Peter Martin Fischer,Shudong Wang,Gavin Wood. Владелец: CYCLACEL LIMITED. Дата публикации: 2002-10-10.

Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents

Номер патента: EP2220054A2. Автор: Nannapaneni Venkaiah Chowdary,Bhujanga Rao Adibhatla Kali Satya,MUDDASANI Pulla Reddy,DURGA PRASAD Konakanchi,Subba Rao Pula,Lakshmi Ananthaneni. Владелец: Natco Pharma Ltd. Дата публикации: 2010-08-25.

NEW DERIVATIVES OF 5-FLUOROURACIL, USEFUL IN PARTICULAR AS ANTI-CANCER AGENTS AND THEIR PREPARATION PROCESS

Номер патента: FR2363562A1. Автор: . Владелец: Ono Pharmaceutical Co Ltd. Дата публикации: 1978-03-31.

Variolin derivatives as anti-cancer agents

Номер патента: US20050014778A1. Автор: Jonathan Morris,Ignacio Manzanares,Modesto Remuinan,Regan Anderson. Владелец: Pharmamar SA. Дата публикации: 2005-01-20.

Novel Dihydropyrimidine Derivatives And Their Use As Anti-Cancer Agents

Номер патента: US20080145453A1. Автор: Roman Lopez,Bernard Rousseau,Dimitrios Skoufias,Frank Kozielsky,Salvatore De Bonis. Владелец: Commissariat a lEnergie Atomique CEA. Дата публикации: 2008-06-19.

Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents

Номер патента: WO2009098715A3. Автор: Nannapaneni Venkaiah Chowdary,Bhujanga Rao Adibhatla Kali Satya,MUDDASANI Pulla Reddy,DURGA PRASAD Konakanchi,Subba Rao Pula,Lakshmi Ananthaneni,Ramakrishna Pilli. Владелец: NATCO PHARMA LIMITED. Дата публикации: 2009-10-15.

Dihydrodibenzo(de,h)isoquinolines derivatives and their use as anti-cancer agents

Номер патента: CA2188833A1. Автор: Miguel Fernandez Brana,Jose Maria Castellano Berlanga,Cynthia Romerdahl. Владелец: Individual. Дата публикации: 1995-11-09.

Azabenzimidazole Derivatives, Their Manufacture and Use as Anti-Cancer Agents

Номер патента: US20090227578A1. Автор: Wolfgang Schaefer,Petra Rueger,Richard Engh,Stefan Scheiblich,Manfred Schwaiger,Hubert Hertenberger,Konrad Honold,Birgit Masjost. Владелец: Hoffmann La Roche Inc. Дата публикации: 2009-09-10.

Azine-carboxamides as anti-cancer agent

Номер патента: CN101023063A. Автор: P·赖恩,B·阿奎拉,S·伊奥安尼迪斯,T·庞特茨. Владелец: AstraZeneca AB. Дата публикации: 2007-08-22.

Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents

Номер патента: UA101168C2. Автор: Дурга Прасад Конаканчи,Субба Рао Пула,Лакшми Анантанели,Редди Муддасани Пулла,Кали Сатиа Бхуджанга Рао Адибхатла,Човдари Наннапанени Венкаиах. Владелец: Натко Фарма Лимитед. Дата публикации: 2013-03-11.

Substituted quinazolines as anti-cancer agents

Номер патента: IL179580A0. Автор: . Владелец: Lee John W. Дата публикации: 2007-05-15.

Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment

Номер патента: AU2002332640B2. Автор: Andrew D. Hamilton,Hairuo Peng,Said Sebti. Владелец: UNIVERSITY OF SOUTH FLORIDA. Дата публикации: 2007-11-08.

SPIRINE DERIVATIVES PARTENIN AS NEW ANTI-CANCER AGENTS

Номер патента: RU2010140598A. Автор: Махабаларао Сампатх Кумар ХАЛМУТХУР,Аджит Кумар САКСЕНА,Субхаш Чандра ТАНЕДЖА,Шашанк Кумар СИНГХ,Виджай Кумар СЕТХИ,Навид Ахмед КВАЗИ,Сангхапал Дамодхар САВАНТ,Махендхар Редди ДОМА,Абид Хуссайн БАНДАЙ,Моника ВЕРМА,Гхуларн Наби КВАЗИ,Махабаларао Сампатх Кумар ХАЛМУТХУР (IN),Аджит Кумар САКСЕНА (IN),Субхаш Чандра ТАНЕДЖА (IN),Шашанк Кумар СИНГХ (IN),Виджай Кумар СЕТХИ (IN),Навид Ахмед КВАЗИ (IN),Сангхапал Дамодхар САВАНТ (IN),Махендхар Редди ДОМА (IN),Абид Хуссайн БАНДАЙ (IN),Моника ВЕРМА (IN),Гхуларн Наби КВАЗИ (IN). Владелец: Каунсил Оф Сайентифик Энд Индастриал Рисерч (In). Дата публикации: 2012-04-10.

Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents

Номер патента: CA2614156A1. Автор: Wolfgang Schaefer,Petra Rueger,Richard Engh,Stefan Scheiblich,Manfred Schwaiger,Hubert Hertenberger,Konrad Honold,Birgit Masjost. Владелец: Birgit Masjost. Дата публикации: 2007-02-15.

Substituted Quinazolones as Anti-Cancer Agents

Номер патента: US20080275022A1. Автор: John Lee,Brian Aquila,Jayachandran Ezhuthachan,Paul Lyne,Timothy Pontz,Les Dakin. Владелец: AstraZeneca AB. Дата публикации: 2008-11-06.

Heterocyclic hydrazones for use as anti-cancer agents

Номер патента: EP1361224A1. Автор: Gottfried Institut Fur Pharmazie Heinisch,Johnny Institut Fur Pharmazie Easmon,Gerhard Institut Fur Pharmazie Purstinger,Heinz-Herbert Oncotest Gmbh Fiebig,Johann Inst. für Med. C.u.B. der Uni I. Hoffmann. Владелец: Innovationsagentur GmbH. Дата публикации: 2003-11-12.

Substituted quinazolones as anti-cancer agents

Номер патента: EP1761506A1. Автор: Brian AstraZeneca R & D Boston AQUILA,Timothy AstraZeneca R & D Boston PONTZ,Paul AstraZeneca R & D Boston LYNE,Les AstraZeneca R & D Boston DAKIN,Jayachandran AstraZeneca R & D EZHUTHACHAN,John AstraZeneca R & D Boston LEE. Владелец: AstraZeneca AB. Дата публикации: 2007-03-14.

7-aryl-6(z)heptatrienoic acid retinamides as apoptosis inducing compounds and their use as anti-cancer agents

Номер патента: CA2355714A1. Автор: Adrian Wai-Hing Cheung,Louise Helen Foley,Allen J. Lovey,Stephen B. Ferguson. Владелец: Individual. Дата публикации: 2000-06-22.

Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment

Номер патента: EP2014291A2. Автор: Andrew D. Hamilton,Hairuo Peng,Said Sebti. Владелец: UNIVERSITY OF SOUTH FLORIDA. Дата публикации: 2009-01-14.

Variolin derivatives as anti-cancer agents

Номер патента: WO2002004447A1. Автор: Ignacio Manzanares,Regan James Anderson,Jonathan Charles Morris,Modesto Remuinan. Владелец: Ruffles, Graham, Keith. Дата публикации: 2002-01-17.

Substituted quinazolones as anti-cancer agents

Номер патента: AU2005254771A1. Автор: John Lee,Brian Aquila,Jayachandran Ezhuthachan,Paul Lyne,Timothy Pontz,Les Dakin. Владелец: AstraZeneca AB. Дата публикации: 2005-12-29.

Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents

Номер патента: AU2008320342A2. Автор: Nannapaneni Venkaiah Chowdary,Bhujanga Rao Adibhatla Kali Satya,MUDDASANI Pulla Reddy,DURGA PRASAD Konakanchi,Subba Rao Pula,Lakshmi Ananthaneni. Владелец: Natco Pharma Ltd. Дата публикации: 2010-09-02.

Purine derivatives useful as anti - cancer agents

Номер патента: WO2010111406A3. Автор: In Chul Kim,Michael Saunders,Dange Vijay Kumar,J. Adam Willardsen,Jeffrey W. Lockman,Weston R. Judd,Daniel Feodore Zigar,Kraig M. Yager,Daniel P. Parker,Ian A. Mcalexander,Matthew Gregory Bursavich,Mark D. Shenderovich,Paul M. Slattum,Christophe Hoarau,David A. Gerrish,Brandi L. Williams,Keith D. Tardif. Владелец: Myriad Pharmaceuticals, Inc.. Дата публикации: 2011-07-07.

Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti-cancer agents

Номер патента: US20100298351A1. Автор: Nannapaneni Venkaiah Chowdary,MUDDASANI Pulla Reddy,DURGA PRASAD Konakanchi,Subba Rao Pula,Lakshmi Ananthaneni,Ramakrishna Pilli,Bhujanga Rao Adibhatla Satya. Владелец: Natco Pharma Ltd. Дата публикации: 2010-11-25.

Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents

Номер патента: US10759790B2. Автор: Michael Ohlmeyer,Nilesh ZAWARE. Владелец: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2020-09-01.

Heterocyclic hydrazones for use as anti-cancer agents

Номер патента: US20030166658A1. Автор: Gerhard PÜRSTINGER,Heinz-Herbert Fiebig,Johann Hofmann,Gottfried Heinisch,Johnny Easmon. Владелец: Johnny Easmon. Дата публикации: 2003-09-04.

SPIRINE DERIVATIVES PARTENIN AS NEW ANTI-CANCER AGENTS

Номер патента: RU2013141438A. Автор: Махабаларао Сампатх Кумар ХАЛМУТХУР,Аджит Кумар САКСЕНА,Субхаш Чандра ТАНЕДЖА,Шашанк Кумар СИНГХ,Виджай Кумар СЕТХИ,Навид Ахмед КВАЗИ,Сангхапал Дамодхар САВАНТ,Махендхар Редди ДОМА,Абид Хуссайн БАНДАЙ,Моника ВЕРМА,Гхуларн Наби КВАЗИ. Владелец: Каунсил Оф Сайентифик Энд Индастриал Рисерч. Дата публикации: 2015-03-20.

4-anilino-quinoline compounds as anti-cancer agents

Номер патента: WO2018007648A1. Автор: Thierry Passeron,Rachid BENHIDA,Pascal DAO,Anthony Martin,Donatis Gian Marco De. Владелец: CHU de Nice. Дата публикации: 2018-01-11.

Inhibitors of cyclin dependent kinases as anti-cancer agent

Номер патента: EP1373253A1. Автор: Peter Martin Fischer,Shudong Wang,Gavin Wood. Владелец: Cyclacel Ltd. Дата публикации: 2004-01-02.

Inhibitors of cyclin dependent kinases as anti-cancer agent

Номер патента: CA2440228A1. Автор: Peter Martin Fischer,Shudong Wang,Gavin Wood. Владелец: Individual. Дата публикации: 2002-10-10.

Bis-diazeniumdiolate compounds as anti-cancer agents

Номер патента: US20190106396A1. Автор: Shengxi Chen. Владелец: Arizona Board of Regents of ASU. Дата публикации: 2019-04-11.

N-aminotetrahydroisoquinolines as anti-cancer agents

Aryl-substituted benzimidazole and imidazopyridine ethers as anti-cancer agents

Номер патента: CA2572218A1. Автор: Alice Lee-Dutra,J. Guy Breitenbucher,Danielle K. Neff. Владелец: Individual. Дата публикации: 2006-01-12.

Aryl-substituted benzimidazole and imidazopyridine ethers as anti-cancer agents

Номер патента: EP1824832A1. Автор: Alice Lee-Dutra,J. Guy Breitenbucher,Danielle K. Neff. Владелец: Janssen Pharmaceutica NV. Дата публикации: 2007-08-29.

New carbazole derivatives sensitizing cells to anti-cancer agents

Номер патента: EP3804812A1. Автор: Jean-Charles Lancelot,Sylvain Rault,Patrick Dallemagne,Peggy Suzanne,Eric Denarier,Laurence Lafanechere,Renaud Prudent,Serge Perato,Lauralie PERONNE,Marc BILLAUD,Audrey VERNET,Aurélien Lesnard. Владелец: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS. Дата публикации: 2021-04-14.

Substituted afpo (6-aryl-4h-furo[3,2-c]pyran-4-one) derivatives as anti-cancer agents

Номер патента: WO2010080415A3. Автор: Pei-Chi Wu,Yizhou Dong,Kuo-Hsiung Lee,Kenneth F. Bastow,Qian Shi. Владелец: The University of North Carolina at Chapel Hill. Дата публикации: 2010-11-25.

Personalized anti -cancer agent screening system

Номер патента: US20230213501A1. Автор: Do Hyun Nam,Kyeung Min Joo. Владелец: Aimed Bio Inc. Дата публикации: 2023-07-06.

Method for screening patient-specific anti-cancer agent using limiting dilution assay

Номер патента: US09562891B2. Автор: Do Hyun Nam,Kyeung Min Joo,YeonSook Choi. Владелец: SAMSUNG LIFE PUBLIC WELFARE FOUNDATION. Дата публикации: 2017-02-07.

Synthesis and improvement of a nucleoside analogue as an anti-cancer and anti-viral drug

Номер патента: WO2021101475A1. Автор: Seyithan Taysi,Omeed Akbar Ali Ali,Firas Shawqi Abdulrazzaq Al-Gburi. Владелец: Gaziantep Universitesi Rektorlugu. Дата публикации: 2021-05-27.

Synthesis and improvement of a nucleoside analogue as an anti-cancer and anti-viral drug

Номер патента: EP4114406A1. Автор: Seyithan Taysi,Omeed Akbar Ali Ali,Firas Shawqi Abdulrazzaq Al-Gburi. Владелец: Gaziantep Universitesi. Дата публикации: 2023-01-11.

Process for the preparation of 1-(2'-deoxy-2',2'-difluoro- d-ribopentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro- beta-d-ribo-pentopyranose

Номер патента: CA2168080C. Автор: David Dale Wirth. Владелец: Eli Lilly and Co. Дата публикации: 2007-05-29.

Chemical compound for inhibition of SHP2 function and for use as an anti-cancer agent

Номер патента: US9932288B2. Автор: Yehenew Agazie,Zachary Hartman. Владелец: WEST VIRGINIA UNIVERSITY. Дата публикации: 2018-04-03.

Synthesis and improvement of a nucleoside analogue as an anti-cancer and anti-viral drug

Номер патента: EP4114406A4. Автор: Seyithan Taysi,Omeed Akbar Ali Ali,Firas Shawqi Abdulrazzaq Al-Gburi. Владелец: Gaziantep Universitesi. Дата публикации: 2024-02-28.

PROCESS FOR THE MANUFACTURE OF NUCLEOSIDE DERIVATIVES USEFUL IN PARTICULAR AS ANTI-CANCER AGENTS

Номер патента: FR2574412B1. Автор: Chung Il Hong. Владелец: Boryung Pharmaceutical Co Ltd. Дата публикации: 1989-06-09.

Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same

Номер патента: CA2454799A1. Автор: Dong Huang,Dong Feng Qi. Владелец: Individual. Дата публикации: 2003-02-06.

6- or 7-methylenandrosta-1,4-diene-3,17-dione derivatives and process for their preparation

Номер патента: US4824830A. Автор: Paolo Lombardi,Franco Buzzetti,Enrico DI Salle,Natale Barbugian. Владелец: Farmitalia Carlo Erba SRL. Дата публикации: 1989-04-25.

Novel benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent comprising the same

Номер патента: EP3907230B1. Автор: Junghun KIM,Keumsoo SONG,Taisun Kim. Владелец: Biometrix Technology Inc. Дата публикации: 2024-08-28.

Transition metal complexes of amino acids and related ligands and their use as catalysts, anti-microbials, and anti-cancer agents

Номер патента: US20130096090A1. Автор: Joseph S. Merola. Владелец: Virginia Tech Intellectual Properties Inc. Дата публикации: 2013-04-18.

2-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents

Номер патента: CA2102782A1. Автор: John A. Montgomery,John A. Secrist. Владелец: John A. Secrist. Дата публикации: 1992-11-11.

Phosphate ester derivatives, and their use as anti-cancer agents.

Номер патента: ES8704918A1. Автор: . Владелец: Sankyo Co Ltd. Дата публикации: 1987-04-16.

Process for preparing novel crystalline forms of (2s)-1-[[(7r)-7-(3,4-dichlorophenyl)-4,7-dihydro-5-methylpyrazolo[1,5]pyrimidine-6-yl]carbonyl]-2-(4-fluorophenyl) pyrrolidine, novel stable forms produced therein and formulations

Номер патента: CA2589468A1. Автор: Lin Yan,Jack Z. Gougoutas,John D. Dimarco,Rajesh Babulal Gandhi,Chiajen Lai,Nachimuthu Soundararajan,Xuebao Wang,Nina Nguyen,Krishnaswamy Srinivas Raghavan,Lori S. Burton,Xiaotian Yin,Yuji Simon Zhou,Weiming Ying,Ronald C. West. Владелец: Individual. Дата публикации: 2006-06-01.

METHOD OF DELIVERING AN ANTI-CANCER AGENT TO A CELL

Номер патента: US20160106706A1. Автор: Ying Jackie Y.,Kurisawa Motoichi,CHUNG Joo Eun. Владелец: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH. Дата публикации: 2016-04-21.

METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY

Номер патента: US20130171135A1. Автор: Scherer Stefan,ANDRES Herbert,De Haas Sanne Lysbet,Karl Johann,Wild Norbert. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2013-07-04.

METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY

Номер патента: US20130183300A1. Автор: Scherer Stefan,ANDRES Herbert,De Haas Sanne Lysbet,Karl Johann,Wild Norbert. Владелец: Hoffmann-La Roche Inc.. Дата публикации: 2013-07-18.

METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY

Номер патента: US20130243758A1. Автор: Scherer Stefan,ANDRES Herbert,De Haas Sanne Lysbet,Karl Johann,Wild Norbert. Владелец: Hoffmann-La Roche Inc.. Дата публикации: 2013-09-19.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: US20130336959A1. Автор: Scherer Stefan,ANDRES Herbert,De Haas Sanne Lysbet,Karl Johann,Wild Norbert,Elliott Rebecca,Meng Yu-Ju Gloria,Plowman Gregory D.. Владелец: . Дата публикации: 2013-12-19.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: US20130344059A1. Автор: Scherer Stefan,ANDRES Herbert,De Haas Sanne Lysbet,Karl Johann,Wild Norbert,Elliott Rebecca,Meng Yu-Ju Gloria,Plowman Gregory D.. Владелец: . Дата публикации: 2013-12-26.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: US20130344060A1. Автор: Herbert Andres,Johann Karl,Sanne Lysbet De Haas,Stefan Scherer,Norbert Wild. Владелец: Hoffmann La Roche Inc. Дата публикации: 2013-12-26.

METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY

Номер патента: US20140017232A1. Автор: Scherer Stefan,ANDRES Herbert,De Haas Sanne Lysbet,Karl Johann,Wild Norbert,Elliott Rebecca,Meng Yu-Ju Gloria,Plowman Gregory D.. Владелец: . Дата публикации: 2014-01-16.

METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY

Номер патента: US20140023639A1. Автор: Scherer Stefan,ANDRES Herbert,De Haas Sanne Lysbet,Karl Johann,Wild Norbert,Elliott Rebecca,Meng Yu-Ju Gloria,Plowman Gregory D.. Владелец: . Дата публикации: 2014-01-23.

METHOD TO IDENTIFY A PATEINT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY

Номер патента: US20140023640A1. Автор: Scherer Stefan,ANDRES Herbert,De Haas Sanne Lysbet,Karl Johann,Wild Norbert. Владелец: Hoffmann-La Roche Inc.. Дата публикации: 2014-01-23.

METHOD TO IDENTIFY A PATEINT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY

Номер патента: US20140056874A1. Автор: Scherer Stefan,ANDRES Herbert,De Haas Sanne Lysbet,Karl Johann,Wild Norbert,Elliott Rebecca,Meng Yu-Ju Gloria,Plowman Gregory D.. Владелец: . Дата публикации: 2014-02-27.

METHOD TO IDENTIFY A PATEINT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY

Номер патента: US20140056875A1. Автор: Scherer Stefan,ANDRES Herbert,De Haas Sanne Lysbet,Karl Johann,Wild Norbert,Elliott Rebecca,Meng Yu-Ju Gloria,Plowman Gregory D.. Владелец: . Дата публикации: 2014-02-27.

METHOD TO IDENTIFY A PATEINT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY

Номер патента: US20140056876A1. Автор: Scherer Stefan,ANDRES Herbert,De Haas Sanne Lysbet,Karl Johann,Wild Norbert. Владелец: Hoffmann-La Roche Inc.. Дата публикации: 2014-02-27.

USE OF ANTIBODIES AGAINST ICAM-1 IN COMBINATION WITH AN ANTI CANCER DRUG IN THE TREATMENT OF PATIENTS

Номер патента: US20150352207A1. Автор: Frendeus Bjorn,Hansson Markus. Владелец: . Дата публикации: 2015-12-10.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: WO2012010549A1. Автор: Herbert Andres,Johann Karl,Sanne Lysbet De Haas,Stefan Scherer,Norbert Wild. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2012-01-26.

Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy

Номер патента: CA2804246A1. Автор: Herbert Andres,Johann Karl,Sanne Lysbet De Haas,Stefan Scherer,Norbert Wild. Владелец: F Hoffmann La Roche AG. Дата публикации: 2012-01-26.

Agent improving anti-cancer effect and containing liposomal agent containing oxaliplatin, and anti-cancer agent containing liposomal agent

Номер патента: RU2492863C2. Автор: Тацухиро ИСИДА,Хироси КИВАДА. Владелец: Дзе Юниверсити Оф Токусима. Дата публикации: 2013-09-20.

Therapeutic use of at least one botulinum neurotoxin for managing pain indused by at least one anti-cancer agent

Номер патента: RU2483747C2. Автор: ДЕ ЛАССОНЬЕР Пьер-Этьенн ШАБРИЕ,Мишель ОГЕ,Кристин ФАВР. Владелец: Ипсен Фарма С.А.С.. Дата публикации: 2013-06-10.

Assay to identify anti-cancer agents

Номер патента: US20230349885A1. Автор: Angus Dalgleish,Wai LUI. Владелец: LDN Pharma Ltd. Дата публикации: 2023-11-02.

Assay to identify anti-cancer agents

Номер патента: US20200110070A1. Автор: Angus Dalgleish,Wai LUI. Владелец: LDN Pharma Ltd. Дата публикации: 2020-04-09.

Assay to identify anti-cancer agents

Номер патента: EP3602048A1. Автор: Angus Dalgleish,Wai LUI. Владелец: LDN Pharma Ltd. Дата публикации: 2020-02-05.

Assay to identify anti-cancer agents

Номер патента: WO2018178675A1. Автор: Angus Dalgleish,Wai LUI. Владелец: LDN Pharma Limited. Дата публикации: 2018-10-04.

Assay to identify anti-cancer agents

Номер патента: US11885796B2. Автор: Angus Dalgleish,Wai LUI. Владелец: LDN Pharma Ltd. Дата публикации: 2024-01-30.

Anti-cancer agent

Номер патента: US20060030517A1. Автор: Toshikazu Nakamura. Владелец: Individual. Дата публикации: 2006-02-09.

Cancer therapy using a combination of cdk7 inhibitor with an anti-cancer agent

Номер патента: US20240277722A1. Автор: Ramulu Poddutoori,Akhil Kumar,Leena KHARE. Владелец: Aurigene Oncology Ltd. Дата публикации: 2024-08-22.

Anti-cancer agent

Номер патента: US20170027968A1. Автор: Takashi Nakano,Tomoyuki Nishizaki. Владелец: KTN BIOTEC Inc. Дата публикации: 2017-02-02.

Anti-cancer agent containing a diacylphosphatidylethanolamine as an active ingredient

Номер патента: US9770458B2. Автор: Takashi Nakano,Tomoyuki Nishizaki. Владелец: Nishizaki Bioinformation Research Institute. Дата публикации: 2017-09-26.

Anti-cancer agent containing a diacylphosphatidylethanolamine as an active ingredient

Номер патента: US09770458B2. Автор: Takashi Nakano,Tomoyuki Nishizaki. Владелец: Nishizaki Bioinformation Research Institute. Дата публикации: 2017-09-26.

Combination of an anti-cancer agent such as a tyrosinekinase inhibitor and a STAT5 antagonist, preferably a thiazolidinedione, for eliminating hematologic cancer stem cells in vivo and for preventing hematologic cancer relapse

Номер патента: US09623015B2. Автор: Stephane Prost,Marek Kirszenbaum,Philippe Leboulch,Philippe Rousselot,Mikael LE DANTEC. Владелец: Commissariat a lEnergie Atomique et aux Energies Alternatives CEA. Дата публикации: 2017-04-18.

Anti-cancer agent and mitochondrial division inhibitor combination

Номер патента: GB2508890A. Автор: Afthab Hussain,Helen Maddock,Ahmed Mayel Gharanei. Владелец: Coventry University. Дата публикации: 2014-06-18.

Anti-cancer agent

Номер патента: CA2235805C. Автор: Toshikazu Nakamura. Владелец: Individual. Дата публикации: 2008-10-28.

Anti-cancer agent

Номер патента: CA2235805A1. Автор: Toshikazu Nakamura. Владелец: Individual. Дата публикации: 1997-05-09.

Anti-cancer agent

Номер патента: US20020004480A1. Автор: Toshikazu Nakamura. Владелец: Individual. Дата публикации: 2002-01-10.

Anti-cancer agent delivery vehicles capable of improved loading

Номер патента: US9687464B2. Автор: Jackie Y. Ying,Kun Liang,Motoichi Kurisawa,Joo Eun Chung,Susi Tan. Владелец: Agency for Science Technology and Research Singapore. Дата публикации: 2017-06-27.

Combination of an anti-cancer agent such as a tyrosinekinase inhibitor and a stat5 antagonist preferably a thiazolid nedione, for eliminating hematologic cancer stem cells in vivo and for preventing hematologic cancer relapse

Номер патента: CA2890086C. Автор: Stephane Prost,Marek Kirszenbaum,Philippe Rousselot,Mikael LE DANTEC,Philipe LEBOULCH. Владелец: Commissariat a lEnergie Atomique et aux Energies Alternatives CEA. Дата публикации: 2022-05-31.

Kefir extract as an anti-cancer agent

Номер патента: CA2417131A1. Автор: Stan Kubow,Chujian Chen,Laurie Hing Man Chan,Maryam Fotouhinia. Владелец: Individual. Дата публикации: 2001-12-20.

An anti-cancer active substance from antrodia camphorata, method for preparing the same and use thereof

Номер патента: MY161596A. Автор: CHIANG Been-Huang,Yu-Wei-Lin. Владелец: Univ Nat Taiwan. Дата публикации: 2017-04-28.

Kefir extract as anti-cancer agent

Номер патента: US20040033282A1. Автор: Stan Kubow,Chujian Chen,Maryam Fotouhinia,Laurie Chan. Владелец: McGill University. Дата публикации: 2004-02-19.

Kefir extract as an anti-cancer agent

Номер патента: WO2001095917A3. Автор: Stan Kubow,Chujian Chen,Laurie Hing Man Chan,Maryam Fotouhinia. Владелец: Maryam Fotouhinia. Дата публикации: 2002-08-08.

An anti-cancer therapy agent of arsenic hexoxide (as4o6) of a natural chemical substance and its pharmaceutical composition

Номер патента: CA2298093A1. Автор: Illju Bae. Владелец: Individual. Дата публикации: 2001-08-03.

Anti-cancer agents with benzophenanthridine structure and preparations containing them

Номер патента: RU2492862C2. Автор: Эцио БОМБАРДЕЛЛИ,Паоло МОРАЦЦОНИ,Габриеле ФОНТАНА,Антонелла РИВА. Владелец: Индена С.П.А.. Дата публикации: 2013-09-20.

Methods for producing chemoembolic agents for the delivery of anti-cancer agents

Номер патента: US20180353522A1. Автор: Joseph Cappello,Hamid Ghandehari,Mark Martin Jensen,Azadeh Poursaid. Владелец: University of Utah Research Foundation UURF. Дата публикации: 2018-12-13.

Methods For Producing Chemoembolic Agents For The Delivery Of Anti-Cancer Agents

Номер патента: US20210060037A1. Автор: Joseph Cappello,Hamid Ghandehari,Mark Martin Jensen,Azadeh Poursaid. Владелец: University of Utah Research Foundation UURF. Дата публикации: 2021-03-04.

Enhanced anti-cancer agent delivery to solid tumors by primer compounds

Номер патента: AU8106198A. Автор: Kristofer Rubin,Mats Sjoquist,Rolf Reed. Владелец: Biophausia Ab. Дата публикации: 1998-12-21.

Enhanced anti-cancer agent delivery to solid tumors by primer compounds

Номер патента: WO1998055112A1. Автор: Kristofer Rubin,Mats Sjoquist,Rolf Reed. Владелец: Biophausia Ab. Дата публикации: 1998-12-10.

Enhanced anti-cancer agent delivery to solid tumors by primer compounds

Номер патента: AU733882B2. Автор: Kristofer Rubin,Mats Sjoquist,Rolf Reed. Владелец: Biophausia Ab. Дата публикации: 2001-05-31.

Enhanced anti-cancer agent delivery to solid tumors by primer compounds

Номер патента: US6303660B1. Автор: Kristofer Rubin,Mats Sjoquist,Rolf Reed. Владелец: Biophausia Ab. Дата публикации: 2001-10-16.

Use of compositions of water/alcohol extracts of antrodia cinnamomea cut-log wood cultivated fruiting body and solid-state cultivated mycelium as auxiliaries for anti-cancer agents

Номер патента: MY197711A. Автор: CHEN Yun-Yu,LIN CHIN-CHUNG,LAI Tzung-Hsien,HSU Li-Chuan,Ping Lo Chiu. Владелец: Taiwan Leader Biotech Corp. Дата публикации: 2023-07-09.

Nanoparticle, containing rapamycin and albumin as anti-cancer agent

Номер патента: RU2483714C2. Автор: Патрик СООН-ШИОНГ,Нейл П. ДИСЭЙ,Вуонг ТРИЕУ. Владелец: АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи.. Дата публикации: 2013-06-10.

Selective anti-cancer agent effective for prevention and treatment

Номер патента: WO2019191776A1. Автор: John L. Hall,Sylvie P. Beljanski. Владелец: Beljanski Sylvie P. Дата публикации: 2019-10-03.

Selective anti-cancer agent effective for prevention and treatment

Номер патента: US20210015803A1. Автор: John L. Hall,Sylvie P. Beljanski. Владелец: MOLECULAR INTERNATIONAL RESEARCH Inc. Дата публикации: 2021-01-21.

Anti-cancer agents for the treatment of canine cancers

Номер патента: CA3149796A1. Автор: Gerald Post,Benjamin Lewis,Madison Luker,Christina Kelly Lopes,Lindsay Lambert,Garrett Harvey,Thaddeus A. Allen,Aubrey Miller,Lucas Rodrigues. Владелец: OneHealthCompany Inc. Дата публикации: 2021-02-11.

Synergistic anti-cancer composition and a process for the preparation thereof

Номер патента: US09861653B2. Автор: Rajkumar Banerjee,Debabrata Mukhopadhyay. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2018-01-09.

A chain-end functionalized poly(ethylene oxide) and process for the preparation of a nano-sized transition metal or metal salt using the same

Номер патента: EP1899404A1. Автор: Jungahn Kim,Jang Seop Kim,Dong Youn Shin,Joon Hyeong Park,Kwang Ung KIM,Seung Sang Hagye 2-cha Hyundai Apt. HWANG,Soon Man Samsung Cheongdam Gongwon Apt. HONG,Soonjong KWAK,Ji Hee KIM,Soon Geun Buheung Villa D-202 HWANG,Han Wook Jugong 14-danji Apt. RYU. Владелец: Youlchon Chemical Co Ltd. Дата публикации: 2008-03-19.

A chain-end functionalized poly(ethylene oxide) and process for the preparation of a nano-sized transition metal or metal salt using the same

Номер патента: EP1899404A4. Автор: Ji Hee Kim,Soonjong Kwak,Seung Sang Hwang,Soon Man Hong,Jungahn Kim,Kwang Ung Kim,Jang Seop Kim,Dong Youn Shin,Joon Hyeong Park,Soon Geun Hwang,Han Wook Ryu. Владелец: Youlchon Chemical Co Ltd. Дата публикации: 2009-09-09.

Pharmaceutical composition for preventing or treating brain cancer including crystal polymorph of tetraarsenic hexoxide, and method for preparing same

Номер патента: MY196811A. Автор: Ill Ju Bae,Zenglin Lian. Владелец: Chemas Co Ltd. Дата публикации: 2023-05-03.

Pharmaceutical composition for preventing or treating brain cancer including crystal polymorph of tetraarsenic hexoxide, and method for preparing same

Номер патента: CA3043145C. Автор: Ill Ju Bae,Zenglin Lian. Владелец: Chemas Co Ltd. Дата публикации: 2021-11-09.

Methods for delivering an anti-cancer agent to a tumor

Номер патента: US20170290915A1. Автор: Abhijit Ray,Nate Larson,Adam Gormley,Hamid Ghandehari. Владелец: University of Utah Research Foundation UURF. Дата публикации: 2017-10-12.

Arginine deiminase, its manufacturing method, and an anti-cancer agent containing this enzyme as an effective ingredient

Номер патента: CA2022177A1. Автор: Kaoru Miyazaki,Haruo Takaku,Miho Aoshima. Владелец: Nippon Mining Co Ltd. Дата публикации: 1991-02-03.

Manipulation of hairy and enhancer of split 3 (Hes3) and its regulators/mediators as an anti-cancer strategy

Номер патента: US09943570B2. Автор: Andreas Androutsellis-Theotokis. Владелец: TECHNISCHE UNIVERSITAET DRESDEN. Дата публикации: 2018-04-17.

Method for mass producing natural killer cell and use of natural killer cell obtained by the method as anti-cancer agent

Номер патента: US20200277574A1. Автор: In Pyo Choi,Sooyun LEE,Suk Ran Yoon. Владелец: Korea Research Institute of Bioscience and Biotechnology KRIBB. Дата публикации: 2020-09-03.

Fas-associated factor 1 (faf1)-loaded exosomes and use thereof as anti-cancer agent

Номер патента: CA3215574A1. Автор: Eunhee Kim,Jeong-Hoon Han. Владелец: Kainos Medicine Inc. Дата публикации: 2022-10-06.

Fas-associated factor 1 (faf1)-loaded exosomes and use thereof as anti-cancer agent

Номер патента: AU2022247243A1. Автор: Eunhee Kim,Jeong-Hoon Han. Владелец: Kainos Medicine Inc. Дата публикации: 2023-10-05.

Molecular predictors of therapeutic response to specific anti-cancer agents

Номер патента: US09506926B2. Автор: Joe W. Gray,Wen-Lin Kuo,Paul T. Spellman,Anguraj Sadanandam,Nicholas J. Wang,Laura M. Heiser,William J. Gibb. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2016-11-29.

Anti-cancer agent, method for inducing apoptosis of cancer cells, and method for screening for anti-cancer agent

Номер патента: US20120115935A1. Автор: Naohisa Tomosugi,Yasuhito Ishigaki. Владелец: Individual. Дата публикации: 2012-05-10.

COMPOUND OR SALT THEREOF, ANTI-INFLAMMATORY AGENT, ANTI-CANCER AGENT AGAINST LUNG CANCER, METHOD OF PRODUCING COMPOUND OR SALTS THEREOF, METHOD OF TREATING INFLAMMATORY DISEASES AND METHOD OF TREATING LUNG CANCER

Номер патента: US20190177440A1. Автор: Yamaguchi Yoshiki,HIDAKA Yasuhiro,Nishizawa Takashi,NAKAMURA Shinichiro,Hayashi Akiyoshi,TODA Nobuhiro,KANIE Osamu. Владелец: . Дата публикации: 2019-06-13.

Compound or salt thereof, anti-inflammatory agent, anti-cancer agent against lung cancer, method of producing compound or salts thereof, method of treating inflammatory diseases and method of treating lung cancer

Номер патента: CA3038021A1. Автор: YASUHIRO Hidaka,Shinichiro Nakamura,Takashi Nishizawa,Akiyoshi Hayashi,Yoshiki Yamaguchi,Osamu Kanie,Nobuhiro Toda. Владелец: TFK Inc. Дата публикации: 2018-03-29.

Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent

Номер патента: CA2698129A1. Автор: Yoshinori Itoh,Ryozo Oishi,Nobuaki Egashira. Владелец: Nobuaki Egashira. Дата публикации: 2009-03-05.

Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent

Номер патента: US20110111051A1. Автор: Yoshinori Itoh,Ryozo Oishi,Nobuaki Egashira. Владелец: Nippon Zoki Pharmaceutical Co Ltd. Дата публикации: 2011-05-12.

Fas-associated factor 1 (faf1)-loaded exosomes and use thereof as anti-cancer agent

Номер патента: EP4316467A1. Автор: Eunhee Kim,Jeong-Hoon Han. Владелец: Kainos Medicine Inc. Дата публикации: 2024-02-07.

Anti-cancer agent, method for inducing apoptosis of cancer cells, and method for screening for anti-cancer agent

Номер патента: EP2455103A4. Автор: Naohisa Tomosugi,Yasuhito Ishigaki. Владелец: Medical Care Proteomics Biotechnology Co Ltd. Дата публикации: 2013-04-03.

Molecular Predictors of Therapeutic Response to Specific Anti-Cancer Agents

Номер патента: US20120214829A1. Автор: Joe W. Gray,Wen-Lin Kuo,Paul T. Spellman,Anguraj Sadanandam,Nicholas J. Wang,Laura M. Heiser,William J. Gibb. Владелец: UNIVERSITY OF CALIFORNIA. Дата публикации: 2012-08-23.

Fas-associated factor 1 (faf1)-loaded exosomes and use thereof as anti-cancer agent

Номер патента: IL307240A. Автор: . Владелец: Kainos Medicine Inc. Дата публикации: 2023-11-01.

Anti-cancer agent comprising hvj-e and cxcl2

Номер патента: EP3342428B1. Автор: Toshihiro NAKAJIMA,Yasufumi Kaneda. Владелец: GenomIdea Inc. Дата публикации: 2020-10-14.

MARKER FOR DETERMINATION OF SENSITIVITY TO TRIPLET COMBINATION ANTI-CANCER AGENT

Номер патента: US20130302327A1. Автор: Nishiyama Masahiko,Eguchi Hidetaka,Wada Satoru. Владелец: KABUSHIKI KAISHA YAKULT HONSHA. Дата публикации: 2013-11-14.

METHOD FOR MASS PRODUCING NATURAL KILLER CELL AND USE OF NATURAL KILLER CELL OBTAINED BY THE METHOD AS ANTI-CANCER AGENT

Номер патента: US20180015123A1. Автор: CHOI In Pyo,YOON Suk Ran,LEE Sooyun. Владелец: Korea Research Institute of Bioscience and Biotechnology. Дата публикации: 2018-01-18.

Stereocomplexes for the delivery of anti-cancer agents

Номер патента: US20220072139A1. Автор: Der-Yang Tien. Владелец: Individual. Дата публикации: 2022-03-10.

SPALAX FIBROBLAST-DERIVED ANTI-CANCER AGENTS

Номер патента: US20220079992A1. Автор: Avivi Aaron,Shams Imad,Manov Irena. Владелец: . Дата публикации: 2022-03-17.

PERSONALIZED ANTI-CANCER AGENT SCREENING SYSTEM

Номер патента: US20160103119A1. Автор: Nam Do Hyun,Joo Kyeung Min. Владелец: . Дата публикации: 2016-04-14.

PERSONALIZED ANTI-CANCER AGENT SCREENING SYSTEM

Номер патента: US20200110071A1. Автор: Nam Do Hyun,Joo Kyeung Min. Владелец: . Дата публикации: 2020-04-09.

SPALAX FIBROBLAST-DERIVED ANTI-CANCER AGENTS

Номер патента: US20140248371A1. Автор: Avivi Aaron,Shams Imad,Manov Irena. Владелец: CARMEL-HAIFA UNIVERSITY ECONOMIC CORP. LTD.. Дата публикации: 2014-09-04.

SPALAX FIBROBLAST-DERIVED ANTI-CANCER AGENTS

Номер патента: US20180200304A1. Автор: Avivi Aaron,Shams Imad,Manov Irena. Владелец: . Дата публикации: 2018-07-19.

ANTI-CANCER AGENT COMPRISING HVJ-E AND CXCL2

Номер патента: US20180243355A1. Автор: NAKAJIMA Toshihiro,Kaneda Yasufumi. Владелец: . Дата публикации: 2018-08-30.

ANTI-CANCER AGENT SENSITIVITY-DETERMINING MARKER

Номер патента: US20170248578A1. Автор: Takahashi Hiroyuki,Tanigawara Yusuke,Sugimoto Shinji,HARA Kanako,NAKAMURA Miki. Владелец: . Дата публикации: 2017-08-31.

METHOD FOR MASS PRODUCING NATURAL KILLER CELL AND USE OF NATURAL KILLER CELL OBTAINED BY THE METHOD AS ANTI-CANCER AGENT

Номер патента: US20200277574A1. Автор: CHOI In Pyo,YOON Suk Ran,LEE Sooyun. Владелец: KOREA RESEARCH INSTITUTE OF BIOSCIENCE. Дата публикации: 2020-09-03.

Novel screening system for personalized anti-cancer agents

Номер патента: KR101327533B1. Автор: 남도현,주경민. Владелец: 사회복지법인 삼성생명공익재단. Дата публикации: 2013-11-08.

Composition for enhancing sensitivity to anti-cancer agent comprising of miR-133a-3p as an active ingredient

Номер патента: KR102104478B1. Автор: 김미연,장민선,류서원. Владелец: 숙명여자대학교산학협력단. Дата публикации: 2020-04-24.

Method and antisense compound for potentiating anti-cancer agents

Номер патента: CA2544923A1. Автор: Patrick L. Iversen,Gayathri R. Devi. Владелец: Gayathri R. Devi. Дата публикации: 2005-05-26.

Marker for determination of sensitivity to triplet combination anti-cancer agent

Номер патента: US8980557B2. Автор: Masahiko Nishiyama,Satoru Wada,Hidetaka Eguchi. Владелец: Yakult Honsha Co Ltd. Дата публикации: 2015-03-17.

Anti-cancer agent sensitivity-determining marker

Номер патента: EP3550306A1. Автор: Hiroyuki Takahashi,Miki Tanaka,Shinji Sugimoto,Yusuke Tanigawara,Kanako HARA. Владелец: Yakult Honsha Co Ltd. Дата публикации: 2019-10-09.

Method and antisense compound for potentiating anti-cancer agents

Номер патента: WO2005047465A3. Автор: Patrick L Iversen,Gayathri R Devi. Владелец: Gayathri R Devi. Дата публикации: 2007-04-12.

Anti-cancer agent comprising hvj-e and cxcl2

Номер патента: WO2017033912A1. Автор: 安史金田,中島　俊洋. Владелец: ジェノミディア株式会社. Дата публикации: 2017-03-02.

Coordination compound composed of diaminocyclohexane platinum (ii) and block copolymer and anti-cancer agent comprising the same

Номер патента: WO2006098496A1. Автор: Kazunori Kataoka,Nobuhiro Nishiyama,Horacio Cabral. Владелец: THE UNIVERSITY OF TOKYO. Дата публикации: 2006-09-21.

Stereocomplexes for the delivery of anti-cancer agents

Номер патента: EP3891207B1. Автор: Der-Yang Tien. Владелец: Individual. Дата публикации: 2022-11-02.

Anti-cancer agent comprising hvj-e and cxcl2

Номер патента: EP3342428A4. Автор: Toshihiro NAKAJIMA,Yasufumi Kaneda. Владелец: GenomIdea Inc. Дата публикации: 2019-03-27.

Method for mass producing natural killer cell and use of natural killer cell obtained by the method as anti-cancer agent

Номер патента: EP3252152B1. Автор: In Pyo Choi,Sooyun LEE,Suk Ran Yoon. Владелец: Korea Research Institute of Bioscience and Biotechnology KRIBB. Дата публикации: 2020-07-22.

Fas-associated factor 1 (faf1)-loaded exosomes and use thereof as anti-cancer agent

Номер патента: US20240156905A1. Автор: Eunhee Kim,Jeong-Hoon Han. Владелец: Kainos Medicine Inc. Дата публикации: 2024-05-16.

Anti-cancer agents based on 4-(hetero)Ary1-1,2,5-oxadiazol-3-yl Amino derivatives and a method of making

Номер патента: US8362047B1. Автор: Konstantin A. Rufanov,Mikhail Krasavin,Andrei A. Gakh,Ruben Karapetian,Igor Konstantinov,Elena Godovykh,Olga Soldatkina,Andrey V. Sosnov. Владелец: US Department of Energy. Дата публикации: 2013-01-29.

Anti-cancer agents based on N-acyl-2, 3-dihydro-1H-pyrrolo[2,3-b] quinoline derivatives and a method of making

Номер патента: US8420815B1. Автор: Konstantin A. Rufanov,Mikhail Krasavin,Andrei A. Gakh,Ruben Karapetian,Igor Konstantinov,Elena Godovykh,Olga Soldatkina,Andrey V. Sosnov. Владелец: US Department of Energy. Дата публикации: 2013-04-16.

No-releasing nonoate(nitrogen-bound)sulfonamide-linked-coxib anti-cancer agents

Номер патента: US20140018544A1. Автор: Eduardo J. Martinez,John J. Talley,Terri L. Boehm,Kevin D. Jerome. Владелец: Euclises Pharmaceuticals Inc. Дата публикации: 2014-01-16.

Device and method for administering an anti-cancer substance

Номер патента: US09694128B1. Автор: Brian LeBerthon. Владелец: Individual. Дата публикации: 2017-07-04.

A combined method for predicting the response to an anti-cancer therapy

Номер патента: CA2725171A1. Автор: Kirsten Vang Nielsen,Nils Aage Bruenner,Bent Laursen Ejlertsen. Владелец: Dako Denmark ApS. Дата публикации: 2009-11-26.

A combined method for predicting the response to an anti-cancer therapy

Номер патента: AU2009250169A1. Автор: Kirsten Vang Nielsen,Nils Aage Brünner,Bent Laursen Ejlertsen. Владелец: Dako Denmark ApS. Дата публикации: 2009-11-26.

A combined method for predicting the response to an anti-cancer therapy

Номер патента: WO2009140973A1. Автор: Nils Brunner. Владелец: KOBENHAVNS UNIVERSITET. Дата публикации: 2009-11-26.

Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness

Номер патента: US20240018484A1. Автор: Pan-Chyr Yang,Huei-Wen Chen,Wan-Jiun Chen. Владелец: National Taiwan University NTU. Дата публикации: 2024-01-18.

Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness

Номер патента: US11834682B2. Автор: Pan-Chyr Yang,Huei-Wen Chen,Wan-Jiun Chen. Владелец: National Taiwan University NTU. Дата публикации: 2023-12-05.

Compositions and methods for diagnosis and prognosis of cancer and progression, and for screening anti-cancer agents

Номер патента: WO2010115119A3. Автор: Dimitrios Iliopoulos,Philip N. Tsichlis,Christos Polytarchou. Владелец: Tufts Medical Center, Inc.. Дата публикации: 2011-03-31.

Limiting Dilution Assay for Screening of Patient-specific Anti-cancer Agents

Номер патента: KR101592305B1. Автор: 남도현,주경민,최연숙. Владелец: 사회복지법인 삼성생명공익재단. Дата публикации: 2016-02-05.

Novel aglycon dammarane sapogenins, their use as anti-cancer agents, and a process for producing same

Номер патента: US20030087835A1. Автор: DONG Qi,Dong Huang. Владелец: Individual. Дата публикации: 2003-05-08.

Medicament, particularly an anti-cancer medicament, for treatment using immunotherapy, particularly autologous

Номер патента: WO2006122914A2. Автор: Patrick Frayssinet,Nicole Rouquet,Daniel Ciocca. Владелец: Urodelia. Дата публикации: 2006-11-23.

Medicament, particularly an anti-cancer medicament, for treatment using immunotherapy, particularly autologous

Номер патента: EP1885337B1. Автор: Patrick Frayssinet,Nicole Rouquet,Daniel Ciocca. Владелец: Urodelia. Дата публикации: 2012-08-01.

Production process of the lymphocytes fighting against cancero us cells and anti-cancer agents containing them

Номер патента: PT75148B. Автор: . Владелец: Otsuka Pharma Co Ltd. Дата публикации: 1986-08-14.

Metastatic melanoma cell lines from monodelphis domestica for use in anti-cancer agent discovery

Номер патента: US5910424A. Автор: Thomas P. Dooley,Edward S. Robinson. Владелец: Texas Biomedical Research Institute. Дата публикации: 1999-06-08.

THE USE OF KAEMPFEROL-3-O-β-D-GLUCOPYRANOSIDE (KOG) COMPOUND AS AN ANTI-CANCER AGENT AND MAPK PATHWAY INHIBITOR

Номер патента: WO2019112534A3. Автор: Hulya SIVAS,Oguzhan KARAOSMANOGLU,Victor Kuete. Владелец: ANADOLU UNIVERSITESI. Дата публикации: 2019-08-08.

Anti-cancer active substance from Antrodia camphorata, method for preparing the same and use thereof

Номер патента: US09950021B2. Автор: Yu-Wei Lin,Been-Huang Chiang. Владелец: National Taiwan University NTU. Дата публикации: 2018-04-24.

Synergistic composition of inulin and an anti-cancer drug for use in the treatment of cancer

Номер патента: EP1079840A1. Автор: Anne Frippiat,Jan Van Loo,Marcel Roberfroid,Henryk Taper. Владелец: Tiense Suikerraffinaderij Nv. Дата публикации: 2001-03-07.

THE USE OF KAEMPFEROL-3-O-β-D-GLUCOPYRANOSIDE (KOG) COMPOUND AS AN ANTI-CANCER AGENT AND MAPK PATHWAY INHIBITOR

Номер патента: WO2019112534A2. Автор: Hulya SIVAS,Oguzhan KARAOSMANOGLU,Victor Kuete. Владелец: ANADOLU UNIVERSITESI. Дата публикации: 2019-06-13.

Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent

Номер патента: US09770414B2. Автор: William Lambert,Louie Daniel Garcia,Liangjin Zhu,Lois Gibson,Benjamin W. Li. Владелец: Pacira Pharmaceuticals Inc. Дата публикации: 2017-09-26.

ANTI-CANCER AND ANTI-CHEMORESISTANCE PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-CANCER AGENT AND AT LEAST ONE PEPTIDE

Номер патента: FR2786398B1. Автор: Jamal Temsamani,Michel Kaczorek,De Verdieree Annick Colin. Владелец: Synt EM SA. Дата публикации: 2002-12-27.

Process for the preparation of Rhus verniciflua extract and anti-cancer composition containing same

Номер патента: US6099845A. Автор: Chun-Soo Na,Nam-Chul Jung,Eun-Sun Na. Владелец: Forest Genetics Research Institute. Дата публикации: 2000-08-08.

Composition intended to vectorise an anti-cancer agent

Номер патента: WO2017021508A1. Автор: Caroline Robic,Jean-François Mayer. Владелец: GUERBET. Дата публикации: 2017-02-09.

An anti-cancer active substance from Antrodia camphorata, method for preparing the same and use thereof

Номер патента: TW201200144A. Автор: Yu-Wei Lin,Been-Huang Chiang. Владелец: Univ Nat Taiwan. Дата публикации: 2012-01-01.

COMBINATION OF AN ANTI-CANCER AGENT SUCH AS A TYROSINEKINASE INHIBITOR AND A STAT5 ANTAGONIST, PREFERABLY A THIAZOLIDINEDIONE, FOR ELIMINATING HEMATOLOGIC CANCER STEM CELLS IN VIVO AND FOR PREVENTING HEMATOLOGIC CANCER RELAPSE

Номер патента: US20150265588A1. Автор: Leboulch Philippe,Prost Stéphane,Kirszenbaum Marek,Le Dantec Mikael,Rousselot Philippe. Владелец: . Дата публикации: 2015-09-24.

Method to identify a patient with an increased likelihood of responding to an anti-cancer agent.

Номер патента: MX2012002862A. Автор: Nicholas Van Bruggen,Robby Weimer,Maresa Caunt,Alvin Gogineni,Anil D Bagri. Владелец: Genentech Inc. Дата публикации: 2012-08-15.

Treatment of hematological cancer refractory to an anti-cancer agent

Номер патента: EP2928456B1. Автор: Manoj Maniar,Azra Raza,Francois WILHELM. Владелец: Onconova Therapeutics Inc. Дата публикации: 2021-02-03.

Combination of an anti-cancer agent such as a tyrosinekinase inhibitor and a stat5 antagonist, preferably a thiazolidinedione, for eliminating hematologic cancer stem cells in vivo and for preventing hematologic cancer relapse

Номер патента: EP2914250B1. Автор: Stephane Prost,Marek Kirszenbaum,Philippe Rousselot,Mikael LE DANTEC,Philipe LEBOULCH. Владелец: Commissariat a lEnergie Atomique et aux Energies Alternatives CEA. Дата публикации: 2018-04-04.

Use of gaseous nitric oxide as an anti-cancer agent

Номер патента: WO2008095311A1. Автор: Christopher C. Miller. Владелец: PULMONOX TECHNOLOGIES CORPORATION. Дата публикации: 2008-08-14.

Cancer therapy using a combination of cdk7 inhibitor with an anti-cancer agent

Номер патента: EP4346765A2. Автор: Ramulu Poddutoori,Akhil Kumar,Leena KHARE. Владелец: Aurigene Oncology Ltd. Дата публикации: 2024-04-10.

An anti-cancer composition of herbal extracts and its method of preparation thereof

Номер патента: WO2024111000A1. Автор: AK Srinivas Murthy. Владелец: M/S Valyou Products Private Limited. Дата публикации: 2024-05-30.

Compositions comprising a radiosensitizer and an anti-cancer agent and methods of uses thereof

Номер патента: US20120093918A1. Автор: Leon Sanche,Gabriel Charest. Владелец: SOCPRA Sciences Sante et Humaines sec. Дата публикации: 2012-04-19.

SUSTAINED RELEASE FORMULATION OF METHOTREXATE AS A DISEASE-MODIFYING ANTIRHEUMATIC DRUG (DMARD) AND AN ANTI-CANCER AGENT

Номер патента: US20130183370A1. Автор: Garcia Louie Daniel,Zhu Liangjin,Lambert William Joseph,Gibson Lois,Li Benjamin W.. Владелец: PACIRA PHARMACEUTICALS, INC.. Дата публикации: 2013-07-18.

SUSTAINED RELEASE FORMULATION OF METHOTREXATE AS A DISEASE-MODIFYING ANTIRHEUMATIC DRUG (DMARD) AND AN ANTI-CANCER AGENT

Номер патента: US20130183371A1. Автор: Garcia Louie Daniel,Zhu Liangjin,Lambert William Joseph,Gibson Lois,Li Benjamin W.. Владелец: PACIRA PHARMACEUTICALS, INC.. Дата публикации: 2013-07-18.

PRODUCT COMPRISING A NICOTINE-CONTAINING MATERIAL AND AN ANTI-CANCER AGENT

Номер патента: US20140088044A1. Автор: RIGAS Basil,Rigas Jason B.. Владелец: . Дата публикации: 2014-03-27.

PRODUCT COMPRISING A NICOTINE-CONTAINING MATERIAL AND AN ANTI-CANCER AGENT

Номер патента: US20140088045A1. Автор: RIGAS Basil,Rigas Jason B.. Владелец: . Дата публикации: 2014-03-27.

Composition Intended to Vectorise an Anti-Cancer Agent

Номер патента: US20190099496A1. Автор: Robic Caroline,MAYER Jean-François. Владелец: . Дата публикации: 2019-04-04.

METHODS FOR DELIVERING AN ANTI-CANCER AGENT TO A TUMOR

Номер патента: US20160129111A1. Автор: Ray Abhijit,Larson Nate,GHANDEHARI Hamid,GORMLEY Adam. Владелец: UNIVERSITY OF UTAH RESEARCH FOUNDATION. Дата публикации: 2016-05-12.

COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT

Номер патента: US20160166526A1. Автор: Kitamoto Naomi. Владелец: Takeda Pharmaceutical Company Limited. Дата публикации: 2016-06-16.

METHODS FOR DELIVERING AN ANTI-CANCER AGENT TO A TUMOR

Номер патента: US20140358116A1. Автор: Ray Abhijit,Larson Nate,GHANDEHARI Hamid,GORMLEY Adam. Владелец: UNIVERSITY OF UTAH RESEARCH FOUNDATION. Дата публикации: 2014-12-04.

Composition for Vectorizing an Anti-Cancer Agent

Номер патента: US20160346202A1. Автор: Caroline Robic,Jean-François Mayer. Владелец: . Дата публикации: 2016-12-01.

Composition intended to vectorise an anti-cancer agent

Номер патента: EP3331494B1. Автор: Caroline Robic,Jean-François Mayer. Владелец: Guerbet SA. Дата публикации: 2021-04-21.

Composition for vectorizing an anti-cancer agent

Номер патента: ZA201605463B. Автор: Caroline Robic,Jean-François Mayer. Владелец: Guerbet SA. Дата публикации: 2017-08-30.

Pharmaceutical composition comprising an anti-cancer agent and at least a peptide

Номер патента: EP1135169A1. Автор: Michel Kaczorek,Jamal Résidence de l'Empereur TEMSAMANI,Annik Colin De Verdiere. Владелец: Synt EM SA. Дата публикации: 2001-09-26.

Product comprising a nicotine-containing material and an anti-cancer agent

Номер патента: EP2916847A4. Автор: Basil Rigas,Jason Rigas. Владелец: Jason Rigas. Дата публикации: 2016-06-08.

Product comprising a nicotine-containing material and an anti-cancer agent

Номер патента: CN104918621A. Автор: 巴兹尔·里格斯,杰森·里格斯. Владелец: Individual. Дата публикации: 2015-09-16.

Composition for vectorizing an anti-cancer agent

Номер патента: WO2015118113A1. Автор: Caroline Robic,Jean-François Mayer. Владелец: GUERBET. Дата публикации: 2015-08-13.

Composition for vectorizing an anti-cancer agent

Номер патента: HK1225983A1. Автор: Caroline Robic,Jean-François Mayer. Владелец: Guerbet SA. Дата публикации: 2017-09-22.

Compositions comprising a radiosensitizer and an anti-cancer agent and methods of uses thereof

Номер патента: CA2792953A1. Автор: Leon Sanche,Gabriel Charest. Владелец: SOCPRA Sciences Sante et Humaines sec. Дата публикации: 2010-10-28.

CANCER TREATMENT AND METASTASIS INHIBITION USING AN ANTI-CANCER STEM CELL AGENT IN COMBINATION WITH A NEU1 SIALIDASE INHIBITOR OR A CYTOKINE INHIBITOR AFTER PRIMARY CANCER TREATMENT

Номер патента: US20200306283A1. Автор: HARLESS William Warren,SZEWCZUK Myron. Владелец: . Дата публикации: 2020-10-01.

USE OF BIODEGRADABLE MICROSPHERES RELEASING ANTI-CANCER AGENT FOR THE TREATMENT OF GLIOBLASTOMA, PROCESS FOR PREPARING SUCH MICROSPHERES AND SUSPENSION CONTAINING THEM

Номер патента: FR2793684A1. Автор: Jean Pierre Benoit,Philippe Menei,Nathalie Faisant. Владелец: Ethypharm SAS. Дата публикации: 2000-11-24.

Therapeutic uses of an anti-cancer composition derived from rice bran

Номер патента: WO2007106821A3. Автор: Rukmini Cheruvanky,Reddy Sastry V Cherukuri. Владелец: Reddy Sastry V Cherukuri. Дата публикации: 2007-12-06.

USE OF BIODEGRADABLE MICROSPHERES RELEASING ANTI-CANCER AGENT FOR THE TREATMENT OF GLIOBLASTOMA, PROCESS FOR PREPARING SUCH MICROSPHERES AND SUSPENSION CONTAINING THEM

Номер патента: FR2793684B1. Автор: Jean Pierre Benoit,Philippe Menei,Nathalie Faisant. Владелец: Ethypharm SAS. Дата публикации: 2001-08-10.

PFKFB3 INHIBITOR AND METHODS OF USE AS AN ANTI-CANCER THERAPEUTIC

Номер патента: US20150064175A1. Автор: Chand Pooran,Tapolsky Gilles H.. Владелец: . Дата публикации: 2015-03-05.

USE OF COMPOSITIONS WITH A LOW POLYAMINE CONTENT IN THE PREVENTION OR TREATMENT OF UNDESIRABLE EFFECTS LINKED TO AN ANTI-CANCER TREATMENT

Номер патента: US20160228389A1. Автор: Cipolla Bernard,ANTIGNAN Xavier. Владелец: . Дата публикации: 2016-08-11.

PFKFB3 INHIBIT AND METHODS OF USE AS AN ANTI-CANCER THERAPEUTIC

Номер патента: US20170258783A1. Автор: Chand Pooran,Tapolsky Gilles H.. Владелец: . Дата публикации: 2017-09-14.

Extract of Sparassis crispa and Its Use as an Anti-cancer Medicine

Номер патента: KR101105632B1. Автор: 정용환,박수영,윤원종,오대주,함영민,김길남,장시흡. Владелец: (주)우성바이오. Дата публикации: 2012-01-18.

USE OF PM01183, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN SYNERGIC COMBINATION WITH AN ANTI-CANCER ANTIBIOTIC AND KIT

Номер патента: BR122017028566B1. Автор: Victoria Moneo Ocaña,Gema Santamaría Núñez,Luis Francisco García Fernández,Carlos María GALMARINI,María José Guillén Navarro,Pablo Manuel Avilés Marín. Владелец: PHARMA MAR, S.A.. Дата публикации: 2022-03-03.

Nanoparticle Containing Rapamycin and Albumin as an Anti-Cancer Factor

Номер патента: CY1120547T1. Автор: Neil P. Desai,Vuong Trieu,Patrick Soon-Shiong. Владелец: ABRAXIS BIOSCIENCE, LLC. Дата публикации: 2019-07-10.

Therapeutic uses of an anti-cancer composition derived from rice bran

Номер патента: US20070212470A1. Автор: Rukmini Cheruvanky,Reddy Sastry Cherukuri. Владелец: NutraCea. Дата публикации: 2007-09-13.

An anti-cancer supplement agent containing pyrazolo[1,5-?]pyrimidine class compound

Номер патента: KR100762931B1. Автор: 황진택,김학수,하주헌. Владелец: 경희대학교 산학협력단. Дата публикации: 2007-10-04.

AN ANTI-CANCER DRUG CONTAINING OZONIZED VITAMIN C

Номер патента: TR2022000209A2. Автор: Özduyan Yağmur. Владелец: Özge Güven. Дата публикации: 2022-02-21.

An anti-cancer composition for the prevention and treatment of carcinogenesis containing the extracts of Asparagus cochinchinensis as an active ingredient

Номер патента: KR101115504B1. Автор: 이아영,김호경,전명숙,추병길,천진미. Владелец: 한국 한의학 연구원. Дата публикации: 2012-02-27.

An anti-cancer formulation comprising sodium pentaborate, curcumin and piperine for use in the treatment of hepatocellular carcinoma

Номер патента: WO2023191746A1. Автор: Fikrettin Sahin,Zehra OMEROGLU ULU,Zeynep Busra BOLAT,Nurdan Sena DEGIRMENCI. Владелец: YEDITEPE UNIVERSITESI. Дата публикации: 2023-10-05.

Anti-cancer agents

Номер патента: WO2024102812A2. Автор: Vuong Trieu. Владелец: Gmp Biotechnology Limited. Дата публикации: 2024-05-16.

Anti-cancer agents

Номер патента: WO2024102812A3. Автор: Vuong Trieu. Владелец: Gmp Biotechnology Limited. Дата публикации: 2024-06-20.

Enhancer of anti-tumor effect of anti-cancer agent

Номер патента: US09889155B2. Автор: Masaki Mori,Hirofumi Yamamoto,Yuichiro Doki,Xin Wu. Владелец: Individual. Дата публикации: 2018-02-13.

Anti-cancer agent

Номер патента: US09700572B2. Автор: Shigetoshi Kadota,Hiroyasu Esumi,Masafumi Ikeda,Satoshi Yomoda,Toshiki Okubo,Takanori Kawashima,Chika Miyoshi,Takafumi Fuse,Shigeki Chiba. Владелец: Kracie Pharma Ltd. Дата публикации: 2017-07-11.

Carbon nanotube-based anti-cancer agent capable of suppressing drug resistance

Номер патента: US09981042B2. Автор: Tae Hyun Nam,Jungil Choi,Dong Woo Khang,Sang Soo Kang. Владелец: Industry Academic Cooperation Foundation of GNU. Дата публикации: 2018-05-29.

IMMUNITY-BOOSTING AGENT, IMMUNO-THERAPEUTIC ANTI-CANCER AGENT, AND ANTI-CANCER THERAPY ADVERSE EFFECT MITIGATING AGENT CONTAINING ANTHOCYANIN-FUCOIDAN COMPLEX AS ACTIVE INGREDIENT

Номер патента: US20200376066A1. Автор: Lee Joo Young,Na Kun,JANG Bong Keun,JO Young-Um,SEO Jeong Deok. Владелец: JBKLAB CO., LTD.. Дата публикации: 2020-12-03.

Immunity-boosting agent, immuno-therapeutic anti-cancer agent, and anti-cancer therapy adverse effect mitigating agent containing anthocyanin-fucoidan complex as active ingredient

Номер патента: EP3701970A4. Автор: Joo Young Lee,Kun Na,Bong Keun Jang,Young-Um JO,Jeong Deok Seo. Владелец: Jbklab Co Ltd. Дата публикации: 2021-08-25.

Immunity-boosting agent, immuno-therapeutic anti-cancer agent, and anti-cancer therapy adverse effect mitigating agent containing anthocyanin-fucoidan complex as active ingredient

Номер патента: WO2019083328A9. Автор: 이주영,나건,서정덕,장봉근,조영엄. Владелец: 주식회사 제이비케이랩. Дата публикации: 2019-08-15.

Anti-cancer agents and androgen inhibition activity compound

Номер патента: US20100113600A1. Автор: Puranik Purushottamachar,Vincent C. O. Njar. Владелец: University of Maryland at Baltimore. Дата публикации: 2010-05-06.

Anti-cancer agents and androgen inhibition activity compound

Номер патента: WO2008076918A9. Автор: Puranik Purushottamachar,Vincent C O Njar. Владелец: Vincent C O Njar. Дата публикации: 2008-08-07.

Anti-cancer agents and androgen inhibition activity compound

Номер патента: WO2008076918A3. Автор: Puranik Purushottamachar,Vincent C O Njar. Владелец: Vincent C O Njar. Дата публикации: 2008-10-02.

Peptide-artesunate conjugates as targeted anti-cancer agents

Номер патента: WO2019006326A1. Автор: Maolin GUO. Владелец: University of Massachusetts. Дата публикации: 2019-01-03.

Anti-cancer agent, method for screening for anti-cancer agent, kit for determination of efficacy on cancer, and method for determining efficacy on cancer

Номер патента: EP3574917A4. Автор: Kazuhiro Morishita,Tomonaga Ichikawa,Shingo Nakahata. Владелец: University of Miyazaki NUC. Дата публикации: 2020-05-06.

Slow release formulations of cell cycle regulators and anti-cancer agents for local treatment of solid cancer

Номер патента: US09801854B1. Автор: Gil Hakim,Dalit Strauss-Ayali,Astar FRIEDMAN,Marina KONORTY. Владелец: Urogen Pharma Ltd. Дата публикации: 2017-10-31.

Block Copolymer For Intraperitoneal Administration Containing Anti-Cancer Agent, Micelle Preparation Thereof, And Cancer Therapeutic Agent Comprising The Micelle Preparation As Active Ingredient

Номер патента: US20120231053A1. Автор: Hiroko Mashiba,Yuichi Akatsu. Владелец: Nippon Kayaku Co Ltd. Дата публикации: 2012-09-13.

Block Copolymer For Intraperitoneal Administration Containing Anti-Cancer Agent, Micelle Preparation Thereof, And Cancer Therapeutic Agent Comprising The Micelle Preparation As Active Ingredient

Номер патента: US20140072604A1. Автор: Hiroko Mashiba,Yuichi Akatsu. Владелец: Nippon Kayaku Co Ltd. Дата публикации: 2014-03-13.

ANTI-TUMOR AQUEOUS SOLUTION, ANTI-CANCER AGENT, AND METHODS FOR PRODUCING SAID AQUEOUS SOLUTION AND SAID ANTI-CANCER AGENT

Номер патента: US20150030693A1. Автор: Kikkawa Fumitaka,Hori Masaru,Kano Hiroyuki,Takeda Keigo,Tanaka Hiromasa,Ishikawa Kenji,KAJIYAMA Hiroaki,MIZUNO Masaaki,Utsumi Fumi,Nakamura Kae. Владелец: . Дата публикации: 2015-01-29.

Methods For Producing Chemoembolic Agents For The Delivery Of Anti-Cancer Agents

Номер патента: US20210060037A1. Автор: Cappello Joseph,JENSEN Mark Martin,GHANDEHARI Hamid,Poursaid Azadeh. Владелец: . Дата публикации: 2021-03-04.

ANTI-CANCER AGENT FOR USE IN COMBINATION THERAPY OF HIGH INTENSITY FOCUSED ULTRASOUND THERAPY AND ANTI-CANCER AGENT THERAPY

Номер патента: US20170258716A1. Автор: Okamoto Jun,Maeda Masanori,Iseki Hiroshi,MURAGAKI Yoshihiro. Владелец: . Дата публикации: 2017-09-14.

METHODS FOR PRODUCING CHEMOEMBOLIC AGENTS FOR THE DELIVERY OF ANTI-CANCER AGENTS

Номер патента: US20180353522A1. Автор: Cappello Joseph,JENSEN Mark Martin,GHANDEHARI Hamid,Poursaid Azadeh. Владелец: UNIVERSITY OF UTAH RESEARCH FOUNDATION. Дата публикации: 2018-12-13.

Immunomodulating agent and anti-cancer agent containing monoacetyldiacylglycerol derivatives

Номер патента: KR100767701B1. Автор: 김상희. Владелец: 김상희. Дата публикации: 2007-10-18.

Micelle comprising benzimidazole-carbohydrate conjugate compound, preparation thereof and use thereof as anti-cancer agent or anti-virus agent comprising the same

Номер патента: KR102342313B1. Автор: 김정훈,송금수,김태선. Владелец: (주)바이오메트릭스 테크놀로지. Дата публикации: 2021-12-24.

COMPOSITION INTENDED FOR CARRYING ANTI-CANCER AGENT

Номер патента: RU2016132461A. Автор: Каролин РОБИК,Жан-Франсуа МАЙЕР. Владелец: Гербе. Дата публикации: 2018-02-08.

Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents

Номер патента: CA2259936C. Автор: Darryl Rideout,Xian-Ping Lu,Magnus Pfahl,Hongyue Zhang. Владелец: Galderma Research and Development SNC. Дата публикации: 2009-02-03.

A COMBINATION OF COMBRETASTATIN AND ANTI-CANCER AGENTS

Номер патента: PE20020909A1. Автор: Marie-Chistine Bissery. Владелец: AVENTIS PHARMA SA. Дата публикации: 2002-12-09.

PRODUCT INCLUDING MIKANOLIDE, DYHYDROMICANOLIDE OR ANALOGUES IN COMBINATION WITH OTHER ANTI-CANCER AGENTS FOR THERAPEUTIC USE FOR TREATMENT OF CANCER

Номер патента: RU2003137833A. Автор: Грегуар ПРЕВО,Кристоф ЛАНКО,Бенг-Поон ТЕНГ,Элен КУЛОМ,Оливье ЛЯВЕРНЬ,Грегуар ПРЕВО (FR),Бенг-Поон ТЕНГ (FR),Элен КУЛОМ (FR),Оливье ЛЯВЕРНЬ (FR),Кристоф ЛАНКО (FR). Владелец: Сосьете Де Консей Де Решерш Э Д`Аппликасьон Сьентифик (С.К.Р.А.С.) (Fr). Дата публикации: 2005-03-27.

Block copolymer for intraperitoneal administration containing anti-cancer agent, micelle preparation, and cancer therapeutic agent comprising the micelle preparation as active ingredient

Номер патента: EP2491951A1. Автор: Hiroko Mashiba,Yuichi Akatsu. Владелец: Nippon Kayaku Co Ltd. Дата публикации: 2012-08-29.

Combinations of dmxaa and other anti-cancer agents

Номер патента: EP1423105B9. Автор: William Robert Wilson,Bronwyn Gae Siim. Владелец: Cancer Research Technology LTD. Дата публикации: 2009-08-12.

Combinations of edelfosine and anti-cancer agents for treatment of cancer

Номер патента: CA2669012C. Автор: Lutz Weber,Vladimir Khazak. Владелец: Alphaptose GmbH. Дата публикации: 2017-06-20.

Anti-cancer agents comprising alkb inhibitors and alkylating agents

Номер патента: WO2004058252A2. Автор: Christopher Joseph Schofield,Luke Alexander Mcneill,Kirsty Sarah Hewitson,Imre Schlemminger,Richard William David Welford. Владелец: ISIS INNOVATION LIMITED. Дата публикации: 2004-07-15.

Combined treatment with and composition of 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents

Номер патента: US20080299113A1. Автор: Lee D. Arnold,Mark Joseph Mulvihill,Qun-Sheng Ji. Владелец: OSI Pharmaceuticals LLC. Дата публикации: 2008-12-04.

Use of bioactive fraction from cow urine distillate ('go mutra') as a bio-enhancer of anti-infective, anti-cancer agents and nutrients

Номер патента: CA2425025C. Автор: Sushil Kumar,Suman Preet Singh Khanuja,Mahendra Pandurang Darokar,Ajit Kumar Shasany,Jai Shankar Arya,Vivek Kumar Gupta,Madan Mohan Gupta,Monika Singh,Prachi Sinha,Soumya Awasthi,Subhash Chandra Gupta,Ram Kishore Verma,Sweta Agarwal,Sunil Balkrishna Mansinghka,Suresh Haribhau Dawle. Владелец: Council of Scientific and Industrial Research CSIR. Дата публикации: 2010-11-23.

Immunomoduating agent, anti-cancer agent and health food containing monoacetyldiacylglycerol derivatives

Номер патента: EP1740169B1. Автор: Sang Hee Kim. Владелец: Enzychem Lifesciences Corp. Дата публикации: 2012-09-05.

Combination mcl-1 inhibitors with anti-cancer agents

Номер патента: AU2022291381A1. Автор: Chandrasekar Venkataramani,Thomas F. KENNEY,Clinton K. MATSON. Владелец: Gilead Sciences Inc. Дата публикации: 2023-11-30.

Combination mcl-1 inhibitors with anti-cancer agents

Номер патента: EP4351564A1. Автор: Chandrasekar Venkataramani,Thomas F. KENNEY,Clinton K. MATSON. Владелец: Gilead Sciences Inc. Дата публикации: 2024-04-17.

Combination mcl-1 inhibitors with anti-cancer agents

Номер патента: CA3222269A1. Автор: Chandrasekar Venkataramani,Thomas F. KENNEY,Clinton K. MATSON. Владелец: Gilead Sciences Inc. Дата публикации: 2022-12-15.

Combination MCL-1 inhibitors with anti-cancer agents

Номер патента: US11957693B2. Автор: Chandrasekar Venkataramani,Thomas F. KENNEY,Clinton K. MATSON. Владелец: Gilead Sciences Inc. Дата публикации: 2024-04-16.

Peptide-Artesunate Conjugates as Targeted Anti-Cancer Agents

Номер патента: US20200179331A1. Автор: Maolin GUO. Владелец: University of Massachusetts UMass. Дата публикации: 2020-06-11.

Anti-cancer agents

Номер патента: WO2018115835A1. Автор: Qi Wang,Heba ALSHAKER,Shyam Srivats RASIPUR,Dmitry PSHEZHETSKIY. Владелец: UEA Enterprises Limited. Дата публикации: 2018-06-28.

Novel curcumin-antibody conjugates as anti-cancer agents

Номер патента: WO2011068894A3. Автор: Raja Krishnaswami,Probal Banerjee. Владелец: RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK. Дата публикации: 2011-10-27.

Hyaluronidase inhibitors as anti-cancer agents

Номер патента: WO2008140500A8. Автор: Vinata B Lokeshwar. Владелец: Vinata B Lokeshwar. Дата публикации: 2009-02-05.

Pharmaceutical composition comprising protein kinase c inhibitor and anti-cancer agent

Номер патента: AU627207B2. Автор: Dieter Herrmann,Elmar Bosies,Johann Hofmann,Hans Hermann Grunicke. Владелец: Boehringer Mannheim GmbH. Дата публикации: 1992-08-20.

Assay to identify anti-cancer agents

Номер патента: EP3602048B1. Автор: Angus Dalgleish,Wai LUI. Владелец: LDN Pharma Ltd. Дата публикации: 2021-09-22.

Self-assembling amphiphilic polymers as anti-cancer agents

Номер патента: US09770442B2. Автор: Anil Diwan,Ann Louise Onton,Jayant G. Tatake. Владелец: Allexcel Inc. Дата публикации: 2017-09-26.

Curcumin-antibody conjugates as anti-cancer agents

Номер патента: US09446145B2. Автор: Raja Krishnaswami,Probal Banerjee. Владелец: Research Foundation Of City University of New York. Дата публикации: 2016-09-20.

Anti-cancer agent delivery vehicles capable of improved loading

Номер патента: US20130004488A1. Автор: Jackie Y. Ying,Kun Liang,Motoichi Kurisawa,Joo Eun Chung,Susi Tan. Владелец: Agency for Science Technology and Research Singapore. Дата публикации: 2013-01-03.

Novel Curcumin-Antibody Conjugates as Anti-Cancer Agents

Номер патента: US20130224229A1. Автор: Banerjee Probal,Krishnaswami Raja. Владелец: RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK. Дата публикации: 2013-08-29.

SELECTIVE ANTI-CANCER AGENT EFFECTIVE FOR PREVENTION AND TREATMENT

Номер патента: US20210015803A1. Автор: HALL John L.,BELJANSKI Sylvie P.. Владелец: Molecular International Research, Inc.. Дата публикации: 2021-01-21.

Silicon nanoparticle with platinum anti-cancer agent

Номер патента: US20190022246A1. Автор: Jacob Berlin,Karen Aboody,Pengpeng CAO,Rachael MOONEY,Wafa ABIDI. Владелец: CITY OF HOPE. Дата публикации: 2019-01-24.

ANTI-CANCER AGENT

Номер патента: US20170027968A1. Автор: NAKANO Takashi,NISHIZAKI Tomoyuki. Владелец: KTN BIOTEC, INC.. Дата публикации: 2017-02-02.

Use of compositions of water/alcohol extracts of antrodia cinnamomea cut-log wood cultivated fruiting body and solid-state cultivated mycelium as auxiliaries for anti-cancer agents

Номер патента: US20210100860A1. Автор: Chin-Chung Lin,Li-Chuan Hsu,Tzung-Hsien Lai,Yun-Yu Chen,Chiu-Ping LO. Владелец: Taiwan Leader Biotech Corp. Дата публикации: 2021-04-08.

ASSAY TO IDENTIFY ANTI-CANCER AGENTS

Номер патента: US20200110070A1. Автор: Dalgleish Angus,Lui Wai. Владелец: . Дата публикации: 2020-04-09.

ENHANCER OF ANTI-TUMOR EFFECT OF ANTI-CANCER AGENT

Номер патента: US20170128487A1. Автор: Mori Masaki,Doki Yuichiro,YAMAMOTO Hirofumi,Wu Xin. Владелец: . Дата публикации: 2017-05-11.

Anti-Cancer Agents

Номер патента: US20200121807A1. Автор: WANG Qi,ALSHAKER Heba,RASIPUR Shyam Srivats,PSHEZHETSKIY Dmitry. Владелец: UEA Enterprises Limited. Дата публикации: 2020-04-23.

Fructose analogs and their combinations as anti-cancer agents

Номер патента: US20180133192A1. Автор: Jia Wei,Chen Wenlian. Владелец: . Дата публикации: 2018-05-17.

CANCER TREATMENT VIA REPOSITIONED TRICYCLIC ANTI-DEPRESSANT-LIKE DRUGS AS ANTI-CANCER AGENTS AND NEW COMBINATIONS OF SUCH DRUGS

Номер патента: US20180133208A1. Автор: CARDELLI James Allen,CIRCU Magdalena Liliana,DYKES Samantha Sarah,EL-OSTA Hazem Edmond. Владелец: Board of Supervisors of Louisiana State University and Agricultural and Mechanical College. Дата публикации: 2018-05-17.

Combination of Small Molecule CD-47 Inhibitors with Other Anti-Cancer Agents

Номер патента: US20200147054A1. Автор: SASIKUMAR POTTAYIL GOVINDAN NAIR,RAMACHANDRA MURALIDHARA,Daginakatte Girish Chandrappa,Balkudru Kiran Aithal. Владелец: AURIGENE DISCOVERY TECHNOLOGIES LIMITED. Дата публикации: 2020-05-14.

NANODROPLET COMPOSITIONS FOR THE EFFICIENT DELIVERY OF ANTI-CANCER AGENTS

Номер патента: US20190160182A1. Автор: TIEN Yang Der. Владелец: . Дата публикации: 2019-05-30.

ANTI-CANCER AGENT

Номер патента: US20210205259A1. Автор: Dillon Carolyn Therese,Carrall Judith Anne. Владелец: . Дата публикации: 2021-07-08.

Anti-Cancer Agent

Номер патента: US20150196576A1. Автор: Kawashima Takanori,Ikeda Masafumi,Esumi Hiroyasu,Chiba Shigeki,Yomoda Satoshi,Okubo Toshiki,Fuse Takafumi,Miyoshi Chika,Kadota Shigetoshi. Владелец: . Дата публикации: 2015-07-16.

Carbon nanotube-based anti-cancer agent capable of suppressing drug resistance

Номер патента: US20150196650A1. Автор: Tae Hyun Nam,Jungil Choi,Dong Woo Khang,Sang Soo Kang. Владелец: Industry Academic Cooperation Foundation of GNU. Дата публикации: 2015-07-16.

Peptide-Artesunate Conjugates as Targeted Anti-Cancer Agents

Номер патента: US20200179331A1. Автор: Guo Maolin. Владелец: . Дата публикации: 2020-06-11.

PROTEIN P8 DERIVED FROM LACTIC ACID BACTERIA AND ITS USE AS ANTI-CANCER AGENT

Номер патента: US20190201481A1. Автор: CHUNG Myung Jun. Владелец: CELL BIOTECH CO., LTD.. Дата публикации: 2019-07-04.

PLATELETS LOADED WITH ANTI-CANCER AGENTS

Номер патента: US20200206143A1. Автор: Moskowitz Keith Andrew,Jorda Rafael,Zheng Ying Yi,Sheik Daniel. Владелец: . Дата публикации: 2020-07-02.

SILK RESERVOIRS FOR SUSTAINED DELIVERY OF ANTI-CANCER AGENTS

Номер патента: US20150238617A1. Автор: Kaplan David L.,Wang Xiaoqin,Yucel Tuna,Lovett Michael. Владелец: . Дата публикации: 2015-08-27.

COVALENT IRREVERSIBLE INHIBITORS OF USP7 AS ANTI-CANCER AGENTS

Номер патента: US20180228789A1. Автор: Wang Feng,Wu Jian,KIZHAKKETHIL-GEORGE Suresh Kumar,WEINSTOCK Joseph,Kodrasov Matthew P.,Agarwal Saket. Владелец: . Дата публикации: 2018-08-16.

ANTI-CANCER AGENT COMPRISING AMINOACETONITRILE COMPOUND AS ACTIVE INGREDIENT

Номер патента: US20180243255A1. Автор: Tanaka Koji,ASTON Roger,ANDOH Nobuharu,SANPEI Osamu,TOGA Tetsuo,MORRIS David Lawson,HINO Tomokazu. Владелец: Pitney Pharmaceuticals Pty Limited. Дата публикации: 2018-08-30.

MICELLE CONTAINING EPIRUBICIN-COMPLEXED BLOCK COPOLYMER AND ANTI-CANCER AGENT, AND PHARMACEUTICAL COMPOSITION CONTAINING SAID MICELLE APPLICABLE TO TREATMENT OF CANCER, RESISTANT CANCER OR METASTATIC CANCER

Номер патента: US20170258922A1. Автор: Kataoka Kazunori,Nishiyama Nobuhiro,Miura Yutaka,FUKUSHIMA Shigeto,Kinoh Hiroaki,Cabral Horacio,Chida Tsukasa. Владелец: . Дата публикации: 2017-09-14.

CANCER TREATMENT VIA REPOSITIONED TRICYCLIC ANTI-DEPRESSANT-LIKE DRUGS AS ANTI-CANCER AGENTS AND NEW COMBINATIONS OF SUCH DRUGS

Номер патента: US20200330447A1. Автор: CARDELLI James Allen,CIRCU Magdalena Liliana,DYKES Samantha Sarah,EL-OSTA Hazem Edmond. Владелец: . Дата публикации: 2020-10-22.

DEMETHYLPENCLOMEDINE ANALOGS AND THEIR USE AS ANTI-CANCER AGENTS

Номер патента: US20160354354A1. Автор: Morgan Lee Roy. Владелец: Dekk-Tec, Inc.. Дата публикации: 2016-12-08.

ARYL IMIDAZOLES AND THEIR USE AS ANTI-CANCER AGENTS

Номер патента: US20150374669A1. Автор: LEE Yoon,HUESCA Mario,YOUNG Aiping H.,AL-QAWASMEH Raed,LOCK Lisa. Владелец: . Дата публикации: 2015-12-31.

Use of compositions of water/alcohol extracts of Antrodia cinnamomea cut-log wood cultivated fruiting body and solid-state cultivated mycelium as auxiliaries for anti-cancer agents

Номер патента: US20170368120A1. Автор: Chin-Chung Lin,Li-Chuan Hsu,Tzung-Hsien Lai,Yun-Yu Chen,Chiu Ping Lo. Владелец: Taiwan Leader Biotech Corp. Дата публикации: 2017-12-28.

PARTICLES, METHOD FOR PRODUCING PARTICLES, DRUG, METHOD FOR PRODUCING DRUG, AND ANTI-CANCER AGENT

Номер патента: US20220362401A1. Автор: Sakurai Kazuo,FUJII Shota,Doan Thi Hong Van,Nguyen Thi Mai Phuong,Nguyen Thi Van Anh,Pham Thi Thu Huong. Владелец: . Дата публикации: 2022-11-17.

STRENGTHENING ANTI-CANCER AGENTS

Номер патента: RU2011115418A. Автор: Ришар БЕЛИВО,Мишель ДЕМЕЛЕ,Кристиан ШЕ,Энтони РЕДЖИНА,Ришар БЕЛИВО (CA),Мишель ДЕМЕЛЕ (CA),Кристиан ШЕ (CA),Энтони РЕДЖИНА (CA). Владелец: Анджиокем Инк. (Ca). Дата публикации: 2012-10-27.

Anti-cancer agent

Номер патента: JPWO2019131794A1. Автор: 啓之清宮,稔吉田,吉田　稔,陽子八代田,由起子村松,文幸白井,鷲塚　健一,健一鷲塚. Владелец: Yakult Honsha Co Ltd. Дата публикации: 2020-12-24.

COMBINATION OF ANTI-CANCER AGENTS

Номер патента: RU2010139840A. Автор: Луиджи ЛЕНАЗ,Гуру РЕДДИ,Гуру РЕДДИ (US),Луиджи ЛЕНАЗ (US). Владелец: Спектрум Фармасьютикалз, Инк. (Us). Дата публикации: 2012-04-10.

Composition for Enhancing Sensitivity to Anti-cancer agent Comprising of ZMYM2

Номер патента: KR101542654B1. Автор: 남순우. Владелец: 가톨릭대학교 산학협력단. Дата публикации: 2015-08-06.

Composition for preventing or treating cancer comprising anti-cancer agents and nonsteroidal antiinflammatory drugs

Номер патента: KR102000834B1. Автор: 이병훈,박승현. Владелец: 서울대학교산학협력단. Дата публикации: 2019-07-16.

Erlotinib dichloroacetate and anti-cancer agent comprising the same

Номер патента: KR101208956B1. Автор: 김준우,권혁진,김경수,박영준,유기원,송현남,김동연,조경석. Владелец: 주식회사 셀트리온제약. Дата публикации: 2012-12-06.

Combinations of dmxaa and other anti-cancer agents

Номер патента: WO2003020259A2. Автор: William Robert Wilson,Bronwyn Gae Siim. Владелец: Cancer Research Technology Limited. Дата публикации: 2003-03-13.

Anti-cancer agent

Номер патента: WO2020158840A1. Автор: 泰斗西野,菜月深澤. Владелец: 日産化学株式会社. Дата публикации: 2020-08-06.

Marker for determination of sensitivity to anti-cancer agent

Номер патента: CA2712966A1. Автор: Mitsuhiro Watanabe,Takeshi Matsuzaki,Shinji Sugimoto,Yusuke Tanigawara,Eri Arita,Akito Nishimuta,Yasuko Yamayoshi. Владелец: Yasuko Yamayoshi. Дата публикации: 2009-08-06.

New use of heyneanol a as anti-cancer agent and extracting method of heyneanol a from the root of vitis amurensis

Номер патента: KR100597839B1. Автор: 이수진,김성훈,이은옥. Владелец: 학교법인 경희대학교. Дата публикации: 2006-07-07.

USE OF RILUZOLE FOR TREATING OR PREVENTING ADVERSE EFFECTS OF ANTI-CANCER AGENTS

Номер патента: FR2957077B1. Автор: Alain Eschalier,Michel Lazdunski,Jerome Busserolles,Abdelkrim Alloui. Владелец: Université Clermont Auvergne. Дата публикации: 2012-04-13.

PRODUCT COMPRISING MIKANOLIDE, DIHYDROMIKANOLIDE OR AN ANALOGUE THEREOF IN ASSOCIATION WITH ANOTHER ANTI-CANCER AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF CANCER

Номер патента: FR2825278A1. Автор: Beng Poon Teng,Gregoire Prevost,Olivier Lavergne,Christophe Lanco,Helene Coulomb. Владелец: Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS. Дата публикации: 2002-12-06.

Treatment of carcinomas using squalamine in combination with other anti-cancer agents

Номер патента: CA2252584A1. Автор: Michael Zasloff,Jon Williams. Владелец: Genaera Corporation. Дата публикации: 1997-11-06.

Composition for enhancing sensitivity to anti-cancer agent targeting epidermal growth factor receptor of non-small cell lung cancer

Номер патента: WO2019172681A1. Автор: 이지연,김재환,김다솜. Владелец: 고려대학교 산학협력단. Дата публикации: 2019-09-12.

Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment

Номер патента: CA2448528A1. Автор: Gregoire Prevost,Olivier Lavergne,Christophe Lanco,Helene Coulomb,Beng-Poon Teng. Владелец: Individual. Дата публикации: 2002-12-05.

Farnesyl protein transferase inhibitor combinations with further anti-cancer agents

Номер патента: CA2397448A1. Автор: Ivan David Horak,Peter Albert Palmer. Владелец: Individual. Дата публикации: 2001-09-07.

Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment

Номер патента: WO2002096348A2. Автор: Gregoire Prevost,Olivier Lavergne,Christophe Lanco,Helene Coulomb,Beng-Poon Teng. Владелец: Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.). Дата публикации: 2002-12-05.

THERAPEUTIC USE OF AT LEAST ONE BOTULINUM NEUROTOXIN IN THE TREATMENT OF PAIN INDUCED BY AT LEAST ONE ANTI-CANCER AGENT

Номер патента: FR2907680B1. Автор: De Lassauniere Pierre Etienne Chabrier,Michel Didier Auguet,Christine Favre. Владелец: Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS. Дата публикации: 2012-12-28.

USE OF RILUZOLE FOR TREATING OR PREVENTING ADVERSE EFFECTS OF ANTI-CANCER AGENTS

Номер патента: FR2957077A1. Автор: Alain Eschalier,Michel Lazdunski,Jerome Busserolles,Abdelkrim Alloui. Владелец: Université Clermont Auvergne. Дата публикации: 2011-09-09.

Anti-cancer agents derived from fertilized incubated shell eggs

Номер патента: CA2197050A1. Автор: Morton P. Shulman. Владелец: MPS Corp. Дата публикации: 1998-08-07.

Methods for screening anti-cancer agents inhibiting interactions between MRS and CDK4

Номер патента: KR101771070B1. Автор: 이진영,김성훈,권남훈. Владелец: 재단법인 의약바이오컨버젼스연구단. Дата публикации: 2017-08-24.

Method for augmenting the antitumor activity of anti-cancer agents

Номер патента: CN1787814A. Автор: Y·M·拉斯特姆,曹寿松,F·杜拉尼. Владелец: Health Research Inc. Дата публикации: 2006-06-14.

Inhibitors of farnesyl protein transferase as anti-cancer agents

Номер патента: GB2261374A. Автор: Claude Dufresne,Frank L Vanmiddlesworth,Kenneth E Wilson. Владелец: Merck and Co Inc. Дата публикации: 1993-05-19.

Conjugate of Cell Penetrating Peptides-Anti-cancer Agent and Composition Comprising the Same

Номер патента: KR20160064726A. Автор: 유재훈,현순실,이연. Владелец: 서울대학교산학협력단. Дата публикации: 2016-06-08.

Use in anti-cancer agent of bis-2-ethylhexyl phthalate

Номер патента: KR101000083B1. Автор: 김수진,이미혜,홍성원,구본성,이영한,정유훈,이창묵,윤상홍,여윤수,강경래,임융호,신순영,안중훈,용연중. Владелец: 건국대학교 산학협력단. Дата публикации: 2010-12-09.

Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents

Номер патента: CN1230111A. Автор: M·普法尔,X·P·卢,D·里德奥特,H·Y·张. Владелец: Galderma Research and Development SNC. Дата публикации: 1999-09-29.

Compositions comprising a combination of diphenyl ura IMPDH inhibitors and apoptosis-inducing anti-cancer agents

Номер патента: AU2003298868A1. Автор: Robert J. Fram,Jugnu Jain-Pandey. Владелец: Vertex Pharmaceuticals Inc. Дата публикации: 2004-06-30.

Compositions and methods for delivery of anti-cancer agents

Номер патента: EP2131849B1. Автор: John Barnard Bremner,Philip Clingan,Julie Myree Locke. Владелец: University of Wollongong. Дата публикации: 2011-10-26.

Enhancer of anti-tumor effect of anti-cancer agent

Номер патента: EP3108890A1. Автор: Masaki Mori,Hirofumi Yamamoto,Yuichiro Doki,Xin Wu. Владелец: Individual. Дата публикации: 2016-12-28.

Anti cancer agent and method of treatment of cancer

Номер патента: CA2385252A1. Автор: John Alexander Edgar. Владелец: Individual. Дата публикации: 2001-04-05.

Combinations of dmxaa and other anti-cancer agents

Номер патента: IL160178A0. Автор: . Владелец: Cancer Rec Tech Ltd. Дата публикации: 2004-07-25.

Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents

Номер патента: EP0920312B1. Автор: Darryl Rideout,Xian-Ping Lu,Magnus Pfahl,Hongyue Zhang. Владелец: Galderma Research and Development SNC. Дата публикации: 2004-12-08.

Enhancer of anti-tumor effect of anti-cancer agent

Номер патента: EP3108890B1. Автор: Masaki Mori,Hirofumi Yamamoto,Yuichiro Doki,Xin Wu. Владелец: Individual. Дата публикации: 2022-12-28.

USE OF SIMALIKALACTONE E AS ANTI-CANCER AGENT

Номер патента: FR2970415A1. Автор: Valerie Jullian,Eric Deharo,Genevieve Marie Anne Bourdy,Patrick Andre Denis Auberger,Guillaume Jean Pierre Robert. Владелец: Institut de Recherche pour le Developpement IRD. Дата публикации: 2012-07-20.

CONJUGATES FATTY ACID-ANTI-CANCER AGENT AND THEIR APPLICATION

Номер патента: RU2001127313A. Автор: Марк ФИШЕР,Найджел Л. ВЕББ,Мэттьюз О. БРЭДЛИ,Форрест ЭНТОНИ,Найджел Л. ВЕББ (US),Мэттьюз О. БРЭДЛИ (US),Форрест ЭНТОНИ (US),Марк ФИШЕР (US). Владелец: Протарга, Инк. (Us). Дата публикации: 2003-09-20.

Use of compositions of water/alcohol extracts of Antrodia cinnamomea cut-log cultivated fruiting body and solid-state cultivated mycelium as auxiliaries for anti-cancer agents

Номер патента: TW201808316A. Автор: 林進忠,駱秋萍,陳韻伃,賴宗賢,許力川. Владелец: 台灣利得生物科技股份有限公司. Дата публикации: 2018-03-16.

Compositions and methods for delivery of anti-cancer agents

Номер патента: CN101657203A. Автор: J·B·布雷姆纳,P·克林甘,J·M·洛克. Владелец: University of Wollongong. Дата публикации: 2010-02-24.

Betulinol derivatives as anti-cancer agents

Номер патента: WO2006031756A3. Автор: Brij B Saxena,Premila Rathnam. Владелец: Cornell Res Foundation Inc. Дата публикации: 2007-02-08.

Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents

Номер патента: CA2259936A1. Автор: Darryl Rideout,Xian-Ping Lu,Magnus Pfahl,Hongyue Zhang. Владелец: Centre International de Recherches Dermatologiques Galderma. Дата публикации: 1998-01-15.

Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents

Номер патента: IL127946A0. Автор: . Владелец: Cird Galderma. Дата публикации: 2000-02-17.

Marker for determination of sensitivity to anti-cancer agent

Номер патента: CN101932939B. Автор: 松崎健,谷川原祐介,西牟田章户,渡边光博,有田惠理,山吉康子,杉本伸二. Владелец: Yakult Honsha Co Ltd. Дата публикации: 2014-01-08.

Anti-tumor aqueous solution, anti-cancer agent and method for producing them

Номер патента: JP6099277B2. Автор: 勝堀,浩之加納,健治石川,宏昌田中,水野　正明,史隆吉川,正明水野,圭吾竹田,加納　浩之,広明梶山,史内海,香江中村. Владелец: NU Eco Engineering Co Ltd. Дата публикации: 2017-03-22.

Cancer treatment via repositioned tricyclic anti-depressant-like drugs as anti-cancer agents and new combinations of such drugs

Номер патента: WO2016179481A1. Автор: James Allen CARDELLI,Magdalena Liliana CIRCU,Samantha Sarah DYKES,Hazem Edmond EL-OSTA. Владелец: EL-OSTA Hazem Edmond. Дата публикации: 2016-11-10.

Protopanaxadiol and protopanaxatriol and their use as anti-cancer agents

Номер патента: CN100441190C. Автор: 黄冬. Владелец: PanaGin Pharmaceuticals Inc. Дата публикации: 2008-12-10.

Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents

Номер патента: AU719311B2. Автор: Darryl Rideout,Xian-Ping Lu,Magnus Pfahl,Hongyue Zhang. Владелец: Centre International de Recherches Dermatologiques Galderma. Дата публикации: 2000-05-04.

Anti-cancer agent containing α-α-α-trifluorothymidine and thymidine phosphorylase inhibitor in combination

Номер патента: TW200637562A. Автор: Akira Mita,Tomohiro Emura. Владелец: Taiho Pharmaceutical Co Ltd. Дата публикации: 2006-11-01.

Anti-cancer agent and reagent for obtaining revertants.

Номер патента: DE3883696D1. Автор: Susumu Nishimura,Osamu Meiji Seika Kaish Makabe,Takashi Meiji Seika Ka Shomura,Kozo Meiji Seika Kaish Nagaoka,Nobuko National Cancer C Okada. Владелец: Meiji Seika Kaisha Ltd. Дата публикации: 1993-10-07.

Treatment of hematologic tumors and cancers with beta-lapachone, a broad spectrum anti-cancer agent

Номер патента: US20050197405A1. Автор: CHIANG Li,Youzhi Li. Владелец: Arqule Inc. Дата публикации: 2005-09-08.

Combination mcl-1 inhibitors with anti-cancer agents

Номер патента: WO2022261301A1. Автор: Chandrasekar Venkataramani,Thomas F. KENNEY,Clinton K. MATSON. Владелец: Gilead Sciences, Inc.. Дата публикации: 2022-12-15.

Nanodroplet compositions for the efficient delivery of anti-cancer agents

Номер патента: US10864280B2. Автор: Der-Yang Tien. Владелец: Individual. Дата публикации: 2020-12-15.

Anti-angiogenic activity of 2-methoxyestradiol in combination with anti-cancer agents

Номер патента: WO2007059111A2. Автор: Anthony M. Treston,William E. Fogler,Theresa M. Lavallee,Stacy M. Plum,Steven J. Strawn,Carolyn F. Sidor. Владелец: ENTREMED, INC.. Дата публикации: 2007-05-24.

Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents

Номер патента: CA2460620A1. Автор: Dong Huang,Dong Feng Qi. Владелец: Individual. Дата публикации: 2003-03-27.

Use of 4 amino-quinazolines as anti cancer agents

Номер патента: WO2004030672A1. Автор: Hans-Michael Eggenweiler,Wilfried Rautenberg,Gerhard Barnickel,Christian Sirrenberg,Rolf Gericke,Volker Eiermann,Burkhard Scharm. Владелец: Merck Patent GmBH. Дата публикации: 2004-04-15.

Composition for mitigating the side-effects of anti-cancer agents

Номер патента: GB2126084A. Автор: Hiromichi Okuda,Shigefumi Takeda,Hiroshi Masuno,Eikichi Hosoya,Masaki Aburada,Moe Matsushita,Eiko Itoh. Владелец: Tsumura Juntendo Inc. Дата публикации: 1984-03-21.

Endogenous, suramin-induced, sulfated glycosaminoglycans as anti-cancer agents in humans

Номер патента: AU7478191A. Автор: Charles E. Myers,Renato V. Larocca,Cy Aaron Stein,Michael R Cooper. Владелец: US Government. Дата публикации: 1991-10-10.

Betulinol derivatives as anti-cancer agents

Номер патента: WO2006031756A2. Автор: Brij B. Saxena,Premila Rathnam. Владелец: Cornell Research Foundation, Inc. Дата публикации: 2006-03-23.

Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities

Номер патента: CA2343133A1. Автор: Mitchell H. Sokoloff,Michael Zasloff,Jon Williams. Владелец: Individual. Дата публикации: 2000-03-23.

An anti-viral and anti-cancer agent

Номер патента: AU714011B2. Автор: Masatoshi Nakano. Владелец: Mitsui Norin Co Ltd. Дата публикации: 1999-12-16.

Product comprising a transduction inhibitor of heterotrimeric G protein signals combined with another anti-cancer agent for therapeutic use in the treatment of cancer

Номер патента: US20060074078A1. Автор: Thomas Gordon,Barry Morgan,Gregoire Prevost,Marie-Odile Lonchampt. Владелец: Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS. Дата публикации: 2006-04-06.

Combinations of dmxaa and other anti-cancer agents

Номер патента: SI1423105T1. Автор: William Robert Wilson,Bronwyn Gae Siim. Владелец: Cancer Rec Tech Ltd. Дата публикации: 2009-08-31.

Polymer-based anti-cancer agents

Номер патента: CN101432005A. Автор: 拉尔斯·布鲁斯,英格丽德·布鲁斯. Владелец: Bruce Medical Ab. Дата публикации: 2009-05-13.

PRODUCT COMPRISING A SIGNAL TRANSDUCTION INHIBITOR OF HETEROTRIMERIC PROTEINS IN ASSOCIATION WITH ANOTHER ANTI-CANCER AGENT FOR THERAPEUTIC USE IN THE TREATMENT OF CANCER

Номер патента: FR2800616B1. Автор: Thomas Gordon,Barry Morgan,Gregoire Prevost,Marie Odile Lonchampt. Владелец: Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS. Дата публикации: 2002-01-18.

NANOPARTICLE CONTAINING RAPAMYCIN AND ALBUMIN AS ANTI-CANCER AGENT

Номер патента: RU2019101632A. Автор: Патрик СООН-ШИОНГ,Нейл П. ДИСЭЙ,Вуонг ТРИЕУ. Владелец: АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи.. Дата публикации: 2020-07-22.

The decision method of sensitivity to anti-cancer agent

Номер патента: CN102597779B. Автор: 谷川原祐介,西牟田章户,鈴木哲也,杉本伸二,铃木小夜,生驹祐介. Владелец: Keio School Corp. Дата публикации: 2016-03-23.

Porphycene anti-cancer agents and treatment methods

Номер патента: US5015478A. Автор: Giulio Jori,Emanuel Vogel,Alexander D. Cross,Matthias Kocher. Владелец: Cytopharm Inc. Дата публикации: 1991-05-14.

Anti-cancer agent loaded hydrophobic bile acid conjugated hydrophilic chitosan oligosaccharide nanoparticles and preparation method thereof

Номер патента: WO2007086651A1. Автор: Su Young Chae,Jae-Woon Nah,Mi Kyeong Jang,Chang Yong Choi,Teok Rae Jung. Владелец: Teok Rae Jung. Дата публикации: 2007-08-02.

Anti-cancer agent

Номер патента: EP3085376A4. Автор: Takashi Nakano,Tomoyuki Nishizaki. Владелец: Nishizaki Bioinformation Research Institute. Дата публикации: 2017-06-21.

A DELEVERY SYSTEM OF ANTI-CANCER AGENT USING pH SENSITIVE METAL NANOPARTICLE

Номер патента: KR101196667B1. Автор: 김성지,남주택. Владелец: 포항공과대학교 산학협력단. Дата публикации: 2012-11-02.

Betulinol derivatives as anti-cancer agents

Номер патента: EP1802648A2. Автор: Brij B. Saxena,Premila Rathnam. Владелец: Cornell Research Foundation Inc. Дата публикации: 2007-07-04.

Hyaluronidase inhibitors as anti-cancer agents

Номер патента: WO2008140500A3. Автор: Vinata B Lokeshwar. Владелец: Vinata B Lokeshwar. Дата публикации: 2008-12-31.

IkB AURKC Method for screening anti-cancer agents comprising detecting interactions of IkB and AURKC

Номер патента: KR101738680B1. Автор: 김현경,정영호,한은희,김남두. Владелец: 한국기초과학지원연구원. Дата публикации: 2017-05-22.

Novel concomitant use of sulfonamide compound with anti-cancer agent

Номер патента: EP1859797A4. Автор: Naoko Hata,Taro Semba,Takashi Owa,Yoichi Ozawa. Владелец: Eisai R&D Management Co Ltd. Дата публикации: 2011-04-13.

Combinations of anti-cancer agents

Номер патента: CN100536840C. Автор: W·R·威尔逊,B·G·西姆. Владелец: Cancer Research Technology LTD. Дата публикации: 2009-09-09.

Compositions comprising a combination of diphenyl ura impdh inhibitors and apoptosis-inducing anti-cancer agents

Номер патента: WO2004052349A2. Автор: Robert J. Fram,Jugnu Jain-Pandey. Владелец: VERTEX PHARMACEUTICALS INCORPORATED. Дата публикации: 2004-06-24.

An anti-viral and anti-cancer agent from "Aspalathus Linearis"

Номер патента: EP0796620A1. Автор: Masatoshi Nakano. Владелец: Mitsui Norin Co Ltd. Дата публикации: 1997-09-24.

Use of a sterically hindered platium coordination compound in combination with a non-platium based anti-cancer agent

Номер патента: TW200637565A. Автор: Trevor Charles Stephens,Mark Peart Smith. Владелец: Anormed Inc. Дата публикации: 2006-11-01.

Adjuvant of anti-cancer agent comprising and an extract of Allium sativum L. for treating and preventing cachexia

Номер патента: KR101996184B1. Автор: 김아름,김성은,이혜진,류재하,권민선,한영은,성미경. Владелец: 숙명여자대학교산학협력단. Дата публикации: 2019-07-03.

Anti-cancer agent delivery vehicles capable of improved laoding

Номер патента: WO2011112156A1. Автор: Jackie Y. Ying,Kun Liang,Motoichi Kurisawa,Joo Eun Chung,Susi Tan. Владелец: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH. Дата публикации: 2011-09-15.

COMBINED THERAPY INCLUDING AN INDOLOPIRROLOCARBAZOLO DERIVATIVE AND ANOTHER ANTI-CANCER AGENT.

Номер патента: ITMI20030317A1. Автор: Marina Ciomei,Enrico Pesenti. Владелец: Pharmacia Italia Spa. Дата публикации: 2004-08-22.

Pharmaceutical composition comprising both streptonigrin and anti-cancer agent for preventing or treating cancer

Номер патента: WO2020106049A1. Автор: 이우진,장현철,김수열,박상재,우상명,한성식. Владелец: (주)엠디바이오랩. Дата публикации: 2020-05-28.

Rapamycin analogs as anti-cancer agents

Номер патента: US20110098241A1. Автор: Connie L. Sun,Xiaoyuan Li. Владелец: Poniard Pharmaceuticals Inc. Дата публикации: 2011-04-28.

Compounds for use as anti-cancer agents

Номер патента: WO2017052360A1. Автор: Mohamed Ashraf Ali,Chern Ein OON,Soo Choon Tan,Keng Yoon YEONG. Владелец: Universiti Sains Malaysia. Дата публикации: 2017-03-30.

Squalamine in combination with other anti-cancer agents for treating tumors

Номер патента: EP0910382B1. Автор: Michael Zasloff,Jon Williams. Владелец: Magainin Pharmaceuticals Inc. Дата публикации: 2003-06-11.

Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias

Номер патента: US20030073745A1. Автор: Darryl Rideout,Xian-Ping Lu,Magnus Pfahl,Hongyue Zhang. Владелец: Hongyue Zhang. Дата публикации: 2003-04-17.

Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents

Номер патента: US7109347B2. Автор: Torsten Hoffmann,Hans-Ulrich Demuth,Stephan von Hoersten. Владелец: PROBIODRUG AG. Дата публикации: 2006-09-19.

Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents

Номер патента: HUP9903834A3. Автор: . Владелец: Galderma Res & Dev. Дата публикации: 2001-02-28.

Cancer treatment via repositioned tricyclic anti-depressant-like drugs as anti-cancer agents and new combinations of such drugs

Номер патента: US11744827B2. Автор: James Allen CARDELLI,Magdalena Liliana CIRCU,Samantha Sarah DYKES,Hazem Edmond EL-OSTA. Владелец: Louisiana State University and Agricultural and Mechanical College. Дата публикации: 2023-09-05.

Selective anti-cancer agent effective for prevention and treatment

Номер патента: EP3773582B1. Автор: John L. Hall,Sylvie P. Beljanski. Владелец: MOLECULAR INTERNATIONAL RESEARCH Inc. Дата публикации: 2023-10-25.

Adamantyl derivatives as anti-cancer agents

Номер патента: WO2001056563A9. Автор: Darryl Rideout,Xian-Ping Lu,Magnus Pfahl,Hongyue Zhang. Владелец: Hongyue Zhang. Дата публикации: 2002-10-31.

Icaritin and desmethylicaritin as anti-cancer agents

Номер патента: US20080214844A1. Автор: Nan Zhang,Stuart K. Calderwood. Владелец: Individual. Дата публикации: 2008-09-04.

Use of isovalerylspiramycins as anti-cancer agents to inhibit metastasis

Номер патента: WO2021183725A1. Автор: Jing Cui,Zhengping Zhuang,Enhong Jiang. Владелец: Asclea Corp.. Дата публикации: 2021-09-16.

Selective anti-cancer agent effective for prevention and treatment

Номер патента: EP3773582C0. Автор: John L Hall,Sylvie P Beljanski. Владелец: Molecular International Res Inc. Дата публикации: 2023-10-25.

Use of isovalerylspiramycins as anti-cancer agents to inhibit metastasis

Номер патента: US20210283159A1. Автор: Jing Cui,Zhengping Zhuang,Enhong Jiang. Владелец: United States, REPRESENTED BY SECRETARY Dept Of Health And Human Svcs AS. Дата публикации: 2021-09-16.

Novel Curcumin-Antibody Conjugates as Anti-Cancer Agents

Номер патента: US20130224229A1. Автор: Raja Krishnaswami,Probal Banerjee. Владелец: Research Foundation Of City University of New York. Дата публикации: 2013-08-29.

Anti-cancer agents

Номер патента: EP3558295A1. Автор: Qi Wang,Heba ALSHAKER,Shyam Srivats RASIPUR,Dmitry PSHEZHETSKIY. Владелец: UEA Enterprises Ltd. Дата публикации: 2019-10-30.

Anti Cancer Agents

Номер патента: GB201621692D0. Автор: . Владелец: UEA Enterprises Ltd. Дата публикации: 2017-02-01.

COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT

Номер патента: US20150051256A1. Автор: Kitamoto Naomi. Владелец: Takeda Pharmaceutical Company Limited. Дата публикации: 2015-02-19.

NITROBENZYL DERIVATIVES OF ANTI-CANCER AGENTS

Номер патента: US20180086693A1. Автор: Matteucci Mark,Duan Jian-Xin,Jiao Hailong,Cao Yeyu,Cai Xiaohong,Ma Jing Yuan. Владелец: OBI Pharma, Inc.. Дата публикации: 2018-03-29.

POLYCYCLIC CARBOGENIC MOLECULES AND USES THEREOF AS ANTI-CANCER AGENTS

Номер патента: US20220267241A1. Автор: Thomson Regan J.,Robinson Emily E.. Владелец: . Дата публикации: 2022-08-25.

Polycyclic carbogenic molecules and uses thereof as anti-cancer agents

Номер патента: US20190127306A1. Автор: Regan James Thomson,Emily E. Robinson. Владелец: Northwestern University. Дата публикации: 2019-05-02.

Polycyclic carbogenic molecules and uses thereof as anti-cancer agents

Номер патента: US20190127306A1. Автор: Regan James Thomson,Emily E. Robinson. Владелец: Northwestern University. Дата публикации: 2019-05-02.

Polycyclic carbogenic molecules and uses thereof as anti-cancer agents

Номер патента: US20220267241A1. Автор: Regan J. Thomson,Emily E. Robinson. Владелец: Northwestern University. Дата публикации: 2022-08-25.

Polycyclic carbogenic molecules and uses thereof as anti-cancer agents

Номер патента: US11286226B2. Автор: Regan James Thomson,Emily E. Robinson. Владелец: Northwestern University. Дата публикации: 2022-03-29.

Polycyclic carbogenic molecules and uses thereof as anti-cancer agents

Номер патента: US11987546B2. Автор: Regan J. Thomson,Emily E. Robinson. Владелец: Northwestern University. Дата публикации: 2024-05-21.

Novel process for preparing 4-substituted-1h-pyrrole-3-carboxylic acid ester

Номер патента: AU3612501A. Автор: Hyun Ik Shin,Jay Hyok Chang,Kyoo Woong Lee,Sung Tak Oh. Владелец: LG Chemical Co Ltd. Дата публикации: 2001-09-03.

Novel process for preparing 4-substituted-1h-pyrrole-3-carboxylic acid ester

Номер патента: EP1257534A1. Автор: Hyun Ik Shin,Jay Hyok Chang,Kyoo Woong Lee,Sung Tak Oh. Владелец: LG Chem Investment Co Ltd. Дата публикации: 2002-11-20.

Novel process for preparing 4-substituted-1h-pyrrole-3-carboxylic acid ester

Номер патента: EP1257534A4. Автор: Hyun Ik Shin,Jay Hyok Chang,Kyoo Woong Lee,Sung Tak Oh. Владелец: LG Chem Investment Co Ltd. Дата публикации: 2003-04-02.

Novel process for preparing 4-substituted-1h-pyrrole-3-carboxylic acid ester

Номер патента: WO2001062727A1. Автор: Hyun Ik Shin,Jay Hyok Chang,Kyoo Woong Lee,Sung Tak Oh. Владелец: Lg Chem Investment Ltd.. Дата публикации: 2001-08-30.

Aziridinylquinolinedione derivatives and process for their preparation

Номер патента: WO2002034742A1. Автор: Dong-Jin Kim,Sang-Woo Park,Dong-Chan Kim,Kyung-Ho YOO,Kye-Jung Shin. Владелец: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY. Дата публикации: 2002-05-02.

N-substituted piperazinylurea derivative useful as an anti-cancer agent and process for preparing same

Номер патента: KR20010112841A. Автор: 박미선,황선경,윤병훈,김중영,오성수,오철민,송경옥. Владелец: 샤콘느엔에스아이(주). Дата публикации: 2001-12-22.

Process for producing indolopyrrolocarbazole derivative

Номер патента: EP1754711A1. Автор: Toshiaki Mase,Takehiko Iida,Akihiro Takezawa,Shouichi Hiraga. Владелец: Banyu Phamaceutical Co Ltd. Дата публикации: 2007-02-21.

Improved process for the preparation of 7-(morpholinyl)-2-(n-piperazinyl)methylthieno[2, 3-c]pyridine derivatives

Номер патента: CA3216161A1. Автор: VENKAIAH CHOWDARY Nannapaneni,AMALA Kompella,PULLA REDDY Muddasani,Tirumala Reddy LANKI REDDY,Narmada PESARU,Kameswara Rao VAGICHERLA. Владелец: Natco Pharma Ltd. Дата публикации: 2022-10-27.

COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT

Номер патента: US20130345304A1. Автор: Kitamoto Naomi. Владелец: Takeda Pharmaceutical Company Limited. Дата публикации: 2013-12-26.

Chemical Compound for Inhibition of SHP2 Function and for Use as an Anti-Cancer Agent

Номер патента: US20170166510A1. Автор: Agazie Yehenew,Hartman Zachary. Владелец: . Дата публикации: 2017-06-15.

COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT

Номер патента: US20150203464A1. Автор: Kitamoto Naomi. Владелец: Takeda Pharmaceutical Company Limited. Дата публикации: 2015-07-23.

Process for preparing exo-methylenepenam compounds

Номер патента: EP1225176A3. Автор: Hideo Tanaka,Sigeru Torii,Yutaka Otsuka Kagaku Kabushiki Kaisha KAMEYAMA,Michio Otsuka Kagaku Kabushiki Kaisha Sasaoka. Владелец: Otsuka Chemical Co Ltd. Дата публикации: 2002-08-07.

Method for synthesizing an anti-cancer compound through a one-pot reaction

Номер патента: WO2023111869A1. Автор: Nasim Batooie,Mohammad Mehdi Khodaei,Kiumars Bahrami,Seyyed Shahram Miraghaee. Владелец: Seyyed Shahram Miraghaee. Дата публикации: 2023-06-22.

C5, C6 SUBSTITUTED AND/OR FUSED OXINDOLES AS ANTI-CANCER AGENTS AND PROCESS FOR PREPARATION THEREOF

Номер патента: US20180127365A1. Автор: KOTAMRAJU Srigiridhar,CHADA Raji Reddy,Karnewar Santosh,Bathini Nagendra Babu,Atulya Nagarsenkar,Singampalli Anuradha. Владелец: . Дата публикации: 2018-05-10.

Improved process for the preparation of 7-(morpholinyl)-2-(n-piperazinyl)methylthieno[2, 3-c]pyridine derivatives

Номер патента: AU2022260846A1. Автор: VENKAIAH CHOWDARY Nannapaneni,AMALA Kompella,PULLA REDDY Muddasani,Tirumala Reddy LANKI REDDY,Narmada PESARU,Kameswara Rao VAGICHERLA. Владелец: Natco Pharma Ltd. Дата публикации: 2023-11-16.

Improved process for the preparation of 7-(morpholinyl)-2-(n-piperazinyl)methylthieno[2, 3-c]pyridine derivatives

Номер патента: EP4326276A1. Автор: VENKAIAH CHOWDARY Nannapaneni,AMALA Kompella,PULLA REDDY Muddasani,Tirumala Reddy LANKI REDDY,Narmada PESARU,Kameswara Rao VAGICHERLA. Владелец: Natco Pharma Ltd. Дата публикации: 2024-02-28.

Improved process for the preparation of 7-(morpholinyl)-2-(n-piperazinyl)methylthieno[2, 3-c]pyridine derivatives

Номер патента: US20240199637A1. Автор: VENKAIAH CHOWDARY Nannapaneni,AMALA Kompella,PULLA REDDY Muddasani,Tirumala Reddy LANKI REDDY,Narmada PESARU,Kameswara Rao VAGICHERLA. Владелец: Natco Pharma Ltd. Дата публикации: 2024-06-20.

Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-b]pyrazin-3-one derivatives

Номер патента: US10100053B2. Автор: Dan Niculescu-Duvaz,Alfonso Zambon,Caroline Joy Springer,Richard Chubb. Владелец: Institute of Cancer Research. Дата публикации: 2018-10-16.

Model system for identifying anti-cancer agents

Номер патента: US20080268438A1. Автор: Vladimir S. SPIEGELMAN,Neehar BHATIA. Владелец: WISCONSIN ALUMNI RESEARCH FOUNDATION. Дата публикации: 2008-10-30.

Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents

Номер патента: DE3069468D1. Автор: Alan Hilary Calvert,Terence Richard Jones,Kenneth Reginald Harrap. Владелец: National Research Development Corp UK. Дата публикации: 1984-11-22.

Straight-chain and branched-chain lipid compounds as selective inhibitors of cyclooxygenase-2, anti-inflammatory agents, and anti-cancer agents

Номер патента: WO2005014528A1. Автор: Zhenhua Yang. Владелец: Zhenhua Yang. Дата публикации: 2005-02-17.

PROPHYLACTIC OR THERAPEUTIC AGENT FOR A PERIPHERAL NERVE DISORDER INDUCED BY ANTI-CANCER AGENTS

Номер патента: US20130296425A1. Автор: OKADA Tomoyuki,Naiki Mitsuru,Iinuma Munekazu,Sawada Kazuyoshi,Furukawa Shoei,Matsumoto Tomonori. Владелец: . Дата публикации: 2013-11-07.

SELECTIVE BCRP/ABCG2 TRANSPORTER INHIBITORS AS AGENTS TO ABOLISH RESISTANCE TO ANTI-CANCER AGENTS

Номер патента: US20220267289A1. Автор: BOUMENDJEL Ahcène,FALSON Pierre,MORENO Alexis,PERES Basile,ROUSSEL Emile. Владелец: . Дата публикации: 2022-08-25.

Highly selective anti-cancer agents targeting non-small cell lung cancer and other forms of cancer

Номер патента: US09862692B2. Автор: William Taylor,Viranga Tillekeratne,Sara Fedorka. Владелец: UNIVERSITY OF TOLEDO. Дата публикации: 2018-01-09.

Polyamine transporter selective compounds as anti-cancer agents

Номер патента: US09598351B2. Автор: Otto Phanstiel, Iv. Владелец: University of Central Florida Research Foundation Inc UCFRF. Дата публикации: 2017-03-21.

Novel Anti-Cancer Agents

Номер патента: US20130261119A1. Автор: WITCHARD Helen,Burgess Antony Wilks,WATSON KEITH GEOFFREY,Walker Francesca,Lessene Guillaume. Владелец: The Walter and Eliza Hall Institute of Medical Research. Дата публикации: 2013-10-03.

NO-RELEASING NONOATE(NITROGEN-BOUND)SULFONAMIDE-LINKED-COXIB ANTI-CANCER AGENTS

Номер патента: US20140018544A1. Автор: MARTINEZ Eduardo J.,Boehm Terri L.,Talley John J.,Jerome Kevin D.. Владелец: . Дата публикации: 2014-01-16.

POLYAMINE TRANSPORTER SELECTIVE COMPOUNDS AS ANTI CANCER AGENTS

Номер патента: US20140057989A1. Автор: Phanstiel,IV Otto. Владелец: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.. Дата публикации: 2014-02-27.

Highly Selective Anti-Cancer Agents Targeting Non-Small Cell Lung Cancer and Other Forms of Cancer

Номер патента: US20180009772A1. Автор: William Taylor,Viranga Tillekeratne,Sara Fedorka. Владелец: UNIVERSITY OF TOLEDO. Дата публикации: 2018-01-11.

Highly Selective Anti-Cancer Agents Targeting Non-Small Cell Lung Cancer and Other Forms of Cancer

Номер патента: US20190023671A1. Автор: Taylor William,Tillekeratne Viranga,Fedorka Sara. Владелец: The University of Toledo. Дата публикации: 2019-01-24.

Novel Anti-Cancer Agents

Номер патента: US20150045365A1. Автор: WITCHARD Helen,Burgess Antony Wilks,WATSON KEITH GEOFFREY,Walker Francesca,Lessene Guillaume. Владелец: . Дата публикации: 2015-02-12.

Polyamine Transporter Selective Compounds as Anti-Cancer Agents

Номер патента: US20160075633A1. Автор: Phanstiel,IV Otto. Владелец: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.. Дата публикации: 2016-03-17.

Novel Anti-Cancer Agents

Номер патента: US20160145243A1. Автор: WITCHARD Helen,Burgess Antony Wilks,WATSON KEITH GEOFFREY,Walker Francesca,Lessene Guillaume. Владелец: . Дата публикации: 2016-05-26.

FUNCTIONALISED AND SUBSTITUTED CARBAZOLES AS ANTI-CANCER AGENTS

Номер патента: US20170158636A1. Автор: Heaton Andrew,James Ian,Dixon Ian,Eiffe Eleanor,Gunning Peter. Владелец: . Дата публикации: 2017-06-08.

FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS

Номер патента: US20170166555A1. Автор: Zeng Jun,James Ian,Feutrill John,Cuzzupe Anthony,Dixon Ian,Gunning Peter,Treutlein Herbert,Nero Tracy. Владелец: . Дата публикации: 2017-06-15.

HETEROCYCLIC CONSTRAINED TRICYCLIC SULFONAMIDES AS ANTI-CANCER AGENTS

Номер патента: US20180251456A1. Автор: OHLMEYER Michael,ZAWARE Nilesh. Владелец: ICHAN SCHOOL OF MEDICINE AT MOUNT SINAI. Дата публикации: 2018-09-06.

HDAC Inhibitors as Anti-Cancer Agents

Номер патента: US20150329560A1. Автор: Almaliti Jehad,Bhansali Pravin,Tillekeratne L. M. Viranga,Al-Hamashi Ayad. Владелец: The University of Toledo. Дата публикации: 2015-11-19.

Highly Selective Anti-Cancer Agents Targeting Non-Small Cell Lung Cancer and Other Forms of Cancer

Номер патента: US20150344448A1. Автор: Taylor William,Tillekeratne Viranga,Fedorka Sara. Владелец: The University of Toledo. Дата публикации: 2015-12-03.

Pyrazolyl derivatives useful as anti-cancer agents

Номер патента: US20220363670A1. Автор: VAUPEL Andrea,LIU Bo,Rigollier Pascal,MACHAUER Rainer,Leblanc Catherine,MAH Robert,STUTZ Stefan,COTESTA Simona,Schneider Nadine,Gerspacher Marc,WILCKEN Rainer,Lorthiois Edwige Liliane Jeanne,Mura Christophe,Warin Nicolas. Владелец: . Дата публикации: 2022-11-17.

Dibenzo[c]chromen-6-one derivatives as anti-cancer agents

Номер патента: CA2438713C. Автор: Shuguang Zhu,John Whelan,Natalie Lazarowych,Julie Mercure,Peter Redden,Jonathan Martin Schmidt. Владелец: Paloma Pharmaceuticals Inc. Дата публикации: 2011-04-26.

Novel 1-(N-substituted carbamoyl)-5-fluorouracil derivatives and anti-cancer agents in which they are present as active constituents

Номер патента: DE3347795A1. Автор: Shoichiro Ozaki,Tomonori Matsuyama Ehime Hoshiko,Tomio Ehime Ogasawara. Владелец: Individual. Дата публикации: 1985-08-01.

METHOD FOR PRODUCING ANTHRAPYRAZOLONE ANTI-CANCER AGENTS AND INTERMEDIATE PRODUCTS

Номер патента: DE69414706D1. Автор: Lin-Hua Zhang,Joseph Auerbach. Владелец: DuPont Merck Pharmaceutical Co. Дата публикации: 1998-12-24.

Anti-cancer agents

Номер патента: US9873699B1. Автор: Raju Suresh Kumar,Periasamy Vaiyapuri Subbarayan,Natarajan Arumugam,Abdulrahman I. Almansour,Ali Abdullah Alshatwi,Jegan Athinarayanan. Владелец: KING SAUD UNIVERSITY. Дата публикации: 2018-01-23.

Novel 1-(N-substituted carbamoyl)-5-fluorouracil derivatives and anti-cancer agents which contain them as active constituents

Номер патента: DE3301107A1. Автор: Shoichiro Ozaki,Tomonori Hoshiko,Tomio Ehime Ogasawara. Владелец: Individual. Дата публикации: 1984-07-19.

Alkyl ketones as potent anti-cancer agents

Номер патента: US6251882B1. Автор: Fatih M. Uckun,Rama Krishna Narla,David Alan Perry. Владелец: Parker Hughes Institute. Дата публикации: 2001-06-26.

Highly Selective Anti-Cancer Agents Targeting Non-Small Cell Lung Cancer and Other Forms of Cancer

Номер патента: US20190023671A1. Автор: William Taylor,Viranga Tillekeratne,Sara Fedorka. Владелец: UNIVERSITY OF TOLEDO. Дата публикации: 2019-01-24.

Highly Selective Anti-Cancer Agents Targeting Non-Small Cell Lung Cancer and Other Forms of Cancer

Номер патента: US20150344448A1. Автор: William Taylor,Viranga Tillekeratne,Sara Fedorka. Владелец: UNIVERSITY OF TOLEDO. Дата публикации: 2015-12-03.

Highly Selective Anti-Cancer Agents Targeting Non-Small Cell Lung Cancer and Other Forms of Cancer

Highly selective anti-cancer agents targeting non-small cell lung cancer and other forms of cancer

Номер патента: US10138216B2. Автор: William Taylor,Viranga Tillekeratne,Sara Fedorka. Владелец: UNIVERSITY OF TOLEDO. Дата публикации: 2018-11-27.

methods to determine the level or state of activation of an oncogenic fusion protein, to optimize therapy and / or to reduce toxicity in a subject having cancer, to select an appropriate anti-cancer drug for the treatment of a cancer, to identify the response of a cancer to treatment with a cancer drug, to identify the response of a cancer to treatment with an anti-cancer drug, to predict the response of a subject having cancer to treatment with an anti-cancer drug, and to determine whether a subject having cancer is resistant to treatment with an anti-cancer drug.

Номер патента: BR112012009296A2. Автор: Xinjun Liu,Sharat Singn. Владелец: Prometheus Laboratories Inc.. Дата публикации: 2021-02-02.

Process for producing 5-fluorouracil riboside and 6-mercaptopurine riboside

Номер патента: US3650897A. Автор: Kiyoshi Nakayama,Toshio Komuro,Takashi Nara,Masanaru Misawa. Владелец: Kyowa Hakko Kogyo Co Ltd. Дата публикации: 1972-03-21.

Device and method for administering an anti-cancer substance

Номер патента: US20180001014A1. Автор: Leberthon Brian J.. Владелец: . Дата публикации: 2018-01-04.

Arsenoplatin anti-cancer agents

Номер патента: US09499574B2. Автор: Thomas V. O'halloran,Denana U. Miodragovic. Владелец: Northwestern University. Дата публикации: 2016-11-22.

ARSENOPLATIN ANTI-CANCER AGENTS

Номер патента: US20170037070A1. Автор: "OHalloran Thomas V.",Miodragovic Denana U.. Владелец: . Дата публикации: 2017-02-09.

ARSENOPLATIN ANTI-CANCER AGENTS

Номер патента: US20150218195A1. Автор: "OHalloran Thomas V.",Miodragovic Denana U.. Владелец: . Дата публикации: 2015-08-06.

GOLD(III) ANTI-CANCER AGENTS

Номер патента: US20170217994A1. Автор: ALTAF Muhammad,Isab Anvarhusein A.. Владелец: KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS. Дата публикации: 2017-08-03.

ANTI-CANCER AGENT AND CANCER CELL KILLING METHOD

Номер патента: US20170240581A1. Автор: Ishikawa Yoshihiro,Eguchi Haruki. Владелец: . Дата публикации: 2017-08-24.

Ginseng saponin intestinal bacterial metabolites and anti-cancer agents containing the same as active ingredients

Номер патента: KR970061909A. Автор: 허재두,성종환,히데오 하세가와,사토시 마쯔미야,마사모리 우찌야마. Владелец: 주식회사 일 화. Дата публикации: 1997-09-12.

PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF THE CYCLE 1 3 2 OXAZA PHOSPHORIL PARTICULARLY USEFUL AS ANTI CANCER AGENTS

Номер патента: IT7969163D0. Автор: Kazuyuki Nakagawa,Tadao Sato Hiraki Ueda. Владелец: Otsuka Pharma Co Ltd. Дата публикации: 1979-11-06.

Surface-enhanced raman spectroscopic method of detecting an anti-cancer drug in a solution

Номер патента: US20240272078A1. Автор: Amir Al-Ahmed,Abdulaziz Abdulrahman AL-SAADI,Nasurullah MAHAR. Владелец: KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS. Дата публикации: 2024-08-15.

Tubulin acetylation and its associated post-translational modifications as biomarkers of response to treatment with taxol, taxanes and other microtubule stabilizing anti-cancer agents

Номер патента: WO2024010479A1. Автор: Helder José MARTINS MAIATO,Danilo DA SILVA LOPES. Владелец: I3S - Instituto De Investigação E Inovação Em Saúde, Associação. Дата публикации: 2024-01-11.

Process for the additivation of wine

Номер патента: WO2008013465A1. Автор: Carlos Rodrigues Pereira,Luis Manuel Da Costa Cabral E Gil. Владелец: Instituto Nacional De Engenharia Tecnologia E Inovacão, I.P.. Дата публикации: 2008-01-31.

Process for the additivation of wine

Номер патента: EP2046937A1. Автор: Carlos Rodrigues Pereira,Luis Manuel Da Costa Cabral E Gil. Владелец: Instituto Nacional De Engenharia Technologia E Inovacao Ip. Дата публикации: 2009-04-15.

Process for the additivation of wine

Номер патента: US20100010077A1. Автор: Carlos Rodrigues Pereira,Luis Manuel Da Costa Cabral E Gil. Владелец: Instituto Nacional de Engenharia Tecnologia E Inov. Дата публикации: 2010-01-14.

Process for preparing fluid suspensions of polysaccharide mixtures

Номер патента: CA2058326C. Автор: Teng-Shau Young. Владелец: Aqualon Co. Дата публикации: 2003-12-16.

Process for preparing fluid suspensions of polysaccharide mixtures

Номер патента: CA2058326A1. Автор: Teng-Shau Young. Владелец: Aqualon Company. Дата публикации: 1992-07-25.

A method to predict a patient's response to an anti-cancer drug from an expression level of a set of genes

Номер патента: WO2020172591A1. Автор: Aaron Goldman,Pradip K. Majumder,Padhma D. Radhakrishnan,Biswanath MAJUMDER,Saravanan Thiyagarajan. Владелец: Mitra Rxdx, Inc.. Дата публикации: 2020-08-27.

The personalized anti-cancer agent screening system and process for EGFR-TKI resistant patients using the circulating tumor cells derived on patients with the lung cancer

Номер патента: KR101876724B1. Автор: 전병희. Владелец: 주식회사 싸이토젠. Дата публикации: 2018-07-13.

Compositions and methods for screening anti-cancer agents in yeast

Номер патента: US7556929B2. Автор: Dean Dawson. Владелец: TUFTS UNIVERSITY. Дата публикации: 2009-07-07.

Compositions and methods for screening anti-cancer agents in yeast

Номер патента: US20060223101A1. Автор: Dean Dawson. Владелец: TUFTS UNIVERSITY. Дата публикации: 2006-10-05.

Method for providing information necessary for diagnosing cancer patient's resistance to anti-cancer agent and/or radiation

Номер патента: US20220276225A1. Автор: Seok Chung,Yong Hun Jung,Dong Hee Choi,Ji Hoon Yang. Владелец: Next and Bio Inc. Дата публикации: 2022-09-01.

Method for providing information necessary for diagnosing cancer patient's resistance to anti-cancer agent and/or radiation

Номер патента: EP3992629A1. Автор: Seok Chung,Yong Hun Jung,Dong Hee Choi,Ji Hoon Yang. Владелец: Next and Bio Inc. Дата публикации: 2022-05-04.

MARKER FOR PREDICTING TREATMENT RESPONSE TO ANTI-CANCER AGENT IN SOLID CANCER PATIENTS

Номер патента: US20190100806A1. Автор: Kim Tae Soo,Chung Hyun Cheol,KIM Jaeyoung,Kwon Woo Sun,Rha Sun Young,CHE Jingmin. Владелец: . Дата публикации: 2019-04-04.

Hsp90 Inhibitor-resistant cell lines and A method for screening anti-cancer agent using the same

Номер патента: KR102066929B1. Автор: 이대호,박강서,양한나. Владелец: 재단법인 아산사회복지재단. Дата публикации: 2020-01-16.

Method for searching and screening for target of anti-cancer agent using non-human animal model having nog established cancer cell line transplanted therein

Номер патента: CN102821600A. Автор: 加藤淳彦,铃木雅实,松原亨一,加藤千惠,小林慎太,陈玉昭,山崎雅辉. Владелец: PHARMALOGICALS RESEARCH Pte Ltd. Дата публикации: 2012-12-12.

Method for searching and screening for target of anti-cancer agent using non-human animal model having nog established cancer cell line transplanted therein

Номер патента: EP2517555A1. Автор: Masami Suzuki,Koichi Matsubara,Atsuhiko Kato,Shinta Kobayashi,Masaki Yamazaki,Chie Kato,Yu Jau Chen. Владелец: Pharmalogicals Res Pte Ltd. Дата публикации: 2012-10-31.

Three-dimensional cell-sheet cancer model, manufacturing method the same and method for screening anti-cancer agents using the same

Номер патента: KR102195799B1. Автор: 노종렬. Владелец: 울산대학교 산학협력단. Дата публикации: 2020-12-28.

1 A method for measuring DNA methylation using by mouse B1 element and the efficiency of anti-cancer agent thereby

Номер патента: KR100735045B1. Автор: 이수만,정경신. Владелец: 이수만. Дата публикации: 2007-07-03.

Method for assessing therapeutic effect of anti-cancer agent having anti-cd4 antibody as active ingredient

Номер патента: EP3229025B1. Автор: Satoru Ito,Shoji Yokochi,Kouji Matsushima,Yoshiro Ishiwata,Satoshi Ueha. Владелец: Idac Theranostics Inc. Дата публикации: 2019-07-17.

Customized anti-cancer agent screening method using patient-derived bodily fluid tumor cells

Номер патента: WO2017196063A1. Автор: 전병희. Владелец: 주식회사 싸이토젠. Дата публикации: 2017-11-16.

The personalized anti-cancer agent screening system using the tumor cells derived on body fluid of patients with cancer

Номер патента: KR101895207B1. Автор: 전병희. Владелец: 주식회사 싸이토젠. Дата публикации: 2018-09-07.

Marker for predicting treatment response to anti-cancer agent in solid cancer patients

Номер патента: CA3018493A1. Автор: JaeYoung Kim,Tae Soo Kim,Hyun Cheol Chung,Jingmin CHE,Sun Young Rha,Woo Sun Kwon. Владелец: Industry Academic Cooperation Foundation of Yonsei University. Дата публикации: 2017-09-28.

Method for screening of anti-cancer agent

Номер патента: WO2009104413A1. Автор: 山田哲司,下重美紀,廣橋説雄. Владелец: 財団法人ヒューマンサイエンス振興財団. Дата публикации: 2009-08-27.

Method for searching and screening for target of anti-cancer agent using non-human animal model having nog established cancer cell line transplanted therein

Номер патента: WO2011078301A1. Автор: 慎太小林,亨一松原,淳彦加藤,鈴木　雅実,加藤　千恵,ユジャウチェン,雅輝山崎. Владелец: 株式会社実験動物中央研究所. Дата публикации: 2011-06-30.

Method for screening of anti-cancer agent

Номер патента: EP2246431B1. Автор: Tesshi Yamada,Setsuo Hirohashi,Miki Shitashige. Владелец: National Cancer Center Japan. Дата публикации: 2014-12-31.

Method of determining a risk of mortality of a cancer patient, method of assessing an anti-cancer therapy, method of selecting cancer patients for treatment

Номер патента: US20230335285A1. Автор: Anna Bauer-Mehren,Dominik Ruettinger,Tim Becker. Владелец: Hoffmann La Roche Inc. Дата публикации: 2023-10-19.

Method of determining a risk of mortality of a cancer patient, method of assessing an anti-cancer therapy, method of selecting cancer patients for treatment

Номер патента: EP4158655A1. Автор: Anna Bauer-Mehren,Dominik Ruettinger,Tim Becker. Владелец: F Hoffmann La Roche AG. Дата публикации: 2023-04-05.

Method of determining a risk of mortality of a cancer patient, method of assessing an anti-cancer therapy, method of selecting cancer patients for treatment

Номер патента: WO2021239816A1. Автор: Anna Bauer-Mehren,Dominik Ruettinger,Tim Becker. Владелец: F. Hoffmann-La Roche AG. Дата публикации: 2021-12-02.

Screening method for the isolation of centrosomal cluster-inhibitors as anti-cancer agents

Номер патента: WO2008014916A1. Автор: Alwin Krämer. Владелец: Deutsches Krebsforschungszentrum Stiftung des offentlichen Rechts. Дата публикации: 2008-02-07.

Screening method for the isolation of centrosomal cluster-inhibitors as anti-cancer agents

Номер патента: US20090264310A1. Автор: Alwin Krämer. Владелец: Deutsches Krebsforschungszentrum DKFZ. Дата публикации: 2009-10-22.

Screening method for the isolation of centrosomal cluster-inhibitors as anti-cancer agents

Номер патента: EP2047255A1. Автор: Alwin Krämer. Владелец: Deutsches Krebsforschungszentrum DKFZ. Дата публикации: 2009-04-15.

Screening method for the isolation of centrosomal cluster-inhibitors as anti-cancer agents

Номер патента: WO2008014916A9. Автор: Alwin Kraemer. Владелец: Alwin Kraemer. Дата публикации: 2009-02-26.

MARKER FOR DETERMINING SENSITIVITY OF IRINOTECAN-CONTAINING ANTI-CANCER AGENT THERAPY

Номер патента: US20210088522A1. Автор: Tanigawara Yusuke,Sugimoto Shinji,SASAKI Nobunari. Владелец: . Дата публикации: 2021-03-25.

METHOD FOR SCREENING PATIENT-SPECIFIC ANTI-CANCER AGENT USING LIMITING DILUTION ASSAY

Номер патента: US20150101070A1. Автор: Nam Do Hyun,Joo Kyeung Min,Choi YeonSook. Владелец: SAMSUNG LIFE PUBLIC WELFARE FOUNDATION. Дата публикации: 2015-04-09.

METHOD FOR PROVIDING INFORMATION NECESSARY FOR DIAGNOSING CANCER PATIENT'S RESISTANCE TO ANTI-CANCER AGENT AND/OR RADIATION

Номер патента: US20220276225A1. Автор: Chung Seok,YANG Ji Hoon,CHOI Dong Hee,JUNG Yong Hun. Владелец: . Дата публикации: 2022-09-01.

System for evaluating sensitivity to anti-cancer agent and a computer readable medium storing programs executing an evaluating method

Номер патента: US20220310273A1. Автор: Jung Eun Kim,Bo Sung Ku. Владелец: MBD Co Ltd. Дата публикации: 2022-09-29.

IN VITRO ASSAY SYSTEMS AND METHODS FOR IDENTIFYING ANTI-CANCER AGENTS

Номер патента: US20150212066A1. Автор: Reu Frederic J.,Vatolin Sergei. Владелец: . Дата публикации: 2015-07-30.

METHOD FOR ASSESSING THERAPEUTIC EFFECT OF ANTI-CANCER AGENT HAVING ANTI-CD4 ANTIBODY AS ACTIVE INGREDIENT

Номер патента: US20170328887A1. Автор: Ito Satoru,Matsushima Kouji,YOKOCHI Shoji,UEHA Satoshi,ISHIWATA Yoshiro. Владелец: . Дата публикации: 2017-11-16.

Methods of identifying potentially therapeutically selective and effective anti-cancer agents that are inducers of apoptosis

Номер патента: US20030027229A1. Автор: Shailaja Kasibhatla,John Drewe,P. Reddy. Владелец: Cytovia Inc. Дата публикации: 2003-02-06.

A kind of Composition analyzed device and detection method for anti-cancer agent vincristine

Номер патента: CN105866210B. Автор: 万海方,陶凡,黄丽霞. Владелец: Hangzhou Red Cross Hospital. Дата публикации: 2018-04-13.

Method for evaluating efficacy of anti-cancer agent using t-cell and macrophage

Номер патента: KR102478897B1. Автор: 이보은,김지효,김사랑. Владелец: 오가노이드사이언스 주식회사. Дата публикации: 2022-12-20.

System for evaluating sensitivity to anti-cancer agent and a computer readable medium storing programs executing an evaluating method

Номер патента: US20220310273A1. Автор: Jung Eun Kim,Bo Sung Ku. Владелец: MBD Co Ltd. Дата публикации: 2022-09-29.

Synergism and antagonism between multiple anti-cancer agents determined by mick assay

Номер патента: WO2015171848A3. Автор: Mathieu Perree,Cary Presant,Allan Hallquist. Владелец: DIATECH ONCOLOGY, LLC. Дата публикации: 2016-05-19.

Anti-cancer agent and method of formation thereof

Номер патента: MY187951A. Автор: Kamada Takashi,Santhanaraju Vairappan Charles. Владелец: Univ Malaysia Sabah. Дата публикации: 2021-10-31.

Copolymers of 2-methyl-5-vinyl-pyridine and n-vinylpyrrolidone, activating production of interleukin-1, and use thereof as anti-cancer agents

Номер патента: RU2430932C1. Автор: Станислав Анатольевич Кедик,Алексей Валерьевич Панов,Юлия Вячеславовна Черта,Максим Андреевич Зайцев. Владелец: Станислав Анатольевич Кедик. Дата публикации: 2011-10-10.

Process for preparation of 6,7-substituted quinazoline-4-one

Номер патента: MY190435A. Автор: KUMAR Ramesh,VARDHAN Anand,Sitaram Deshpande Shailesh,Prakash Dhande Premnath,Nadiah Binti Johari Hasna,Kant Belwal Chandra,Sajid Shahnawaz. Владелец: Oncogen Pharma Malaysia Sdn Bhd. Дата публикации: 2022-04-21.

COMPOUNDS FOR SUPPRESSING A PERIPHERAL NERVE DISORDER INDUCED BY AN ANTI-CANCER AGENT

Номер патента: US20130046000A1. Автор: Kitamoto Naomi. Владелец: . Дата публикации: 2013-02-21.

Extract of plant species hedyotis used as an anti-cancer tea

Номер патента: AU5213586A. Автор: John Ky. Владелец: Ky J. Дата публикации: 1987-04-09.

An anti-cancer, anti-oxidant, and liver-protected composition comprising solid culture of zang zhi

Номер патента: TWI329494B. Автор: Ming Huang Lan,Lan Chang-Chou,Lan Chung-Liang,Lan Chung-Min. Владелец: Well Shine Biotechnology Dev Co Ltd. Дата публикации: 2010-09-01.

Recombinant hybrid inhibitor of angiogenesis, and its production method

Номер патента: RU2499802C1. Автор: Владимир Николаевич Николенко,Андрей Алексеевич Свистунов,Пётр Витальевич Глыбочко,Сергей Викторович Луценко,Андрей Иванович Соловьев,Наталия Борисовна Фельдман. Владелец: Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздравсоцразвития. Дата публикации: 2013-11-27.

Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same

Номер патента: AU2002355156A1. Автор: Dong Huang,Dong Feng Qi. Владелец: PanaGin Pharmaceuticals Inc. Дата публикации: 2003-02-17.

Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment

Номер патента: AU2002313087A1. Автор: Gregoire Prevost,Olivier Lavergne,Christophe Lanco,Helene Coulomb,Beng-Poon Teng. Владелец: Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS. Дата публикации: 2002-12-09.

Anti-cancer agents

Номер патента: AU2003906633A0. Автор: . Владелец: University of Queensland UQ. Дата публикации: 2003-12-11.

Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents

Номер патента: AU2002325745A1. Автор: Dong Huang,Dong Feng Qi. Владелец: PanaGin Pharmaceuticals Inc. Дата публикации: 2003-04-01.

Anti-cancer agents

Номер патента: GB9307044D0. Автор: . Владелец: NORSK HYDRO ASA. Дата публикации: 1993-05-26.

Anti-cancer agents (IIIa)

Номер патента: GB9930188D0. Автор: . Владелец: BTG International Ltd. Дата публикации: 2000-02-09.

Anti-cancer agent

Номер патента: GB9813674D0. Автор: . Владелец: AYUKO WASHINGTON O. Дата публикации: 1998-08-26.

Anti-cancer agent

Номер патента: GB9807773D0. Автор: . Владелец: AYUKO WASHINGTON O. Дата публикации: 1998-06-10.

COMPOSITIONS AND METHODS FOR DIAGNOSIS AND PROGNOSIS OF CANCER AND PROGRESSION, AND FOR SCREENING ANTI-CANCER AGENTS

Номер патента: US20120021983A1. Автор: Iliopoulos Dimitrios,Tsichlis Philip N.,Polytarchou Christos. Владелец: . Дата публикации: 2012-01-26.

KIT AND METHOD FOR PREDICTING SENSITIVITY OF GASTRIC CANCER PATIENT TO ANTI-CANCER AGENT

Номер патента: US20120078527A1. Автор: SHIM Jeo-young,JEON Tae-han,Ahn Tae-Jin,HONG Sung-woo,KIM Myoung-soon,YOO Chang-eun,LEE Kyu-sang,Park Se-Hoon,KIM Ki-eun,KIM Jhin-gook,SOHN In-suk,JUNG Sin-ho. Владелец: SAMSUNG ELECTRONICS CO., LTD.. Дата публикации: 2012-03-29.

COMBINED TREATMENT OF CANCER BY UROKINASE INHIBITION AND A CYTOSTATIC ANTI-CANCER AGENT FOR ENHANCING THE ANTI-METASTATIC EFFECT

Номер патента: US20120165287A1. Автор: . Владелец: Wilex AG. Дата публикации: 2012-06-28.

NOVEL 4-(TETRAZOL-5-YL)-QUINAZOLINE DERIVATIVES AS ANTI CANCER AGENT

Номер патента: US20120172380A1. Автор: ADIBHATLA KALI SATYA Bhujanga Rao,Nannapaneni Venkaiah Chowdary,KONAKANCHI Durga Prasad,MUDDASANI Pulla Reddy,Pula Subba Rao,Ananthaneni Lakshmi. Владелец: NATCO PHARMA LIMITED. Дата публикации: 2012-07-05.

DEMETHYLPENCLOMEDINE ANALOGS AND THEIR USE AS ANTI-CANCER AGENTS

Номер патента: US20120177634A1. Автор: Morgan Lee Roy. Владелец: . Дата публикации: 2012-07-12.

Molecular Predictors of Therapeutic Response to Specific Anti-Cancer Agents

Номер патента: US20120214829A1. Автор: . Владелец: The Regents of the University of California. Дата публикации: 2012-08-23.

METHOD FOR DETERMINATION OF SENSITIVITY TO ANTI-CANCER AGENT

Номер патента: US20120214831A1. Автор: Tanigawara Yusuke,Suzuki Sayo,Ikoma Yusuke,Nishimuta Akito,Suzuki Tetsuya,Sugimoto Shinji. Владелец: . Дата публикации: 2012-08-23.

ANTI-CANCER AGENT

Номер патента: US20120252762A1. Автор: Oohara Nobuhiko,Nakatsui Kazuhiro. Владелец: Nippon Chemical Industrial Co., Ltd.. Дата публикации: 2012-10-04.

Indoline Anti-Cancer Agents

Номер патента: US20120264763A1. Автор: . Владелец: . Дата публикации: 2012-10-18.

IMATINIB DICHLOROACETATE AND ANTI-CANCER AGENT COMPRISING THE SAME

Номер патента: US20120295917A1. Автор: . Владелец: . Дата публикации: 2012-11-22.

METHOD FOR SEARCHING AND SCREENING FOR TARGET OF ANTI-CANCER AGENT USING NON-HUMAN ANIMAL MODEL HAVING NOG ESTABLISHED CANCER CELL LINE TRANSPLANTED THEREIN

Номер патента: US20130019327A1. Автор: Kato Chie,MATSUBARA Koichi,Suzuki Masami,YAMAZAKI Masaki,Kato Atsuhiko,Kobayashi Shinta,Chen Yu Jau. Владелец: . Дата публикации: 2013-01-17.

ANTI-CANCER AGENT

Номер патента: US20130023023A1. Автор: ONO Nobufumi. Владелец: . Дата публикации: 2013-01-24.

ANTI-CANCER AGENTS

Номер патента: US20130045949A1. Автор: Peng Xiaohua,Kuang Yunyan,Cao Sheng,Chen Wenbing,Wang Yibin. Владелец: UWM RESEARCH FOUNDATION, INC.. Дата публикации: 2013-02-21.

N-AMINOPYRROLYLMETHYLTETRAHYDROPYRIDINES AS ANTI-CANCER AGENTS

Номер патента: US20130109724A1. Автор: Redda Kinfe Ken,Gangapuram Madhavi. Владелец: Florida A&M University Board of Trustees. Дата публикации: 2013-05-02.

Anti cancer agent

Номер патента: GB0813213D0. Автор: . Владелец: University of Southampton. Дата публикации: 2008-08-27.

Piperazinone Compounds as Anti-Tumor and Anti-Cancer Agents and the Methods of Treatment

Номер патента: AU2007229363B2. Автор: Andrew D. Hamilton,Hairuo Peng,Said Sebti. Владелец: UNIVERSITY OF SOUTH FLORIDA. Дата публикации: 2009-06-04.

Anti-cancer agent-resistant inhibitor

Номер патента: JP2009018999A. Автор: Hisashi Narimatsu,Hidenobu Ando,隆司大倉,久成松,秀信安藤,Takashi Okura. Владелец: National Institute of Advanced Industrial Science and Technology AIST. Дата публикации: 2009-01-29.

Screening and structural analysis for resistant starch stimulating high yield of anti-cancer agent butyric acid by intestinal flora

Номер патента: CN103728265A. Автор: 张岩,杨艳,周忠凯,陈晓姗,郑排云. Владелец: Individual. Дата публикации: 2014-04-16.

Piperazinone Compounds as Anti-Tumor and Anti-Cancer Agents and the Methods of Treatment

Номер патента: AU2007229363A1. Автор: Andrew D. Hamilton,Hairuo Peng,Said Sebti. Владелец: UNIVERSITY OF SOUTH FLORIDA. Дата публикации: 2007-11-08.

Emulsion formulation containing anti-cancer agent

Номер патента: JPH0623095B2. Автор: 光春藤井,吉雄滝野,久之谷沢,泰之佐塚,昭伸田中,虎比古岸川. Владелец: Morishita Pharmaceuticals Co Ltd. Дата публикации: 1994-03-30.

Anti-viral and anti-cancer agent

Номер патента: CN1160552A. Автор: 中野昌俊. Владелец: Mitsui Norin Co Ltd. Дата публикации: 1997-10-01.

5-substituted quinazolinone derivatives as anti-cancer agents

Номер патента: RS56117B1. Автор: George W Muller,Hon-Wah Man. Владелец: Celgene Corp. Дата публикации: 2017-10-31.

Anti-cancer agents

Номер патента: AU2004293127A1. Автор: David Fairlie,Matthew Glenn,Pia Kahnberg. Владелец: University of Queensland UQ. Дата публикации: 2005-06-09.

Use of bioactive fraction from cow urine distillate (go mutra) as a bio-enhancer of anti-infective, anti-cancer agents and nutrients.

Номер патента: ZA200302276B. Автор: Sushil Kumar,Suman Preet Singh Khanuja,Mahendra Pandurang Darokar,Ajit Kumar Shasany,Jai Shankar Arya,Vivek Kumar Gupta,Madan Mohan Gupta,Monika Singh,Prachi Sinha,Soumya Awasthi,Subhash Chandra Gupta,Ram Kishore Verma,Sweta Agarwal,Sunil Balkrishna Mansinghka,Suresh Haribhau Dawle. Владелец: Council Scient Ind Res. Дата публикации: 2004-04-28.

New compound, application of the new compound as anti-cancer agent as well as method for obtaining the new compound

Номер патента: PL366643A1. Автор: Wojciech Rzeski,Adam Opolski,Joanna Matysiak,Andrzej Niewiadomy. Владелец: Instytut Immunologii i Terapii Doświadczalnej. Дата публикации: 2005-10-03.

Improvements in anti-hiv-1 and anti cancer agents

Номер патента: GB9125482D0. Автор: . Владелец: Individual. Дата публикации: 1992-01-29.

Improvements in anti-hiv-1 and anti-cancer agents

Номер патента: GB9009517D0. Автор: . Владелец: Individual. Дата публикации: 1990-06-20.

Improvements in anti-hiv-1 and anti-cancer agents

Номер патента: GB9019502D0. Автор: . Владелец: Individual. Дата публикации: 1990-10-24.

Anti-cancer agents

Номер патента: GB9011991D0. Автор: . Владелец: Institute of Cancer Research. Дата публикации: 1990-07-18.

HETEROCYCLICALLY SUBSTITUTED METHOXYPHENYL DERIVATIVES WITH AN OXO GROUP, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF AS MEDICAMENTS

Номер патента: US20120004165A1. Автор: Keil Stefanie,DEFOSSA Elisabeth,DIETRICH Viktoria,KLABUNDE Thomas,STENGELIN Siegfried,HASCHKE Guido,HERLING Andreas. Владелец: SANOFI. Дата публикации: 2012-01-05.

(2-ARYLOXYACETYLAMINO) PHENYLPROPIONIC ACID DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF AS MEDICAMENTS

Номер патента: US20120004167A1. Автор: Keil Stefanie,DEFOSSA Elisabeth,DIETRICH Viktoria,KLABUNDE Thomas,STENGELIN Siegfried,HASCHKE Guido,HERLING Andreas. Владелец: SANOFI. Дата публикации: 2012-01-05.

ARYLOXYALKYLENE-SUBSTITUTED HYDROXYPHENYLHEXYNOIC ACIDS, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS A MEDICAMENT

Номер патента: US20120004166A1. Автор: Keil Stefanie,DEFOSSA Elisabeth,DIETRICH Viktoria,KLABUNDE Thomas,STENGELIN Siegfried,HASCHKE Guido,HERLING Andreas. Владелец: SANOFI. Дата публикации: 2012-01-05.

SPIROCYCLICALLY SUBSTITUTED 1,3-PROPANE DIOXIDE DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND USE THEREOF AS A MEDICAMENT

Номер патента: US20120004187A1. Автор: . Владелец: SANOFI. Дата публикации: 2012-01-05.

Process for Preparing Quinoxaline Derivatives

Номер патента: US20120004239A1. Автор: SOLDEVILLA MADRID Nuria,VAZQUEZ MARTINEZ Manel. Владелец: MEDICHEM, S.A.. Дата публикации: 2012-01-05.

PROCESS FOR MANUFACTURING 5-(2--1-HYDROXYETHYL)-8-HYDROXYQUINOLIN-2(1H)-ONE

Номер патента: US20120004414A1. Автор: Marchueta Hereu Iolanda,Moyes Valls Enrique. Владелец: . Дата публикации: 2012-01-05.

Pharmaceutical composition of imatinib or its pharmaceutically acceptable salt, method for preparing it and method(s) of treating

Номер патента: RU2517216C2. Автор: Анастасия Олеговна Хрусталева,Анна Валерьевна Грязнова. Владелец: Закрытое Акционерное Общество "БИОКАД" (ЗАО "БИОКАД"). Дата публикации: 2014-05-27.

Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl) cyclopropanamine, its crystalline form and its salts

Вам могут быть интересны следующие патенты

Главная

Проекты и услуги

Контакты